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Abstract
New experiences are encoded in a fragile short-term form of memory, but with time these memories can
be converted into a stable long-term form of memory through a process known as memory consolidation.
Whereas post-translational modification of existing proteins may be sufficient for short-term memory,
creation of a long-term memory requires de novo gene expression after learning. The ability to express
genes is regulated by association of DNA with histone proteins into a chromatin complex. Chapter 1
reviews the transcriptional mechanisms involved in the memory formation, including the contribution of
chromatin modification by acetylation of histone proteins. Mutating the histone acetyltransferase CREBbinding protein (CBP) impairs long-term memory formation, and pharmacologically blocking histone
deacetylases (HDAC) enhances long-term memory formation. Memory enhancement by HDAC inhibitors
requires the interaction between the transcription factor CREB and CBP, suggesting that these two
processes converge at functionally relevant target genes. As reviewed in Chapter 2
2, the Nr4a family of
CREB target genes are potentially involved in memory formation, and the expression of Nr4a genes is
enhanced when memory is improved by HDAC inhibitor treatment. In Chapter 3
3, I combined genetic and
pharmacological approaches to discover that impeding NR4A signaling impairs memory formation and
blocks the ability of HDAC inhibitors to enhance memory. These studies were performed with the now
well-established approach of using broad-spectrum HDAC inhibitors to enhance memory in the aversive
contextual fear-conditioning task. In Chapter 4
4, I found that long-term memory for another hippocampusdependent task, object location memory, is enhanced by the class I-selective HDAC inhibitor MS-275. This
study provides a new behavioral paradigm for studying the mechanisms by which HDAC inhibitors
enhances memory, refines the relevant list of HDACs targeted for memory enhancement, and
demonstrates the utility of MS-275 as a pharmacological tool in this field. In Chapter 5
5, I examined the
genetic targets of CBP that require the interaction domain between CREB and CBP using mice with a triple
point mutation that blocks this interaction (CBPkix/kix). Using an unbiased microarray strategy, I found that
several learning-induced genes have impaired expression in CBPkix/kix mice, including a member of the
Nr4a gene family.
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ABSTRACT

INVESTIGATION OF THE ROLE OF HISTONE ACETYLATION
IN HIPPOCAMPUS-DEPENDENT MEMORY FORMATION

Joshua Davis Hawk
Ted Abel

New experiences are encoded in a fragile short-term form of memory, but with time
these memories can be converted into a stable long-term form of memory through a
process known as memory consolidation. Whereas post-translational modification of
existing proteins may be sufficient for short-term memory, creation of a long-term
memory requires de novo gene expression after learning. The ability to express genes is
regulated by association of DNA with histone proteins into a chromatin complex.
Chapter 1 reviews the transcriptional mechanisms involved in the memory formation,
including the contribution of chromatin modification by acetylation of histone proteins.
Mutating the histone acetyltransferase CREB-binding protein (CBP) impairs long-term
memory formation, and pharmacologically blocking histone deacetylases (HDAC)
enhances long-term memory formation. Memory enhancement by HDAC inhibitors
requires the interaction between the transcription factor CREB and CBP, suggesting that
these two processes converge at functionally relevant target genes. As reviewed in
Chapter 2, the Nr4a family of CREB target genes are potentially involved in memory
formation, and the expression of Nr4a genes is enhanced when memory is improved by
HDAC inhibitor treatment. In Chapter 3, I combined genetic and pharmacological
approaches to discover that impeding NR4A signaling impairs memory formation and
ii

blocks the ability of HDAC inhibitors to enhance memory. These studies were performed
with the now well-established approach of using broad-spectrum HDAC inhibitors to
enhance memory in the aversive contextual fear-conditioning task. In Chapter 4, I found
that long-term memory for another hippocampus-dependent task, object location
memory, is enhanced by the class I-selective HDAC inhibitor MS-275. This study
provides a new behavioral paradigm for studying the mechanisms by which HDAC
inhibitors enhances memory, refines the relevant list of HDACs targeted for memory
enhancement, and demonstrates the utility of MS-275 as a pharmacological tool in this
field. In Chapter 5, I examined the genetic targets of CBP that require the interaction
domain between CREB and CBP using mice with a triple point mutation that blocks this
interaction (CBPkix/kix). Using an unbiased microarray strategy, I found that several
learning-induced genes have impaired expression in CBPkix/kix mice, including a member
of the Nr4a gene family.
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Chapter 1: The Role of Gene Transcription in
Long-Term Memory Storage

Abstract. The formation of long-term memories requires the synthesis of new mRNA.
Genetic approaches over the last several decades have identified signaling transduction
mechanisms and transcription factors that guide this process and genes that have
increased expression after learning. The expression patterns of these genes are
elucidating systems- and network-level questions about learning and memory. Recent
studies suggest that the epigenetic modifications that regulate transcription are critical
for memory storage. Thus, genetic studies have demonstrated that memory formation
requires molecular processes that regulate neuronal transcription after learning and
suggest that the epigenetic modifications may store information that guides behavior.

Chapter previously published as:
J.D. Hawk, T. Abel, Role of Gene Transcription in Long-Term Memory Storage, in: G.F.
Koob, M. Le Moal, R.F. Thompson (Eds.) Encyclopedia of Behavioral Neuroscience,
Academic Press, Oxford, 2010, pp. 161-179.
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Introduction. More than one hundred years ago, the psychologists Georg Müller and
Alfons Pilzecker (1900) discovered that shortly after learning memories are unstable and
sensitive to retroactive interference from new learning, but with time these labile shortterm memories are converted into stable long-term memory through a process that
became known as consolidation. Since that time, research in organisms ranging from
sea slugs to mice has shown that this consolidation process involves the activation of
neuronal signaling cascades that result in the production of new RNA and protein. This
de novo transcription and translation after learning is a hallmark of the consolidation
process that distinguishes long-term memory from short-term memory (Davis and Squire
1984; Hernandez and Abel 2008). Our understanding of the molecular mechanisms of
memory formation has evolved considerably over the last few decades largely owing to
the development of genetic and molecular strategies to study memories, especially
those memories known to require specific neuronal circuits, such as hippocampusdependent spatial and contextual memory.

Stages of memory: acquisition, consolidation and retrieval. Long-term memory
formation proceeds through three distinct phases: acquisition, consolidation, and
retrieval (McGaugh 2000; Abel and Lattal 2001). Acquisition is the process of learning
information about the world and initially produces a labile short-term memory that can be
disrupted through interference by new learning, seizure, or inhibition of a variety of
cellular and molecular processes. Consolidation occurs with time after learning to confer
resistance to disruption, thus converting a short-term memory into a long-term memory.
Once information has been stored, it must be retrieved to guide behavior. The specific
processes that are required for the formation of long-term memory provide insight into
the mechanisms responsible for each of these phases. For instance, disruptions that
2

selectively affect long-term memory without impairing short-term memory provide
knowledge about the consolidation process. The earliest of these studies showed that
pharmacological inhibition of transcription or translation blocks long-term memory, while
leaving short-term memory intact. In the 1960s and 1970s, researchers working in
organisms ranging from goldfish to mice established that shortly after acquisition there
are windows after learning during which transcription and translation are required to
consolidate memory (Flexner et al. 1963; Agranoff et al. 1967; Squire and Barondes
1970; Squire and Barondes 1976). These early pharmacological studies have been
substantiated by genetic approaches that demonstrate a critical role of transcription
factors in memory consolidation after learning.

The hippocampus is critical for spatial and contextual memory. The pioneering
studies of Scoville and Milner (1957) first suggested that damage to medial temporal
lobes structures, especially the hippocampus, causes an inability to form new episodic
memories in humans. Since that time, experiments in rodent models have substantially
advanced our understanding of the role of the hippocampus in memory formation. Two
behavioral paradigms, contextual fear conditioning and spatial learning in the Morris
water maze (Figure 1), have been particularly useful for understanding the role of the
hippocampus in memory (Morris 1984; Maren 2001; Maren and Quirk 2004). The Morris
water maze, first developed by Richard Morris (Morris 1981), has become the archetypal
measure of spatial learning and memory. Rodents are naturally good swimmers but will
seek escape from water when placed in a pool. In the Morris water maze, this tendency
is used to motivate rodents to find an ‘escape platform’ submerged below the surface of
water that has been made opaque. With repeated training, the rodents find the platform
more quickly in a manner that depends on distal cues. Performance in this task can be
3

measured in a probe test in which the platform is removed and the search pattern of the
swimming rodent is examined for a bias toward the region that previously contained the
platform (Figure 1A). Hippocampal lesions block acquisition in this measure of spatial
memory but leave intact the ability to swim to a visible platform (Morris 1984). Because
rodents require repeated training sessions to learn the platform location, it is often
difficult to dissociate the effect of manipulations on acquisition and consolidation. The
contextual fear conditioning task provides an opportunity to disentangle these two
processes by producing a robust long-lasting memory in only a single training session
with the added benefit that the biochemical consequences of learning can be precisely
related to the time of learning. Contextual fear conditioning involves quantifying a
species-specific, stereotyped fear response, including activation of the sympathetic
nervous system and a characteristic freezing posture, to measure the retention of an
association between a footshock and a particular context (Figure 1B). Measuring shortterm memory in this task provides a key control in consolidation studies by determining
whether learning is possibly impaired. Contextual fear conditioning is disrupted by
lesions of the amygdala and the hippocampus, but the closely related cued fear
conditioning task, in which freezing is measured in response to a discrete cue, is
affected by lesions of the amygdala but not the hippocampus (Phillips and LeDoux
1992). Therefore, cued fear conditioning serves as a control task to suggest
hippocampal specificity when using contextual fear conditioning, providing critical
information about whether observed changes in contextual memory are likely due to
changes in hippocampal function.

Hippocampal synaptic plasticity as a model for memory. The existence of wellcontrolled, hippocampus-dependent memory tasks has been instrumental in establishing
4

a role of individual molecules in memory formation, but another key factor in driving the
study of molecular mechanisms of hippocampal memory has been the development of in
vitro paradigms to examine changes in synaptic strength after electrical stimulation of
neurons, termed “activity-dependent synaptic plasticity” (Figure 2). The discovery by
Bliss and Lomo (1973) that high frequency stimulation of connections between neurons
in the hippocampus leads to a long-lasting increase in the strength of those connections,
termed long-term potentiation (LTP), provided powerful experimental support for Donald
Hebb’s earlier prediction (Hebb 1949) that learning could emerge from the selective
strengthening of connections between neurons firing simultaneously, a key principle of
Hebbian learning theory that is often paraphrased as “Neurons that fire together wire
together.” The initial work by Bliss and Lomo was followed by a flurry of research into the
molecular mechanisms of synaptic plasticity at specific hippocampal synapses using in
vitro preparations. For instance, a single high frequency burst of stimulation to the
Schaffer collateral pathway from CA3 to CA1 of the hippocampus (Figure 2A) produces
a relatively short-lived and protein synthesis-independent form of LTP known as E-LTP
(Figure 2B), but repeated tetani induce a much longer lasting form of LTP (L-LTP) that
requires protein synthesis (Frey et al. 1988) and transcription (Nguyen et al. 1994). The
knowledge gained from studies of these and other forms of LTP continue to guide
learning and memory research (Martin and Morris 2002; Malenka 2003).

Signaling cascades involved in synaptic plasticity and memory formation. By the
late 1980s, pharmacological and physiological experiments had paved the way for
genetic approaches to study memory formation by suggesting key molecular players in
synaptic plasticity and memory formation, such as the N-methyl-D-aspartate (NMDA)
receptor, calcium/calmodulin-dependent kinases II (CaMKII), and cyclic AMP (cAMP)
5

signaling (Figure 4). For instance, the induction of LTP at CA3 to CA1 synapses, the
Schaffer collateral pathway, depends on the activation of NMDA receptors (Collingridge
et al. 1983), a type of ionotropic glutamate receptor that requires both the presence of
glutamate in the synaptic cleft, glycine binding and depolarization of the post-synaptic
neurons, which releases a voltage-dependent magnesium blockade of the channel pore.
Thus, NMDA receptors act as molecular coincidence detectors between pre- and postsynaptic activation, a property that is an important component in the Hebbian theory of
associative learning (Hebb 1949). Unlike other ionotropic glutamate receptors, the
NMDA receptor fluxes large amounts of calcium into neurons. Once inside neurons,
calcium activates signaling cascades through calcium-bound calmodulin (Ca2+/CaM),
including type I adenylyl cyclase and CaMKs. Subsequent pharmacological studies
showed that inhibitors of CaMKII block the induction of LTP at the Schaffer collateral
pathway (Reymann et al. 1988; Malinow et al. 1989). Although CaMKII is required for the
induction of both E-LTP and L-LTP, cAMP-dependent kinase (PKA) activity is required
only for the long-lasting transcription-dependent phase of L-LTP (Huang and Kandel
1994), providing the first suggestion that the PKA pathway may be responsible for
initiating the transcriptional program that mediates long-term changes in synaptic
strength. Behavioral studies have shown striking co-incidence between the molecular
mechanism required for synaptic plasticity and memory formation. For instance,
inhibitors of PKA cause long-term memory impairments but leave short-term memory
intact (Bourtchouladze et al. 1998; Wallenstein et al. 2002). In fact, these deficits emerge
several hours after training, paralleling the memory deficits induced by transcription
inhibitors (Bourtchouladze et al. 1998). Pharmacological studies provided a critical step
in the process of identifying the molecular mechanisms guiding memory formation, but
drugs often have off-target effects and only a few of the molecules involved in memory
6

are likely to be good drug targets. Further, pharmacological agents impact glia as well as
neurons. Reverse genetic approaches on the other hand can readily target an individual
gene and can manipulate specific aspects of protein function, even in defined cell types,
to elucidate the genetic basis of memory.

Genetic approaches to examine the molecular mechanisms of mammalian
memory. The advent of knockout mice in the late 1980s opened entirely new avenues
for the study of mammalian learning and memory. With this technique the role of an
individual gene or isoform in memory formation could be examined without the
limitations of drug specificity. Knockout mice are produced using gene-targeting
techniques developed by Cappechi, Evans, and Smithies for which they won the 2007
Nobel Prize in Physiology. This process involves the careful selection of homologous
recombination events in mouse embryonic stem (ES) cell lines, which are subsequently
injected into developing blastocysts (Figure 3b). Homologous recombination, the
swapping of DNA between identical DNA sequences, occurs at very low frequency, but a
resistance marker in the gene-targeting construct is used to select the few ES cells that
undergo recombination for injection into a developing embryo. In addition to allowing for
selection, the resistance marker replaces an exon, a piece of the gene coding sequence,
leading to elimination of any proteins produced from transcripts that include this exon.
These ‘conventional’ knockout mice have been used extensively to test the requirement
for specific genes in learning and memory.

An individual protein is typically composed of multiple functional domains, each of which
carries out a specific biochemical function. Because gene knockout removes all of these
functions simultaneously, this technique is unable to address the role of particular
7

protein domains or biochemical activities in learning and memory. Yet, with a few
modifications the gene-targeting technology used to create knockouts, one can generate
mice with mutations in individual amino acid residues, called knock-in mice. The process
of producing knock-in mice requires the same homologous recombination process as
knockout, but includes an additional replacement exon bearing the mutations that are to
be knocked-in. The selection cassette is then removed in the ES cells by site-specific
recombinases prior to injection of the ES cells into the embryo, leaving only the mutated
exon in place of the normal exon. The knock-in approach has allowed researchers to go
beyond identifying genes that are necessary for memory and to test hypotheses about
the biochemical role of particular gene products or protein domains in the machinery of
memory.

A major limitation of both knockout and knock-in mice is that the gene is mutated
throughout development and throughout the body. Transgenesis, an approach
developed by Palmiter and colleagues (1982), can circumvent these concerns by
allowing regulation of transgene expression with a specific promoter, a region of DNA
that recruits transcriptional machinery to genes through transcription factor binding sites.
A transgene consists of a promoter regulating expression of a cDNA that encodes a
relevant protein. Often, this transgenic protein is a mutated form of a naturally occurring
protein designed to interfere with the function of the endogenous protein, such as a
dominant negative or competitive inhibitor. Production of a transgenic mouse lines
consists of injection of transgenic DNA into the male pronucleus of fertilized eggs, which
leads to random integration of transgene-encoding DNA fragment into the embryonic
genome (Figure 3a). The site of transgene insertion can affect the transgene expression
pattern, a finding that has been exploited to identify mouse lines with very refined
8

transgene expression patterns. Because specific protein domains can be mutated in the
transgenic protein, this approach often allows identification of the role of specific
biochemical functions. Two major caveats of the transgenic approach are that transgenic
protein must compete with the wild-type protein and that high levels of transgene
expression can interfere with proteins other than the wild-type version of the one that is
transgenically expressed. Thus, it can be difficult to determine whether the wild-type
gene is required during normal learning and memory.

A substantial advance in gene knockout technology has been the development of
conditional knockouts using the Cre/LoxP system, which allows the deletion of an
individual gene in specific cells and at specific times. This technology was made
possible by the discovery of recombinases, enzymes that catalyze the exchange of DNA
at specific sequences, particularly the Cre recombinase from bacteriophage P1 that
targets the 34-bp LoxP sequence (Gu et al. 1993). Using the previously described
knock-in strategy, gene exons can be flanked by these LoxP sites. In mice containing
two LoxP-flanked (‘floxed’) copies of a gene and a transgenically expressed Cre
recombinase, the floxed gene is deleted in cells with Cre expression. The ability to
regulate gene deletion through transgenic Cre expression has been a tremendous boon
to learning and memory research, but there are several major concerns that should be
considered when using the Cre/LoxP system. First, with the Cre/LoxP system all
deletions are final, so if the Cre transgene is expressed in early development all
subsequent cells will lack the gene. This consideration is especially important as many
Cre transgenes are unexpectedly expressed in the germline (Dragatsis and Zeitlin 2000;
Schmidt-Supprian and Rajewsky 2007), which may lead to full body gene knockout.
Another concern is that high levels of Cre expression cause cellular toxicity and can
9

produce observable phenotypes (Forni et al. 2006). Each of the discussed reverse
genetic techniques has been employed to great benefit over the last twenty years of
research on learning and memory. In combination, these genetic techniques helped to
identify many of the components of signaling cascades that guide transcription during
memory consolidation.

α-CaMKII is critical for learning and memory. In 1992, Susumu Tonegawa’s lab
published one of the first studies of learning and memory in a knockout mouse, a
knockout of the α-CaMKII isoform. Four distinct genes encode CaMKII isozymes in the
mammalian genome, but the α-CaMKII isoform is neuron-specific and heavily expressed
in forebrain structures, including the hippocampus. Because of this expression pattern
and the disruption of synaptic plasticity by CaMKII inhibitors, Alcino Silva generated a
knockout mouse line lacking α-CaMKII. These knockout mice have impairments both in
hippocampal long-term potentiation (LTP) and in the hippocampus-dependent Morris
water maze learning (Silva et al. 1992a; Silva et al. 1992b), thus suggesting mechanistic
overlap between synaptic plasticity and learning. The traditional gene knockout
approach used in these studies has two major limitations: the mutation is present
throughout development and all biochemical activities of the protein of interest are
eliminated. These considerations may explain the learning-unrelated behavioral
abnormalities, including a decreased pain threshold and increased aggression, observed
in a later study of this same α-CaMKII knockout mouse line (Chen et al. 1994).

Identifying the mechanisms that guide memory storage requires not only identifying
which proteins are important for memory formation, but also how the proteins carry out
that role. The biochemical cascades that guide memory formation are likely to provide
10

deep insight into how memories are maintained after learning. For instance, after
CaMKII is activated by transient bursts of intracellular calcium, the enzyme becomes
calcium-independent through autophosphorylation at a particular amino acid residue,
threonine

268

(Miller

et

al.

1988).

This

observation suggests

that

CaMKII

autophosphorylation may temporally store information about recent neuronal activity
during synaptic plasticity and learning. Based on this hypothesis, Giese and colleagues
(1998) generated knock-in mice with a single point mutation that converted the
phosphorylated threonine residue into an alanine residue (α-CaMKIIT286A), which cannot
be phosphorylated. In these mutant mice, calcium-dependent CaMKII activity was
preserved, but calcium-independent kinase activity was substantially reduced. αCaMKIIT286A mutant mice have severe deficits both in forms of synaptic plasticity and
spatial learning. In addition to these defects, the firing patterns of hippocampal CA1
place cells in response to spatial location were altered (Cho et al. 1998). When rodents
explore an environment, individual neurons in the CA1 subregion of the hippocampus,
called place cells, become tuned to particular positions within that environment. When a
wild-type mouse is placed back into a previously explored context, these place cells
typically fire in the same location and even come to have a more marked preference for
specific parts of the environment. In α-CaMKIIT286A mutant mice, place cells are unstable
and shift location with repeated context exposure. Furthermore, the spatial information in
place cells, as measured by refinement of place field, does not increase with further
exposure. This work showed that a single amino acid residue on CaMKII is important for
learning, highlighting the possibility that biochemical processes in individual neurons
may store information during memory formation. Furthermore, these studies provided
the first evidence linking synaptic plasticity, spatial learning, and hippocampal place cells
by showing that each of these processes is modulated by CaMKII signaling.
11

Gene knockout and knock-in are extremely useful tools for studying the mechanisms
underlying learning and memory, but these tools have distinct disadvantages. For one,
many of the same cellular signaling pathways are used for different processes in
different parts of the body. Therefore, components of the molecular machinery of
memory may cause decreased overall fitness or even death. Also, gross changes in
behavior caused by mutations can lead to learning and memory deficits that are
secondary to other unrelated causes. In some cases, careful behavioral analysis can
dissociate specific memory deficit in the face of unrelated phenotypic defects, but other
genetic strategies such as transgenesis provide region-specific ways to interfere with
gene function. By targeting regions of the brain that are involved with memory,
transgenic approaches reduce the likelihood that other processes are disturbed.

The forebrain-specific expression pattern of α-CaMKII makes this promoter a versatile
tool for regulating transgene expression specifically in forebrain neurons. Appropriately,
the first use of this promoter was to control transgenic expression of a mutant form of αCaMKII. Calcium/calmodulin-independent activation of α-CaMKII by autophosphorylation
at threonine 286 can be mimicked by replacing the threonine residue with an aspartate
reside (α-CaMKIIT286D), resulting in elevated calcium-independent CaMKII activity. Using
the α-CaMKII promoter, Mark Mayford in Eric Kandel’s lab generated a transgenic
mouse line expressing α-CaMKIIT286D in the forebrain (Mayford et al. 1996). These mice
have impairments in spatial learning and certain forms of hippocampal LTP, which
suggests that dynamics of CaMKII activity are important for effective spatial learning.
Furthermore, these results strengthen the argument that CaMKII is involved in the
mechanisms of memory itself by showing that its signaling is important in a brain region
12

required for spatial memory, the hippocampus. A major benefit of this work was the
identification of a promoter that can regulate, or drive, transgene expression specifically
in forebrain neurons of adult mice.

The utility of the α-CaMKII promoter becomes clear when considering molecules that are
vital to mouse survival. For instance, Nr1 is an obligate subunit of a functioning NMDA
receptor and traditional knockouts of the gene encoding Nr1 die shortly after birth
(Forrest et al. 1994). Therefore, Tsien and colleagues (1996) used the Cre-LoxP system
to remove the Nr1-encoding gene selectively from forebrain neurons. Cre recombinase
was expressed under control of the α-CaMKII. Fortuitious transgene expression
patterns, presumably due to the site of transgene insertion, led to an even more
restricted expression pattern than that seen with the α-CaMKII gene itself. When this
transgene was combined with a two copies of a floxed Nr1-encoding allele, at 3 weeks of
age the Nr1 subunit was deleted predominantly within the CA1 subregion. Spatial
memory and LTP were both severely disrupted in these mice, suggesting that NMDA
receptor activity in hippocampal CA1 neurons is critical for memory formation.

cAMP signaling regulates memory formation. Seminal studies using forward genetics
approaches in the fruit fly Drosophila (Dudai et al. 1976; Byers et al. 1981) and
electrophysiological approaches in the sea slug Aplysia (Brunelli et al. 1976)
independently identified a role of the cAMP pathway in learning and memory in the mid1970s. Nonetheless, evidence supporting a role for the cAMP-signaling pathway in
mammalian memory formation awaited the application of genetic approaches in 1990s.
The first genetic evidence that cAMP signaling plays a role in mammalian memory came
from conventional knockout mice lacking type I adenylyl cyclase, a calcium/calmodulin13

regulated source of cAMP. Daniel Storm’s lab observed that these adenylyl cyclase
mutant mice have reduced calcium-stimulated cAMP and impaired performance in the
spatial version of the Morris water maze (Wu et al. 1995). One of the major effectors of
cAMP signaling is PKA, but studies with conventional knockout of individual PKA
subunits were confounded by redundancy and compensation in null mutant mice
(Brandon et al. 1997). The α-CaMKII promoter provided the opportunity to test the role of
PKA in memory using a transgenic approach (Abel et al. 1997). Forebrain-specific
expression of a mutated form of the PKA regulatory subunit that reduces PKA activity
(R(AB)) under control of the α-CaMKII promoter impaired spatial memory in the Morris
water, but both learning and the visual platform version of this task were unaffected.
Furthermore, long-term contextual fear memory was selectively impaired with normal
short-term contextual and long-term cued fear memory. In wildtype mice, hippocampal
CA1 neurons have place fields that are similar during initial exploration to those found
with context re-exposures one hour or 24 hours later. In addition to defects in long-term
synaptic plasticity and long-term memory, place fields in CA1 neurons change upon reexposure to a context 24 hours after the first exposure, but are stable between reexposure spaced by only an hour (Rotenberg et al. 2000). This finding provides further
support for a role of PKA selectively in formation of long-term representations of spatial
information. An interesting aspect of this work on cAMP signaling is that, unlike
mutations in NMDA and CaMKII, the PKA mutant mice have specific impairments in
long-term memory with normal short-term memory. Thus, NMDA receptor activation and
CaMKII activity are required for hippocampus-dependent learning, but cAMP signaling
appears to mediate subsequent consolidation of learned information into a long-term
memory (Figure 4).

14

Memory storage has distinct phases, such as acquisition, consolidation, and retrieval.
Additionally, memories are subject to changes after initial storage. The study of these
processes independently from one another has required the development of conditional
transgenic systems with some degree of temporal control. For instance, after contextual
fear conditioning repeated re-exposure to the context without reinforcing shock reduces
the fear response through the formation of new memories that suppress the original fear
response (Quirk et al. 2006). This process is referred to as extinction learning and
experiments in R(AB) mutant mouse lines suggested that the molecular processes
guiding the formation of extinction memory are partly distinct from initial fear learning
(Isiegas et al. 2006). In CaMKII-R(AB) mutant mice, contextual fear memories undergo
extinction more rapidly than in wild-type mice. To determine whether this effect was due
to a role of cAMP signaling in the extinction process or a consequence of changes in the
initial contextual fear memory, an inducible dual transgene system was used that
consisted of the α-CaMKII promoter regulating the tetracycline transactivator (CaMKIItTA) and the tetracycline operator regulating R(AB) (tetO-R(AB)) (Figure 5A). The
inducible aspect of this expression system is based on the bacterial tetracyclineinducible operon. In E. coli, the tetracycline repressor (TetR) binds to tetO sequences at
tetracycline-inducible promoters to repress gene transcription under basal conditions,
but when tetracycline binds to the TetR protein, the repressor releases the promoter to
allow transcription. This system has been modified by fusing a strong viral activator
domain (VP16) to the DNA-binding domain of TetR yielding a hybrid tetracyclineregulated transactivator (tTA) for control of transgenes with tetO sequences in their
promoter (Furth et al. 1994; Gossen et al. 1994). The CaMKII-tTA system was
developed for the study of CaMKII in memory formation (Mayford et al. 1996) but was
applied by Isiegas et al. (2006) to show that PKA contributes to extinction as well as fear
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memory formation. In this study, mice were trained in contextual fear conditioning while
being fed doxycycline to repress R(AB) expression and were taken off doxycycline after
learning (Figure 5B). Four weeks later when R(AB) expression was robust throughout
the forebrain, the mice were subjected to repeated exposure to the conditioning context
in the absence of shock. The rate of extinction learning was facilitated by R(AB)
expression, showing that PKA has distinct and opposing roles in initial memory formation
and extinction memory (Figure 5C). An additional advantage to this study was that the
role of PKA in memory per se rather than developmental process was supported by
observation that R(AB) expression in the adult mouse impairs contextual fear memory
consolidation. The development of more rapidly inducible transgenic systems will be
critical for the separation of effects on acquisition, consolidation, and retrieval.

One strategy to more rapidly manipulate neuronal signaling cascades relies on
transgenic expression of receptors that bind ligands not normally present in the brain.
This pharmacogenetic strategy combines the cell and region specificity of genetic
approaches with the temporal control afforded by pharmacological approaches. A recent
study using this strategy provided further support for the role of cAMP in memory
formation (Isiegas et al. 2008). In this work, a Gs-coupled octopamine receptor from the
seaslug Aplysia was expressed in forebrain neurons using the CaMKII-tTA/tetO system.
Octopamine is major neurotransmitter in invertebrates but is present only at trace levels
in vertebrates with no known physiological functions. Because the Aplysia octopamine
receptor is Gs-coupled, binding of octopamine by this receptor activates adenylyl cyclase
and transiently increases cAMP. In mice expressing the octopamine receptor,
octopamine injection increases hippocampal cAMP levels and enhances both short-term
and long-term memory. The lack of a short-term memory deficit in PKA mutant mice
16

suggests that the enhancement of short-term memory by this transient burst of cAMP
may be a consequence of rapid recruitment of consolidation mechanisms. Alternatively,
this enhancement may be mediated by recruitment of other cAMP regulated proteins,
such as exchange-factor activated by cAMP (EPAC), which activates mitogen-activated
kinases (MAPKs). Because of the precise temporal regulation of cAMP increases,
Isiegas et al. (2008) were also able to show that increasing cAMP signals during
memory retrieval enhances performance, suggesting that cAMP signaling modulates
retrieval as well as consolidation. In complementary studies, several other approaches
that increase cAMP signals after training also enhance memory consolidation. For
instance, pharmacological blockade of cAMP degradation produces long-lasting L-LTP
after a stimulation paradigm that normally evokes short-lasting E-LTP and improves
contextual fear memory (Barad et al. 1998). Similarly, overexpression of calciumresponsive adenylyl cyclase produces LTP and memory enhancement (Wang et al.
2004). It is important to note that these approaches increase cAMP dynamics after
learning, leading to an increase in the cAMP signals. In contrast, manipulations that
chronically increase basal cAMP or effector levels often lead to impairments in long-term
memory (Pineda et al. 2004; Bourtchouladze et al. 2006; Viosca et al. 2009).

The CREB family of transcription factors regulates memory formation. The
similarity between the memory and synaptic plasticity deficits caused by PKA inhibitors
and transcriptional inhibitors suggests that PKA may regulate memory formation by
inducing transcription (Bourtchouladze et al. 1998). In many physiological contexts,
cAMP signals are converted into long-lasting changes in cellular physiology by activating
the transcription factor CREB. PKA and MAPKs phosphorylate CREB on serine residue
(S133), causing CREB to bind its coactivator CBP (Kwok et al. 1994; Arthur et al. 2004).
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CREB is constitutively expressed and can be activated via phosphorylation to drive
expression of genes containing cAMP-response elements (CREs) in their promoters.
This inducibility after neuronal activity is a key feature that made CREB an attractive
candidate for initiating transcriptional cascades after learning. Both spatial and
contextual learning are accompanied by increases in CREB phosphorylation within the
hippocampus (Bernabeu et al. 1997; Stanciu et al. 2001; Mizuno et al. 2002; Trifilieff et
al. 2006), and the windows of CREB phosphorylation after learning coincide strikingly
well with the windows of sensitivity to inhibitors of PKA, protein synthesis and mRNA
synthesis (Bernabeu et al. 1997; Bourtchouladze et al. 1998). Once again, research in
both Aplysia and Drosophila foreshadowed subsequent research in mammalian memory
by demonstrating a role of CREB in long-term memory. The first of these invertebrate
studies by Pramod Dash in Eric Kandel’s lab found that injection of excess DNA
containing the CRE sites blocks a form of long-term synaptic plasticity at Aplysia
synapses known as long-term facilitation (LTF) (Dash et al. 1990). The first mammalian
CREB mutant was a conventional knockout of the α and δ isoforms, the major CREB
isoforms in the brain, and the history of these CREBαδ knockout mice illustrates many of
the risks and benefits associated with conventional knockout mice. To reduce the effect
of genetic variability on experimental results, mice are studied on inbred genetic
backgrounds, but these different strains of mice can have very different behavioral
phenotypes (Nguyen et al. 2000). The initial examination of memory in CREBαδ mice on
a mixed B6- and 129-genetic background showed impaired cued and contextual memory
formation, as well as impaired spatial memory formation in the Morris water maze
(Bourtchuladze et al. 1994). Shortly after these mice were generated, it was discovered
that the β-isoform of CREB and the CREB family member cAMP responsive element
modulator (CREM) were upregulated in CREBαδ mice (Hummler et al. 1994; Blendy et
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al. 1996). Although the consequences of these compensatory mechanisms are still
subject to debate, it appears that the overall genetic background may determine whether
a CREBαδ mutant mouse has memory deficits. After initial studies in a B6-129 mixed
genetic background, CREBαδ mutation was backcrossed into two inbred mouse strains,
C57BL/6 (B6) and FVB/N. These B6 and FVB/N heterozygous CREBαδ mutants were
mated to produce CREBαδ knockouts in a defined F1 hybrid. Surprisingly, these F1
hybrid CREBαδ mice lacked the memory deficits previously observed on the B6-129
mixed background (Gass et al. 1998). Yet, when mice from this same F1 hybrid
background contained one CREBαδ mutant allele and one complete CREB knockout
allele, the memory deficits were observed even on this hybrid background, suggesting
that strain-specific differences in compensation by the β-CREB isoforms could account
for the effect of genetic background (Gass et al. 1998). Later studies confirmed that B6129 F1 hybrid CREBαδ mice have fear memory deficits (Graves et al. 2002). These
findings highlight both the risk of compensatory changes in gene regulation after gene
knockout and the possibility that the genetic background of an individual inbred mouse
strain may make a single gene appear more or less pivotal for memory formation.

Because the gene in question is not removed from all cells throughout development,
transgenic approaches suffer to a lesser extent from compensatory changes in gene
expression. The role of CREB in long-term memory has been further studied using
transgenic approaches. For instance, Chris Pittenger in Eric Kandel’s lab generated a
transgenic mouse line expressing a strong dominant negative allele of CREB (KCREB)
that heterodimerizes with CREB family members and blocks DNA binding (Pittenger et
al. 2002). Using the α-CaMKII promoter, this dominant negative transgene was
expressed in the striatum, limited cortex, and the CA1 subregion of the dorsal
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hippocampus. In support of a role for CREB in long-term memory formation, these mice
had deficits in the spatial version of the Morris water maze, but surprisingly no deficit
was observed in contextual fear conditioning. Either the absence of KCREB expression
in the ventral hippocampus, which is more directly connected to the amygdala than the
dorsal hippocampus, or the level of impairment of CREB function by this transgene may
account for the absence of fear memory deficits in these mice. In the same year, Alcino
Silva’s lab produced a transgenic mouse line expressing a form of CREB that lacks the
activating residue at serine 133, once again under control of the α-CaMKII promoter
(Kida et al. 2002). This mutant form of CREB was fused to a variant of the estrogen
ligand-binding domain that preferentially binds to the estrogen analogue tamoxifen
(ERT). The ligand-free ERT domain inactivates the protein by sequestering it into an
HSP90-complex, which dissociates upon tamoxifen binding. In this inducible CREB
repressor (CREBIR) line, a few hours of tamoxifen treatment causes severe impairment
in long-term contextual and cued fear memory tasks but leaves initial learning and shortterm memory intact. The CREBIR transgenic line confirmed the role of CREB family
members in long-term memory and, importantly, showed that serine 133, the site of PKA
phosphorylation, is central to this role. Because the levels and regions of CaMKIIregulated transgene expression vary considerably due to the effect of transgene
insertion site, it is difficult to directly compare behavioral outcomes from distinct
trangenes, an effect that is further confounded by redundancy and compensation among
CREB family members, but the overall message from the last 20 years of research
suggests that CREB or CREB family members play an important role in long-term
memory formation.
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NFκB family members are latent transcription factors that regulate memory
formation. The ability of CREB family transcription factors to lie latent in neurons prior to
activation by extracellular signals is a key feature that places this family at the interface
between environmental signals that encode information about the world and the most
fundamental information storage system in biology, the genome. Another transcription
factor family with similar activity-dependent regulation is the Rel/nuclear factor κB
(NFκB) family, which consists of 5 members (p50, p52, p65, c-Rel, and RelB) that can
act as homo- and hetero-dimers. In the basal state, Iκb inhibitory proteins sequester
NFκb in the cytoplasm by masking a nuclear localization sequence (NLS), but activation
of Iκb kinase (IKK) cause ubiquitination and degradation of Iκb, thus freeing NFκB for
nuclear import and activation of target genes. Two kinases thought to play a role in
memory formation, CaMKII and protein kinase C (PKC), can activate NFκb by
phosphorylation of IKK (Ghosh and Baltimore 1990; Hughes et al. 2001). The earliest
studies of NFκb found increased protein levels for p50 and p65 after high-frequency
stimulation, whereas Iκb levels decrease (Meberg et al. 1996). It was subsequently
shown by Meffert and colleagues (2003) that neuronal activity causes a calciumdependent increase in DNA binding by p65-containing NFκb dimers accompanied by
increased nuclear translocation of GFP-labeled p65 and that mice lacking the p65
subunit have deficits in the spatial version of the radial arm maze, a task that requires
the hippocampus. Further support for a role of NFκb family members in memory
formation comes from mice expressing a dominant negative form of IKK (IKK-AA) under
control of the inducible, neuron-specific CaMKII-tTA/TetO system. These mice have
deficits in the spatial version of the Morris water maze and L-LTP produced by theta
burst stimulation (Kaltschmidt et al. 2006). The most direct consequence of IKK-A
expression is reduced NFκb signaling, but expression of IKK-AA also substantially
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reduces the expression of the catalytic subunit of PKA and impairs forskolin-induced
CREB phosphorylation in the hippocampus, suggesting that NFκb signaling may amplify
CREB-mediated transcription after learning (Kaltschmidt et al. 2006).

Microarray experiments are capable of examining the expression of thousands of genes
simultaneously and computational analysis using bioinformatics techniques allows the
identification of transcription factors that may regulate identified changes in gene
expression. Levenson et al. (2004a) used bioinformatics analysis of microarray results
after fear conditioning to identify another NFκb subunit, c-Rel, as a candidate for
regulating gene expression during memory consolidation. This finding led the
researchers to examine the role of c-Rel in long-term memory using conventional c-Rel
knockout mice, where they saw a significant deficit in long-term contextual fear memory,
but normal short-term contextual and long-term cued fear memory (Levenson et al.
2004a). More recent results have confirmed this initial finding in c-Rel knockout mice and
demonstrated that c-Rel protein is translocated to the nucleus in CA1 neurons at 30
minutes after contextual fear conditioning (Ahn et al. 2008). The identification of c-Rel by
bioinformatics analysis of microarray data highlights the ability of unbiased screening
approaches to reveal important information about molecular mechanisms regulating
memory processes.

The analysis of gene expression after learning raises the question of what component of
associative memory drives hippocampal gene expression: the unconditioned stimulus
(US shock), the conditioned stimulus (CS context), or the CS-US association. In the
study by Levenson et al. (2004a), the vast majority of the learning-induced genes did not
have increased expression in the hippocampus when mice were shocked immediately
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after placement into the novel training context, a protocol that fails to produce
associative memory. In a similar microarray experiment, Keeley et al. (2006) found that
hippocampal gene expression 30 minutes after fear conditioning is very similar to the
pattern observed after context exposure alone, suggesting that contextual learning (CS)
may drive a substantial amount of gene expression after contextual fear learning. These
findings suggest that the control task can affect the expression profile, and perhaps that
the immediate shock control impairs gene expression involved in CS encoding. Yet,
certain immediate early genes, such as Nr4a1/NGFI-B, have increased expression after
context-shock (CS-US) pairing, but not context (CS) exposure alone (von Hertzen et al.,
2005). Thus, the questions of what role the hippocampus is playing in associative
memory processing and how behavioral paradigms affect this processing are still vital
open questions that may be clarified by continued studies of gene expression after
learning paradigms.

Immediate early genes are activated by latent transciption factors after learning.
Immediate early gene (IEG) expression is directly induced by latent transcription factors,
so protein synthesis is not required for expression of these genes after a stimulus.
Interestingly, several IEGs activated after learning and synaptic plasticity are themselves
transcription factors, suggesting that cascades of transcription may be critical for longterm changes in plasticity and memory. Notable among these learning-induced IEGs are
Fos, C/EBP, and Zif268. As immediate early genes, the expression of these transcription
factors after stimulation does not require translation, suggesting that their expression is a
result of activation of latent transcription factors such as NFκb and CREB. In fact, there
is evidence that each of these three immediate early genes is regulated in part by
CREB. Yet, it is important to mention that the expression of genes after learning is
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probably not simply regulated by any single transcription factor, but is a result of
simultaneous binding of multiple transcription factors to the promoter regions of genes
acting as an ‘enhanceosome’ to cooperatively recruit transcriptional coactivators (Figure
4) (Agalioti et al. 2002). For instance, the transcriptional co-activator CREB-binding
protein (CBP) interacts with CREB (Kwok et al. 1994), NFκb (Gerritsen et al. 1997),
C/EBP (Mink et al. 1997), Fos (Bannister and Kouzarides 1995) and Zif268 (Silverman
et al. 1998), and cooperative recruitment of CBP by multiple transcription factors is a
hallmark of this co-activator (Merika et al. 1998). This cooperative CBP recruitment
allows computation through the integration of multiple signals of biochemical activation,
such as the transcription factors activated after learning, as well as cell-type specific
signals.

C/EBP: a second wave of transcription after learning. The role of C/EBP in the
transcriptional cascade supporting memory was first identified in studies of Aplysia longterm facilitation (LTF), a long lasting and protein synthesis-dependent form of synaptic
plasticity. The Aplysia C/EBP gene is expressed rapidly after repeated treatment with
serotonin or pharmacological activation of the cAMP pathway, stimuli known to induce
LTF and increased PKA activity. This expression is protein-synthesis independent,
further suggesting that a constitutively expressed and PKA-activated transcription factors
such CREB drives the expression of this transcription factor. Alberini et al. (1994) used
several approaches to demonstrate LTF requires C/EBP, and perhaps more interestingly
this requirement for C/EBP extends for more than nine hours after LTF induction,
suggesting that long-lasting changes in gene expression are required for long-lasting
changes in synaptic strength. Subsequent studies in rats showed that after a
hippocampus-dependent contextual memory task, long-lasting increases in C/EBP
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expression are observed for 28 hours after learning (Taubenfeld et al. 2001b). Using
antisense oligonucleotides to block expression of the C/EBP β-isoform, Alberini’s lab
went on to show that this transcription factor is required at 24 hours after learning for
memory retrieved at 48 hours after learning (Taubenfeld et al. 2001a). These studies of
C/EBP have highlighted two very important aspects of memory formation: transcriptional
cascades are likely to mediate waves of transcription during memory formation and the
changes in transcription responsible for memory formation are much longer lasting than
previously thought.

Fos expression can be used to stably tag neurons activated by learning.
Expression patterns of immediate early genes have been very useful for addressing
systems- and network-level questions about learning and memory. In 1989, Paul
Worley’s lab examined the expression of seizure-induced genes in the hippocampus
after LTP (Cole et al. 1989), finding that several immediate early gene such as Zif268,
JunB, c-Jun and Fos are rapidly induced in the hippocampus after LTP-inducing stimuli.
Fos, an archetypal immediate early gene that is regulated by a wide variety of cellular
stimuli, heterodimerizes with Jun family members to form the transcription factor AP-1.
Fos gene expression is robustly induced in memory-related structures after acquisition
and recall of memory (Milanovic et al. 1998; Guzowski et al. 2001; Countryman et al.
2005). Because of this expression pattern, Mark Mayford’s lab developed a genetic
system to stably label neurons that have Fos induction during a defined time window,
dubbed the TetTag mouse (Reijmers et al. 2007). This bigenic TetTag system uses the
Fos promoter to regulate the expression of tTA (Fos-tTA), leading to activity-dependent
production of the doxycycline-repressed tTA transactivator. Additionally, a tetO-regulated
bidirectional promoter controlled expression of the reporter enzyme LacZ and a
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doxycycline-insensitive mutant form of tTA (tTA*). These mice were raised on
doxycycline, so that Fos-tTA activation is transient and leaves activated cell unmarked.
When these bigenic TetTag mice are taken off doxycycline, any stimulation that induces
the Fos promoter regulating tTA activates transcription of the doxycycline-insensitive
tTA*, marking these cells with continuous expression of tTA* and the reporter LacZ
(Figure 6A). Therefore, the TetTag mice were trained in the absence of doxycycline.
After training the mice were once again treated with doxycycline to block further marking
of neurons. The initial report of the TetTag system (Reijmers et al. 2007) focused on the
tagging of neurons in the amygdala after fear conditioning. In addition to examining the
neurons marked during learning, expression of the immediate early gene Zif268 was
used as a marker of transcriptional activation after retrieval in the presence of
doxycycline (Figure 6B). More than twice as many neurons were labeled after training
relative to home-cage or context-only controls kept off of doxycycline for the same
interval (Figure 6E). By examining both TetTag LacZ labeling and Zif268 expression, the
researchers asked whether the same neurons activated after learning (LacZ positive)
were also re-activated during retrieval (Zif268 positive). The overlap between LacZ and
Zif268 was significantly above chance in mice that were examined after retrieval and
were trained in the absence of doxycycline. In control mice that did not experience
retrieval and in control mice that were off doxycycline in the home-cage and context-only
group, co-labeling for these two markers was approximately at chance levels (Figure
6F). Additionally, a significant correlation was found between the number of co-labeled
neurons in the amygdala and retrieval performance. This approach allows researchers to
ask network-level questions about the incorporating neurons into potential memory
traces and to use the tTA* transactivator to selectively modulate these neurons.
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Local capture of transcripts correlates with associative aspects of memory. The
utility of this Fos-driven TetTag system for analyzing the incorporation of neurons into
hippocampal networks activated after contextual learning has yet to be examined, but
the Fos-tTA component was used to examine the incorporation of a newly synthesized
AMPA receptors into hippocampal CA1 neurons after contextual fear conditioning
(Matsuo et al. 2008) by combining the Fos-tTA transgene with a TetO-regulated EGFPlabeled AMPA receptor subunit (TetO-GluR1-EGFP). In this study, roughly 25% of
hippocampal CA1 neurons were labeled with GluR1-EGFP after fear conditioning,
compared to approximately 5% of neurons in home-cage mice. A similar level of GluR1EGFP was observed in mice exposed to the context alone, which is in agreement with
previous observations that Fos and many other immediate early genes are transcribed in
the hippocampus in response to configural learning rather than the associative
component of contextual fear memory. Within twenty-four hours, these GluR1-EGFP
proteins were trafficked to dendritic spines, but only about 50% of spines were labeled
within individual EGFP-labeled neurons. Strikingly, the trafficking to a specific spine type,
mushroom body spines, was increased in mice that received context-shock pairing
relative to mice that experienced only context exposure. Repeated exposure to the
context alone in the absence of reinforcing shock reduces freezing in that context
through a process known as extinction, and extinction was accompanied by a reduction
in the percentage of EGFP-labeled mushroom body spines relative to other spine types.
These findings suggest a startling dichotomy of information encoding in the
hippocampus in which neuron-wide transcriptional processes encode information about
context whereas spine-specific “synaptic capture” of transcripts encodes certain
associative components of fear memory. If this dissociation exists, a sharp line may not
be easily drawn between the two processes because de novo transcriptional processes
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most likely account for the transcripts that are “captured” and a few genes appear to be
transcribed selectively in response to associative aspects of contextual fear memory,
such as Nr4a1 (von Hertzen and Giese 2005).

Temporal dynamics of Arc mRNA expression allow examination of place
representation in the hippocampus. The finding in TetTag mice that 25% of
hippocampal neurons are “Fos-activated” by contextual fear conditioning echoes
fascinating studies carried out by John Guzowski (Guzowski et al. 1999), in which a
surprisingly high number of neurons were marked by immediate early gene expression
after learning. In these studies, Guzowski used fluorescent in situ hybridization (FISH) in
conjunction with confocal microscopy to provide extremely high-resolution images of
hippocampal gene expression after context exploration (Figure 7). For the first five
minutes after seizure activity, the transcripts of immediate early genes Arc and Zif268
were identified in discrete foci within the nucleus (Figure 7B), but by fifteen minutes after
seizure these transcripts had been trafficked to the cytoplasm (Figure 7C). Similar
dynamics were found after the exploration of a novel context. Impressively,
approximately 45% of CA1 pyramidal neurons were found to have nuclear Arc transcript
after 5 minutes of context exploration, the same number had cytoplasmic Arc transcript
when examined after a 25 minutes delay, and very few (<5%) had detectable transcripts
in both compartments simultaneously (Figure 7D). This knowledge of the temporal
dynamics of Arc trafficking allowed Guzowski to ask a variety of interesting questions
about the recent activity of neural networks during context exposure. When the rat was
returned to the same context after a 20-minute delay, roughly 40% of CA1 neurons had
Arc transcripts in both nuclear and cytoplasmic, showing that the network of neurons
activated by a particular context was stable across time and that these networks are
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surprisingly large. When the rat was exposed to a distinct context after the same 20minute delay, only 20% of CA1 neurons had exclusively nuclear or cytoplasmic labeling
and 16% of CA1 neurons displayed both nuclear and cytoplasmic labeling, suggesting
that these representations overlap at roughly the same level that would be predicted by
chance (Figure 7D). The observation that a large percentage of CA1 neurons is
activated by single context fits well with observations using electrophysiological and
biochemical techniques suggesting that between 20-40% of CA1 neurons are involved in
representation of a single context. With such a large number of neurons involved in each
single representation, how is it possible that the hippocampus is not quickly
overwhelmed in the daily life of a wild rat? First, the actual number of distinct
representations consisting of 120,000 neurons (40%) within 300,000 CA1 neurons is
staggering. The question really requires knowing how much of a difference between any
two representations is needed for faithful discrimination, but by assuming that 10,000
neurons is a sufficient difference to robustly differentiate memories it is possible to
estimate the lower limit of this number. If neurons are imagined to function in a bundle of
10,000 neurons, guaranteeing a difference of 10,000 neurons between any two
representations, there are still 86 million different representations consisting of 120,000
neurons possible within a CA1 network composed of 300,000 neurons. Second,
systems-level consolidation limits the time of hippocampal storage by transferring
hippocampal memories to the cortex in representations that may use fewer neurons, a
possibility that would be consistent with both systems-level consolidation and the
increased generalization that often occurs with remote memories. Third, it is possible
that hippocampal representations become more refined in the days following learning.
Such a focusing of memory could account for the basic principle that memory becomes
more resistant to interference with consolidation. Fourth, the analysis above ignores the
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temporal order of neuronal activation, but a given contextual representation is likely to be
defined by the sequential activation of neurons representing distinct but adjacent
components of the environment. If this sequence of activity matters, then a vastly larger
number of firing patterns are possible with the same number of neurons. And lastly,
analysis of activation of a few IEGs may not reflect the induction patterns of other IEGs.
Perhaps genes other than Arc have more selectively expression patterns in the
hippocampus, just as some have more selectivity for associative aspects of memory
(von Hertzen and Giese 2005).

Transcriptional metaplasticity: recent experience regulates the ability to induce
transcription. Although Arc activation occurs in the same neurons with repeated
exposure, the ability to induce Arc in these neurons is affected by the recent activity
history of the neurons (Guzowski et al. 2006). Massed repeated re-exposure to a context
substantially decreases the number of neurons activated by a final exposure to that
context but only mildly affects Arc induction in response to a distinct context, suggesting
that the recent transcriptional activity modulates the ability to induce further transcription
and that this modulation is neuron-wide rather than synapse-specific. The firing
properties of CA1 neurons measured by electrophysiological methods did not change
with repeated context exposure, showing that this change in transcriptional activity is not
a consequence of altered electrical activity. Thus, transcription is not only dynamic after
learning, but the ability to transcribe genes is altered by experience, a process that could
be considered transcriptional metaplasticity. Transcriptional metaplasticity may explain
the ability of spaced training to facilitate long-lasting memory more readily than massed
training and may allow for better separation of memories by selectively biasing against
incorporation of neurons that are involved in recently encoded events. Selectivity of
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incorporation into neuronal networks based on transcriptional capacity is consistent with
recent work by Sheena Josselyn in the amygdala, where she has observed that the level
of CREB activity in a neuron can modify the likelihood that it is incorporated into a
memory trace (Han et al. 2007). A remarkable aspect of these findings is that if different
immediate early genes show distinct patterns of transcriptional metaplasticity, a wealth
of information may be stored by mechanisms that guide the ability to re-induce gene
expression based on recent neuronal activity.

Epigenetic mechanisms in memory formation. Together the existing data on
transcriptional regulation after learning suggest that long-lasting changes in gene
expression accompany memory formation and that the regulation of transcription during
memory may contribute to information storage. Transcriptional activation is a
tremendously complex computation that integrates multiple distinct cellular signaling
events to determine whether genes are expressed. In developmental biology, the results
of these computations are stably stored in the form of epigenetic marks that can alter the
future transcription of a gene. Epigenetic marks include covalent modifications to the
chromatin complex that packages DNA, as well as to DNA itself. The fundamental unit of
chromatin is the repeated nucleosome structure, which consists of the four core
histones, each in duplicate, tightly encircled by genomic DNA. The amino-terminal tails
of histone proteins protrude out of the nucleosome and are sites for post-translational
modifications that regulate the ability of the transcriptional machinery to bind to and
transcribe the underlying genes. Specific amino acid residues on histone tails are targets
for acetylation, methylation, phosphorylation, sumoylation, and/or ubiquitination. Histone
modifications, often associated with another epigenomic mark, DNA methylation
(Vaissiere et al. 2008), facilitate or repress transcription, and synergistic interactions
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have been identified among many of these modifications. The exact combination of
these epigenomic marks at the promoter and enhancers of a gene is thought to
represent a “histone code” that determines the present rate and future capacity for
transcription of that gene (Jenuwein and Allis 2001). Therefore, epigenomic marks play
an acute signaling role that regulates transcriptional activation and an information
storage role that dictates the transcriptional programs available for a cell based on prior
signaling events (Wood et al. 2006b). This information storage role of epigenetic
modifications may account for the metaplasticity observed in Arc studies and has been
shown to stably maintain changes in behavior caused by early life experience (Weaver
et al. 2004).

The histone acetyltransferase CBP regulates memory formation. The role of CREB
in long-term memory formation provides a compelling connection between memory and
one particular epigenetic mark, histone acetylation, through the known interaction of
CREB with the histone acetyltransferase CREB-binding protein (CBP). Phosphorylation
by PKA on serine 133 stabilizes an alpha-helix domain of CREB that recruits the
transcriptional co-activators CBP and p300, which are important for transcription of some
CREB target gene. CBP and p300 are histone acetyltransferases that modify the local
chromatin environment to allow transcription at repressed genes. Acetylation of histone
proteins is a type of epigenomic mark that can acutely alter the rate of transcription of
underlying genes and potentially function as a type of information storage about past
gene activity to regulate future gene transcription. Increased histone acetylation occurs
within CA1 of the hippocampus after contextual fear conditioning (Levenson et al.
2004b). Humans with mutations in CBP have a disorder known as Rubinstein-Taybi
Syndrome (RTS), a genetic disorder characterized by facial abnormalities, broad toes
32

and thumbs, and mental retardation (Petrij et al. 1995). Although the cognitive deficits in
RTS could be explained by developmental abnormalities, the role of cAMP signaling and
CREB in memory consolidation suggests an acute role for CBP during memory
formation. This hypothesis has been tested with many of the genetic approaches
mentioned earlier in this chapter. Mice with a single knockout allele of CBP have bone
morphologies characteristic of RTS, but also have impaired long-term contextual and
cued fear memory (Alarcon et al. 2004). Using the α-CaMKII promoter to allow
expression of mutant forms of CBP in postnatal forebrain excitatory neurons, two
different groups found that expression of mutant forms of CBP lacking the histone
acetyltransferase activity selectively impairs long-term memory (Korzus et al. 2004;
Wood et al. 2005), suggesting that histone acetylation regulates memory consolidation.
Additionally, mice homozygous for a knock-in mutation in the domain of CBP that
interacts with phosphorylated CREB, the kinase inducible interaction (KIX) domain, have
defects in long-term contextual fear memory but normal learning and cued fear memory
(Wood et al. 2006a). This series of papers on the co-activator CBP suggests that not
only genetically encoded information but also interactions of the environment with the
gene at the epigenetic level are important for memory formation, an exciting possibility
that has opened an entirely new avenue of research into the contribution of epigenetic
modifications in memory formation. Additionally, as discussed previously, CBP may
provide a critical role in integrating the activity of multiple transcription factors with the
ultimate readout being histone acetylation.

HDACs act as memory suppressors. The role of histone acetyltransferases in memory
consolidation predicts that the histone deacetylases (HDACs) opposing histone
acetylation may act as memory suppressors and, in fact, inhibitors of these HDAC
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enzymes enhance long-term memory formation (Levenson et al. 2004b; Yeh et al. 2004;
Lattal et al. 2007; Vecsey et al. 2007; Bredy and Barad 2008). The first demonstration of
a role for HDACs in hippocampus-dependent memory showed that systemic
administration of HDAC inhibitors enhances contextual fear memory. In subsequent
studies, it was demonstrated that direct injection of the HDAC inhibitor trichostatin A
(TSA) into the hippocampus immediately after learning enhances long-term memory
without affecting short-term memory (Vecsey et al. 2007). Thus, HDAC inhibitors act
within the hippocampus during memory consolidation to strengthen memory storage.
This memory-enhancing effect of HDAC inhibitors requires the CREB-CBP interaction,
suggesting that HDAC inhibitors may enhance memory through increased transcription
of CREB-CBP target genes. Although many CREB target genes have been identified,
TSA was found to effect the expression of only two out of thirteen CREB target genes
after learning, the orphan nuclear receptors Nr4a1 and Nr4a2. Further studies that
identify the subset of CREB target genes that mediates the enhancement in memory by
TSA and the individual HDAC(s) that target them promise to provide novel drug targets
for memory enhancement and amelioration of cognitive deficits in neuropsychiatric and
neurodevelopmental disorders.

DNA methylation dynamics regulate memory formation. Histone acetylation is only
one of collection of epigenetic marks that includes histone phosphorylation, methylation,
sumoylation, ubiquitination, as well as DNA methylation. DNA methylation represses
transcription through direct disruption of transcription factor binding sites and recruitment
of methyl-DNA binding repressors, such as MeCP2 a transcriptional repressor that
recruits histone deacetylases (Nan et al. 1998) providing a potential link between DNA
methylation and histone acetylation. Recent research from David Sweatt’s lab suggests
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that DNA methylation regulates memory formation (Levenson et al. 2006; Miller and
Sweatt 2007; Lubin et al. 2008). For instance, DNA methylation decreases after learning
at the CREB target gene Bdnf (Lubin et al. 2008). Surprisingly, intrahippocampal
injection of DNA methyltransferase (DNMT) inhibitors blocks the change in DNA
methylation and the increase in histone acetylation that accompany learning in the
absence of inhibitor, and impairs long-term memory formation. Although the findings on
DNA methylation in memory consolidation are more perplexing than those for histone
acetylation, they suggest that the dynamics of DNA methylation may be a critical aspect
of memory formation. This possibility is supported by the recent findings of Huda
Zoghbi’s lab that MeCP2 can function as a transcriptional activator as well as a
repressor, especially at CREB target genes (Chahrour et al. 2008). Thus, MeCP2
binding through DNA methylation may regulate both basal repression by recruiting
HDAC activity and the ability to achieve maximal activity-mediated gene expression
during memory consolidation, a possibility that might explain the results observed with
DNMT inhibitors and connect DNA methylation directly with histone acetylation.

Conclusion. Research on memory formation has moved through three stages that
reflect our growing understanding of information storage in the brain. First, it was
discovered that neurons are electrically excitable, allowing for the insight that
communication between neurons via these electrical signals can compute information
and guide behavior. Second, biochemical changes in neurons were identified that could
alter the relative strength of these connections within neuronal networks, suggesting
plasticity as a mechanism of learning. And recently, it has been discovered that
transcriptional processes guide these changes in plasticity, allowing for the possibility
that one of the most ancient information storage and processing systems in biology, the
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genome, has been adapted for behavioral information storage through epigenetic
modifications.
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Figure 2. Hippocampal Synaptic Plasticity
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Figure 3. Generation of Mutant Mouse Lines
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Figure 4. Signaling Cascades in Memory Formation
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Figure 5. Conditional R(AB) expression in forebrain neurons
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Figure 6. TetTag System
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Figure 7. Immediate Early Gene Imaging: catFISH
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Figure 1. Hippocampus-dependent memory task. (A) The hippocampus and
amygdala, located in the medial temporal lobe of the cerebral cortex, play critical roles in
memory formation. (B) The Morris water maze is a spatial learning and memory task that
requires the hippocampus but not the amygdala. In this task, mice learn the position of a
hidden escape platform during repeated training session, as measured by a reduced
time to find the platform (escape latency). Memory for the platform location is assessed
in a probe trial in which the platform is removed. A trained mouse will search extensively
within the quadrant that formerly held the platform, whereas a mouse with hippocampal
lesions will have no spatial bias to its search for escape. (C) Fear conditioning is an
associative memory task that typically involves the pairing of a shock with a novel
context and a cue, such as a white noise or tone. During training, a mouse is placed in a
novel context and allowed to explore briefly. After the exploration period, a sound is
played that co-terminates with a foot shock. This training paradigm produces both
context-shock and cue-shock associations that can be measured by quantifying a
stereotyped and species-specific fear response characterized by immobility, or freezing.
The freezing response upon re-exposure to the cue in a distinct context measures cueshock association, while freezing upon re-exposure to the training context measures
context-shock association. Both of these forms of associative memory require the
amygdala, but cued fear conditioning does not require the hippocampus. (Source:
Memory, Kandel)

Figure 2. Hippocampal Synaptic Plasticity. (A) The most heavily studied synapses in
the brain are those of the CA3-CA1 Schaffer collateral pathway. This connection is
commonly examined using in vitro hippocampal slice preparations as illustrated here. A
stimulating electrode is placed in the CA3 axon bundles projecting to CA1, and a
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recording electrode measures field excitatory post-synaptic potentials (fEPSPs) in the
synaptic layer of CA1. (B) Representive fEPSPs are illustrated before potentiation with
dashed lines (1) and 2 hours after potentiation with solid lines (2). Sample fEPSPs are
measured by stimulation at one-minute intervals throughout the recording and the initial
slope of the fEPSP is plotted relative to baseline fEPSPs prior to potentiation. The slope
of the fEPSP increases after both a single 100hz tetanus (blue) and four 100 hz tetani
(red), producing long-term potentiation (LTP). LTP induced by a single tetanus, which
dissipates more quickly, is referred to as early-LTP (E-LTP), but LTP produced by four
tetani, which persists much longer, is called late-LTP. Both E-LTP and L-LTP require
NMDA receptor and CamKII activity, but only L-LTP requires PKA activity.

Figure 3. Generation of Mutant Mouse Lines. (A) Transgenic mice are produced by
injecting transgene DNA into the pronucleus of recently fertilized oocytes, which
integrates into the genome without site specificity. The oocyte develops into an early
stage embryo, which is then implanted into a pseudopregnant host female mouse. The
offspring of host female are genotyped to identify founders that have incorporated the
transgene into their genome. Each founder may have distinct transgene expression
patterns, presumably due to the site of transgene insertion. (B) Gene targeting
approaches rely on homologous recombination in embryonic stem (ES) cells to knockout
a gene with a selectable marker or knock-in an excisable selectable marker along with
the allele of interest. Selection using these markers and a marker against random
insertion, typically thymidine kinase (tk), allows purification of only those ES cells that
have undergone homologous recombination. The ES cells are injected into a developing
mouse embryo from a mouse line with a coat color distinct from the coat color of the
mice used to produce the ES cells, and the embryo is implanted into a pseudo-pregnant
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female host. The resulting chimeric offspring are derived partly from the original embryo
and partly from the ES cells leading to diverse coat color patterns that can be used to
assess the contribution of the ES cells to the mouse. These chimeric mice are mated to
a mouse with a recessive coat color. If the ES cells have contributed to the germline of
the chimera, some offspring will have the ES cell-derived coat color. These mice will
contain the knockout or knock-in mutation.

Figure 4. Signaling Cascades in Memory Formation. Many of the signaling cascades
that regulate short-term and long-term memory formation have been identified using
genetic approaches to study mouse memory. Calcium ions (Ca2+) enter neurons through
NMDA receptors and bind calmodulin, which activates kinases including CaMKII to
mediate changes in neuronal physiology that underlie short-term memory. Ca2+calmodulin also activates type I adenylyl cyclase to increase intracellular cAMP levels,
which activate protein kinase A (PKA) directly and MAP kinase pathways through
exchange factor activated by cAMP (Epac). Signals converge to recruit enhanceosomes
consisting of transcription factors (such as NFκ-B, CREB, and C/EBP) and
transcriptional coactivators (CBP) to cause histone acetylation and transcription. These
transcriptional processes are thought to mediate the long-term stabilization of memory
that occurs during memory consolidation.

Figure 5. Conditional Reduction of PKA Activity Enhances Extinction Memory. (A)
Temporal and spatial regulation of the PKA inhibitor R(AB) was achieved using a dual
transgenic tTA/tetO system. The specificity of this system stems from the tetracycline
transactivator (tTA) under control of the α-CaMKII promoter, which drives forebrain
restricted transgene expression. The tTA protein binds tetO sequences in the promoter
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of the R(AB) transgene to induce expression of R(AB) in forebrain neurons. In the
presence of the tetracycline analog doxycycline, tTA cannot bind the tetO sequence,
allowing temporal regulation of R(AB) expression by feeding the mice doxycycline. (B) In
situ hybridization shows that administration of a doxycycline diet efficiently suppresses
R(AB) expression (On Dox). Additionally, the transgene is specifically expressed in
forebrain structures when the mice are removed from the doxycycline diet for 28 days
(Off Dox). (C) Inhibition of PKA activity facilitates extinction of contextual fear memory.
Wild-type and R(AB) transgenic mice were raised on doxycycline, trained in contextual
fear conditioning, and taken of a doxycycline diet 24 hours after training. Contextual fear
extinction was performed after 28 days on a doxycycline-free diet. Repeated reexposure to the context formerly associated with a footshook reduced freezing more
rapidly in R(AB) transgenic mice than in wild-type littermates. Error bars indicate SEM.
Source: Isiegas et al., 2007

Figure 6. Identifying a Memory Trace: TetTag System. (A) The TetTag systems
combines two transgenes to stably label neurons activated during a defined time
window. The first of these transgenes is a Fos promoter-regulated tetracycline
transactivator (Fos-tTA). The second transgene consists of a LacZ marker and a
tetracycline-insensitive version of tTA (tTA*) under control of a bi-directional tetracycline
operator (TetO-LacZ-tTA*). In the presence of doxycycline (dox), which can be mixed
into the mouse’s food, the Fos-tTA transgene is expressed with neuronal activity, but the
dox inactivates tTA. In the absence of dox, tTA expressed after neuronal activity binds to
the TetO-LacZ-tTA* to induce the expression of the doxycycline-insensitive tTA*,
resulting in continued expression of tTA* and the LacZ marker even when the animals
are returned to a dox-containing diet. Thus, the window of tagging is limited to when the
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animals are not being fed dox, but the tag persists after dox is returned to the diet. (B)
This system was used in conjunction with immediate early gene labeling of Zif268 to
determine whether the same neurons that were activated by learning were re-activated
during retrieval. (C) For these experiments, mice were reared on dox to prevent labeling,
taken off dox to allow neuronal tagging for a short window during which the experimental
mice received fear conditioning, and placed back on dox for 3 days to prevent tagging
during the retrieval. (D) Mice learned the context-shock association as measured by the
percent time spent freezing during a retrieval test. (E) Fear conditioning led to
significantly more labeling of neurons than exploration of the context alone (NS) or being
left in the homecage (HC). (F) Neurons activated during training (LacZ+ neurons) were
more likely to be activated during retrieval (ZIF+ neurons) than chance levels, whereas
neurons activated in the homecage or simply with context exploration were not. Source:
Reijmers et al., 2008

Figure 7. Immediate Early Gene Imaging with catFISH. Fluorescent in situ
hybridization (FISH) can be used to provide high resolution images of the localization of
mRNAs in neurons. Compartment analysis of temporal activity by fluorescent in situ
hybridization (catFISH) uses this resolution to identify the neurons activated at two
times. (A) Prior to context exploration, Arc is largely absent from hippocampal CA1
neurons. (B) At 5 minutes after exposure to a context, Arc mRNA is localized to
intranuclear foci that presumably mark the sites of transcription. (C) At 30 minutes after
context exposure, Arc mRNA moves to the cytoplasmic and intranuclear foci are no
longer found. (D) More than 40% of neurons in area CA1 have intranuclear Arc foci
immediately after context exposure, and a similar number have cytoplasmic Arc labeling
20 minutes after context exploration. Repeated exposure to the same context leads to
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intranuclear and cytoplasmic labeling in the same neurons, suggesting that the same
neurons are activated with repeated exposure to the same context. When a second
context is explored 20 minutes after the first, three populations of neurons are identified:
22% with only intranuclear labeling, 23% with only cytoplasmic labeling, and 16% with
both intranuclear and cytoplasmic labeling. These results suggest that immediate early
gene expression patterns may be context-specific and extensive representations of
contextual information. Source: Guzowski et al., 1999.
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Chapter 2: The potential role of NR4A
transcription factors in memory formation

Abstract
In various physiological contexts, Nr4a genes are transcribed in response to external
stimuli as part of an immediate early response that initiates a cascade of gene
expression ultimately leading to distinct physiological outcomes in each of these
contexts. The signaling pathway that initiates Nr4a gene expression in most of these
contexts consists of elevated intracellular cAMP activating PKA, which in turn leads to
phosphorylation of CREB and new gene synthesis. This cAMP-PKA-CREB pathway is a
central molecular pathway in the formation of a long-term memory. Indeed, learning
induces Nr4a family gene expression, and long-term memory formation requires at least
two waves of transcription after learning, suggesting that NR4A nuclear receptors may
contribute to the second of these waves of gene expression. In this article, we review
insights gained in other physiological contexts regarding Nr4a function and regulation
and highlight how these lessons can be applied to the study of memory formation.

Chapter previously published as:
Hawk JD, Abel T. 2011. The role of NR4A transcription factors in memory formation.
Brain Res Bull., epub Feb 18
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Introduction
The NR4A family of transcription factors consists of three members, NR4A1 (NGFIB/Nur77/TR3), NR4A2 (NURR1/HZF-3/RNR1), and NR4A3 (NOR1/MINOR/TEC), each
of which was identified roughly 20 years ago in studies examining activity-dependent
processes in neurons or during neuronal differentiation (Milbrandt 1988; Law et al. 1992;
Ohkura et al. 1994). Yet, the last twenty years of research has demonstrated that these
transcription factors contribute to a broad array of processes including energy
metabolism,

atherosclerogenesis,

T-cell

receptor

(TCR)-mediated

apoptosis,

inflammatory response, hypothalamic-pituitary axis (HPA) regulation and reproductive
processes (Liu et al. 1994; Woronicz et al. 1994; Fernandez et al. 2000; Winoto and
Littman 2002; Maxwell and Muscat 2006; Robert et al. 2006; Zhao and Bruemmer 2010).
The unifying principle that emerges from these studies is that NR4A transcription factors
are the first-wave transcriptional response to environmental cues that cause diverse, but
critical, changes in cellular physiology. A common set of signaling pathways, including
PKA and MAPK activity, converge to induce the expression of Nr4a genes after an
environmental stimulus. The transcriptional activity and genetic targets of NR4A family
members are further refined by post-translational modifications and protein-protein
interactions that specify the second-wave transcriptional response to the stimulus. The
formation of a long-term memory requires PKA, MAPK and two waves of transcription in
the hours following learning (Hawk and Abel 2010), suggesting that, in analogy to the
role of NR4A elsewhere, NR4A transcription factors may act to shape the second of
these memory promoting transcriptional waves. Only recently have the insights learned
about NR4A family function from other systems been applied to examine how these
transcription factors might contribute to the activity-dependent processes that underlie
memory formation.
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Signaling cascades important for memory storage regulate Nr4a gene expression.

The three genes encoding NR4A transcription factors, Nr4a1, Nr4a2, and Nr4a3, are
immediate early genes that can be induced by a variety of stimuli, including activation of
G protein-coupled receptors, tyrosine receptor kinases and direct activation of
intracellular protein kinase pathways.

The specific intracellular signaling cascades

responsible for Nr4a gene induction depends on the stimulus and cell type involved, and
in many of these contexts all three Nr4a genes are induced in parallel. For instance, the
expression of all three Nr4a genes increases after lipopolysaccharide treatment of
macrophages, a process that appears to be mediated by the NFκ-B signaling pathway
(Pei et al. 2005). In fibroblasts stimulated with growth factors, increased Nr4a family
gene expression requires mitogen- and stress-activated kinases (MSKs) and is blocked
by a dominant negative form of the transcription factor cAMP-response element binding
protein (CREB) (Darragh et al. 2005). Consistent with the regulation of Nr4a family
members by CREB, increased expression of Nr4a family genes was observed in the
neuron-like PC12 cell line expressing a constitutively active CREB derivative (VP16CREB). This increase in expression was mimicked by increasing cAMP with forskolin
and activation of protein kinase A (PKA), which leads to phosphorylation of CREB and
recruitment of the coactivator CREB-binding protein (CBP) (Kwok et al. 1994).

The

effect of forskolin on Nr4a gene expression in PC12 cells was blocked by
overexpression of a dominant negative form of CREB (Fass et al. 2003).

Additionally,

the induction of Nr4a gene expression in skeletal muscle by β-adrenergic receptor
activation is mediated by elevated cAMP production, PKA activation, MAPK signaling,
and CREB–mediated transcription (Pearen et al. 2006).
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Both PKA and CaMKII

contribute to Nr4a gene expression in corticotroph-derived cells, but MAPK activity is not
necessary for Nr4a gene expression in these cells (Kovalovsky et al. 2002). In the
neuroblastoma cell line N2A, treatment with MEK inhibitors impairs the induction of
Nr4a2 gene expression by forskolin, whereas MEK inhibitor treatment enhances the
induction of Nr4a2 by forskolin in the glioblastoma line C6 (Lee and Nikodem 2004). In
both of these cell lines, PKA activity is required for Nr4a2 expression (Lee and Nikodem
2004). Thus, the contribution of MAPK and NFκ-B signaling to the induction of Nr4a
family gene expression depends on the cell type and signal examined, but the
involvement of the cAMP-PKA-CREB pathway is a common feature (Figure 1). The
signals that induce Nr4a family gene expression differ slightly among different cellular
contexts, but the molecular pathways that drive Nr4a gene expression in these various
contexts (NFκ-B, MAPK, CaMKII, PKA, and CREB) coincide strikingly well with
molecular mechanisms thought to underlie long-term memory formation (Hawk and Abel
2010), suggesting the possibility that NR4A transcription factors may also contribute to
the cascade of gene expression that leads to memory storage (Figure 1).

NR4A proteins are ligand-independent members of the nuclear receptor family.

The three NR4A transcription factors compose a single subfamily within the nuclear
receptor superfamily (Mangelsdorf et al. 1995; Bookout et al. 2006). Nuclear receptor
superfamily members have a common structure consisting of a weakly conserved
amino-terminal A/B region containing the activation function (AF)-1 transactivation
domain, a highly conserved DNA-binding domain (DBD), and a highly conserved
carboxy-terminal ligand-binding domain (LBD) (Figure 2A). Classically, nuclear receptor
activation is accomplished by the binding of a lipophilic ligand in a hydrophobic pocket
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within the LBD.

Ligand binding causes a conformational shift that regulates the

recruitment of coactivators and corepressors to the AF-2 transactivation region within the
LBD (Glass and Rosenfeld 2000). In contrast, NR4A activity is independent of the LBD
(Paulsen et al. 1992; Wansa et al. 2003), relying instead on the AF-1 domain (Castro et
al. 1999; Maira et al. 1999; Wansa et al. 2002; Maira et al. 2003; Wansa et al. 2003).
Because they have no known ligand, NR4A proteins are described as orphan nuclear
receptors. The presence of this unusual mechanism of action is supported by the fact
that the hydrophobic coactivator-binding cleft observed in the LBD of other NRs is
replaced in the NR4A subfamily with a hydrophilic surface that does not support classical
coactivator recruitment to AF-2, whereas the AF-1 domain interacts directly with the
coactivators SRC-2, p300 and PCAF (Wansa et al. 2003). Additionally, the LBD of NR4A
proteins adopts a fold resembling the ligand bound state of other nuclear receptors, and
bulky side-chain hydrophobic residues are tightly packed in place of the ligand-binding
pocket (Wang et al. 2003). Thus, a major difference between NR4A and classical
nuclear receptors is ligand-independent regulation. Given the apparent role of NR4A
proteins as a multi-purpose response system to environmental stimulation in various
cellular contexts, it is perhaps fitting that these proteins do not require a specific ligand
for activation.

NR4A proteins regulate target gene expression as monomers, homodimers, and
heterodimers.

The C-terminal LBD of NR4A proteins have lost ligand-binding and transactivation
functions, but this region retains at least one major role: protein-protein dimerization
(Figure 2B).

Dimerization upon DNA binding is a feature of many members of the
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nuclear receptor family, where the DNA binding sites, called hormone response
elements (HRE), typically consist of two direct repeats of the canonical half-site
AGGTCA separated by differing length nucleotide spacers for different nuclear receptor
partner combinations (Yu et al. 1991; Mangelsdorf and Evans 1995; Perlmann et al.
1996). Initial studies using a yeast genetic selection approach, identified the binding site
of NR4A monomers as the NGFI-B response element (NBRE) consisting of the core
nuclear

receptor

binding

site

preceded

by

two

additional

adenosines

(AAAGGTCA)(Wilson et al. 1991). Two highly conserved zinc finger domains (>90%)
within the NR4A DBD mediate the sequence-specific interaction with the core AGGTCA,
but a separate domain, the A-box within the C-terminal extension (CTE), is responsible
for interaction with the two extended A-T base pairs (Wilson et al. 1992). Each of the
three NR4A family members is capable of activating transcription by binding the NBRE
sequence in reporter systems (Paulsen et al. 1995; Zetterstrom et al. 1996a; Cheng et
al. 1997). Activation from certain NBRE variants has been reported to be impaired by
co-expression of combinations of NR4A members (Murphy et al. 1996), suggesting that
NR4A family members may have opposing actions at monomer-regulated target genes.
Later work identified a variant of the Nur response element (NurRE) as a functional
binding site for NR4A1 homodimers in the promoter of POMC (Philips et al. 1997). The
NurRE sequence resembles the NBRE site identified by Wilson and colleagues (Wilson
et al. 1991) but is instead composed of an everted repeat of the octanucleotide
AAAGGTCA separated by 6 base pairs (Maira et al. 1999) (Figure 2B). Interestingly,
different NR4A family members combine to form heterodimers that synergistically
enhance NurRE-mediated gene expression to a greater extent than homodimers alone
(Maira et al. 1999). An additional level of complexity arises from dimerization of NR4A1
and NR4A2, but not NR4A3, with the alpha and gamma isoforms of RXR (Perlmann and
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Jansson 1995; Aarnisalo et al. 2002; Sacchetti et al. 2002), a retinoid receptor that acts
as a partner to a variety of nuclear receptor (Mangelsdorf et al. 1990; Yu et al. 1991).
NR4A-RXR heterodimers bind to DR5 sequences composed of direct repeats of the core
nuclear receptor half-site AGGTCA followed by the NBRE site separated by a 5-bp
spacer between the core half-sites (Figure 2B). In addition to binding DR5 sequences
through RXR and NR4A DBDs, these dimers may be recruited to NBRE sequence
independently of the RXR DBD (Forman et al. 1995). As a partner to several nuclear
receptors, RXR is often a “silent” partner, because RXR ligand-binding capacity can be
suppressed by these interactions (Kurokawa et al. 1994; Forman et al. 1995). In
contrast, NR4A-RXR heterodimers are responsive to the RXR ligand, 9-cis retinoic acid
(Perlmann and Jansson 1995; Zetterstrom et al. 1996a). Strikingly, this ligand
dependence is bestowed on NR4A-mediated activation of NBRE-regulated sequences
even in the absence of the DBD of RXR (Forman et al. 1995). Thus, the ability of NR4A
nuclear receptors to dimerize greatly increases the potential range of targets and means
of NR4A regulation (Figure 2B). Monomeric activation of NBRE can be achieved by
individual NR4A members, or in a retinoic acid-sensitive manner by heterodimers with
RXR at NBRE or DR5 sequences. Further, NurRE-regulated genes can be activated to
varying levels depending on whether they are bound by homodimers or heterodimers
composed of NR4A factors (Maira et al. 1999).

This richness of target sequence

selection may be one factor that allows the NR4A family of transcription factors to be a
general mechanism that engages distinct responses to stimuli in differing cellular
contexts.
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The transcriptional activity of NR4A proteins is regulated by post-translational
modification.

As discussed above, signaling cascades that are important for memory storage regulate
expression of the genes encoding NR4A nuclear receptors. These signaling cascades
also regulate the activity of the newly synthesized NR4A proteins by means of posttranslational modifications.

Shortly after the discovery of NR4A1, this protein was

determined to be heavily phosphorylated by cellular stimulation (Fahrner et al. 1990),
and the extent of this phosphorylation depends on the stimulus (Hazel et al. 1991;
Katagiri et al. 1997). For instance, the MAPK pathway member RSK is capable of
phosphorylating NR4A1 in the C-terminal extension of the DBD (Figure 2A)(Wingate et
al. 2006), an event that has been associated with reduced DNA binding capacity (Hirata
et al. 1993; Li and Lau 1997), impaired transactivation ability (Katagiri et al. 1997; Li and
Lau 1997), and exclusion of NR4A1 from the nucleus (Masuyama et al. 2001). Although
this phosphorylation event appears to be mediated by MAPK members RSK and MSK in
certain cell types (Davis et al. 1993; Wingate et al. 2006), AKT may carry out this role in
other contexts (Masuyama et al. 2001; Pekarsky et al. 2001). Thus, in certain contexts
the MAPK pathway limits the ability of newly synthesize NR4A to drive gene expression
by leading to nuclear export (Figure 1). In contrast, MAPK activity is required for full
induction of NR4A reporters by cAMP in corticotrophs (Kovalovsky et al. 2002). This
regulation was not reflected in Nr4a transcript levels, but instead appeared to be
mediated by MAPK-dependent phosphorylation to enhance the activity of NR4A
transcription factors (Kovalovsky et al. 2002). Another pathway known to be important
for memory formation, cAMP-PKA signaling, is capable of rapidly reversing inhibitory
phosphorylation in the DBD of NR4A, enhancing the DNA-binding and transcriptional
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activity achieved by NR4A dimers but not monomers (Maira et al. 2003). Perhaps this
interplay between MAPK- and PKA-mediated post-translational modifications allows the
activity of stimulus-induced NR4A family members to be fine tuned for particular
responses. A recent study found that NR4A1 is acetylated in the LBD by the histone
acetyltransferase p300 (Kang et al. 2010).

This work goes on to suggest that this

acetylation event blocks the degradation of NR4A1 leading to enhanced expression of
NR4A1 target genes (Kang et al. 2010).

In addition to regulation of Nr4a gene

expression, several proteins involved in long-term memory formation (Hawk and Abel
2010) also regulate the subcellular localization and activity of newly synthesized NR4A
proteins.

NR4A family members are expressed in distinct but overlapping regions of the
brain.

The genes encoding NR4A nuclear receptors were each cloned from neurons or
neuronal precursors and are expressed throughout the brain with both overlapping and
distinct regions of expression (Saucedo-Cardenas and Conneely 1996; Xiao et al. 1996;
Zetterstrom et al. 1996b). Indeed, anatomical profiling of nuclear receptor expression
patterns shows that all three of the Nr4a genes fall into a cluster that is expressed
predominantly in the central nervous system (Figure 3A) (Bookout et al. 2006). The
most striking example of distinct expression profiles is that of Nr4a2, the only Nr4a family
member expressed at high levels in the substantia nigra pars compacta and ventral
tegmental area (Saucedo-Cardenas and Conneely 1996; Xiao et al. 1996; Zetterstrom
et al. 1996b). In contrast, expression of Nr4a1, Nr4a2, and Nr4a3 overlap in areas CA1
and CA3 of the hippocampus (Xiao et al. 1996), although the relative abundance in
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these areas differs for the three genes (Figure 3B). Because the relative levels of NR4A
family members can impact NR4A-mediated transcriptional activity (Murphy et al. 1996;
Maira et al. 1999), these differences in expression may lead to very different target gene
activation profiles in different brain regions.

NR4A2 contributes to development of midbrain dopaminergic circuitry

The bulk of research on the role of NR4A nuclear receptors in the central nervous
system has focused on the role of NR4A2 in the dopaminergic system (Perlmann and
Wallen-Mackenzie 2004). Based on high expression of NR4A2 in tyrosine hydroxylaseexpressing (TH+) dopaminergic neurons found in the ventral tegmental area (VTA) and
substantia nigra pars compacta (SN), the role of this transcription factor in the
development of dopaminergic was examined using knockout mouse lines (Zetterstrom et
al. 1997; Castillo et al. 1998; Saucedo-Cardenas et al. 1998). Homozygous null mice
(Nr4a2-/-) die shortly after birth, but prenatal development of the dopaminergic system is
strongly disrupted by this mutation. Specifically, markers of dopaminergic cell fate fail to
be expressed in ventral dopaminergic precursors, followed by the death of these
precursors around birth (Zetterstrom et al. 1997; Castillo et al. 1998; Saucedo-Cardenas
et al. 1998).

As would be expected, this loss of dopaminergic neurons leads to a

substantial reduction in dopamine levels in the striatum of newborn Nr4a2-/- pups, and a
reduction in dopamine was also observed in heterozygous null (Nr4a2+/-) pups
(Zetterstrom et al. 1997; Castillo et al. 1998; Saucedo-Cardenas et al. 1998). Recently,
a conditional knockout system (see (Hawk and Abel 2010) for review) was used to show
that Nr4a2 plays a cell-autonomous role in the development of dopaminergic neurons
and is required for the maintenance, in addition to the induction, of this cell lineage
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(Kadkhodaei et al. 2009).

Work on the dopaminergic system provides the most

complete characterization of a potential NR4A transcription factor function in the brain,
but the breadth of NR4A roles in other tissues suggests NR4A signaling may contribute
to other processes within the brain.

NR4A function may contribute to the etiology of schizophrenia

The role of NR4A2 in the development and maintenance of dopaminergic neurons in the
VTA and SN has received considerable attention because of the involvement of the
dopaminergic system in neuropsychiatric disorders, such as addiction (Koob and Volkow
2010), depression (Nestler and Carlezon 2006), Parkinson’s (Levesque and Rouillard
2007), and schizophrenia (Kellendonk et al. 2009). Intriguingly, missense mutations that
reduce the activity of NR4A2 have been identified in schizophrenic patients but not
unaffected individuals (Buervenich et al. 2000; Chen et al. 2001). These mutations
represent a small fraction of the patients analyzed (Buervenich et al. 2000; Chen et al.
2001), and some studies have failed to find an association between Nr4a genes and
schizophrenia (Carmine et al. 2003), but given the complex etiology of schizophrenia it is
perhaps not surprising that any single mutation would explain only a small portion of
patients (Kellendonk et al. 2009). Further support for a role of NR4A function in
schizophrenia is provided by the observation that both Nr4a1 and Nr4a2 expression is
reduced in postmortem cortical tissue from schizophrenic patients (Xing et al. 2006).
Interpretation of this observation should be tempered by the fact that treatment with
antipsychotic drugs can alter the expression of Nr4a genes (Beaudry et al. 2000; Werme
et al. 2000; Langlois et al. 2001; Maheux et al. 2005).

Acute treatment with

antipsychotic drugs typically increases Nr4a gene expression, but in some brain regions
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chronic treatment may reduce expression (Beaudry et al. 2000). Increased Nr4a
expression in the striatum and nucleus accumbens appears to be maintained without
sensitization during chronic antipsychotic treatment (Beaudry et al. 2000; Werme et al.
2000), suggesting that these changes could contribute to the efficacy of neuroleptic
drugs.

Further support for a relationship between NR4A function and schizophrenia has come
from studies of Nr4a2 heterozygous null (Nr4a2+/-) mice. This Nr4a2 mutant mouse
model has no apparent reduction in midbrain TH+ dopaminergic neurons at 2-3 months
of age (Le et al. 1999), but displays an age-dependent decrease in TH+ neurons and
striatal dopamine levels between 10 and 15 months of age (Jiang et al. 2005). At birth,
dopamine levels in the brains of Nr4a2+/- mice are reduced significantly (40-50%)
(Zetterstrom et al. 1997; Castillo et al. 1998; Saucedo-Cardenas et al. 1998). At 5
months of age, dopamine levels have normalized to wild-type levels in the striatum, but
reduced dopamine levels are still observed in some regions, such as the prefrontal
cortex and hippocampus of male mice (Rojas et al. 2007). Nr4a2+/- mice have been
proposed as a mouse model of schizophrenia because they display behaviors that are
thought to be endophenotypes of schizophrenia and are responsive to antipsychotic
drugs. For instance, these mice display hyperactivity in novel environments and an
enhanced response to the psychotomimetic drug PCP. The hyperactivity phenotype is
blocked by haloperidol treatment (Rojas et al. 2007). Additionally, Nr4a2+/- mice have
deficits in long-term memory in the hippocampus-dependent passive avoidance task
(Rojas et al. 2007), which is consistent with the observation that schizophrenic patients
often present with cognitive deficits (Nuechterlein et al. 2004). These studies suggest
that Nr4a family function may be involved with specific endophenotypes of
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schizophrenia, but given the constitutive nature of the mutation it is difficult to determine
whether these phenotypes are a consequence of independent functions of NR4A2 in
multiple brain regions or are due to alterations in the dopaminergic system. Further work
is required to determine the contribution of NR4A proteins in non-dopaminergic neurons
to endophenotypes of schizophrenia.

NR4A family members have been implicated in hippocampus-dependent memory.

Despite the identification of NR4A family members as activity-induced transcription
factors in neurons or neuronal precursors nearly 20 years ago, the role of NR4A
transcription factors in activity-dependent neuronal plasticity and memory formation has
only recently begun to be investigated.

The first studies to show activity-dependent

regulation of Nr4a family genes in the intact brain, rather than cell lines, examined
seizure-induced gene expression in the hippocampus, a brain region that is required for
spatial and contextual memory formation (McGaugh 2000; Abel and Lattal 2001; Maren
and Quirk 2004; Abel and Nguyen 2008). The genes encoding both NR4A1 and NR4A2
are robustly induced by seizure activity (Watson and Milbrandt 1989; Pena de Ortiz and
Jamieson 1996; Xing et al. 1997; French et al. 2001).

Further, the seizure-induced

expression of Nr4a1 and Nr4a2 in the hippocampus is attenuated in CREB mutant mice
(Lemberger et al. 2008), demonstrating that these genes are regulated in an activitydependent and CREB-dependent manner in the hippocampus.

As might be predicted from the similarity between the signaling cascades that mediate
memory storage (Hawk and Abel 2010) and those that induce Nr4a genes in various
cellular contexts (Maxwell and Muscat 2006), Nr4a family gene expression increases
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within the hippocampus after learning of hippocampus-dependent tasks (Malkani and
Rosen 2000; Pena de Ortiz et al. 2000; von Hertzen and Giese 2005b; Mizuno et al.
2006). Learning of a spatial discrimination task leads to increased expression of Nr4a2
mRNA in the CA1 and CA3 subregions of the dorsal hippocampus (Pena de Ortiz et al.
2000). Similarly, training in contextual fear conditioning, a hippocampus-dependent task
that involves learning an association between a specific training context and an aversive
foot-shock (Maren 2008), increases expression of Nr4a1 in area CA1 of the dorsal
hippocampus (Malkani and Rosen 2000; von Hertzen and Giese 2005b), an effect that is
blocked in mice with a defect in CaMKII signaling that impairs efficient memory formation
(Irvine et al. 2005; von Hertzen and Giese 2005a). The overlap of mechanisms between
Nr4a gene activation and the mechanisms of memory formation, the observation that
Nr4a family gene expression increases in the hippocampus under conditions that
generate a memory, and the importance of Nr4a family members in a variety of context
for generating changes in cellular physiology in response to environmental signals
together suggest the possibility that NR4A transcription factors may also contribute to
memory formation. Several recent studies provide further support for this hypothesis.
Injection of antisense oligodeoxynucleotides targeting Nr4a2 into the hippocampus
impairs long-term memory and reversal learning in an appetitive spatial learning task
(Colon-Cesario et al. 2006). Consistent with this finding, mice lacking one copy of the
Nr4a2 gene have impaired long-term memory for the hippocampus-dependent passive
avoidance task (Rojas et al. 2007). Also, memory enhancement by intrahippocampal
injection of HDAC inhibitors is accompanied by increased expression of both Nr4a1 and
Nr4a2 (Vecsey et al. 2007).

These studies begin to address the role of NR4A

transcription factors in memory formation, but considerations brought to light by previous
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studies of NR4A function in other cellular and anatomical contexts should be used to
guide work on the role of NR4A nuclear receptors in memory formation.

NR4A transcription factors regulate genes implicated in memory formation.

In addition to the role of signaling mechanisms that activate Nr4a gene expression in the
formation of memories, several of the target genes transcribed in response to NR4A
proteins have been implicated in memory formation (Figure 1). For instance, NR4A2
has been shown to regulate expression of the gene encoding BDNF (Volpicelli et al.
2007), a neurotrophic factor that contributes to the formation of hippocampus-dependent
memories (Lee et al. 2004; Liu et al. 2004; Monteggia et al. 2004; Heldt et al. 2007;
Barnes and Thomas 2008). Expression of several components of the NFκ-B signaling
cascade increase upon overexpression of NR4A proteins (Pei et al. 2006), including the
NFκ-B

family member c-Rel that is required for hippocampus-dependent memory

formation (Levenson et al. 2004; Ahn et al. 2008). Other intriguing NR4A target genes
include two receptor protein tyrosine phosphatases (RPTPs) (Pei et al. 2006; Jacobs et
al. 2009), a class of molecule implicated in excitatory synapse formation (Dunah et al.
2005; Woo et al. 2009), and the protein kinase C target MARCKS that can modulate
memory formation (Calabrese and Halpain 2005; McNamara et al. 2005; Timofeeva et
al. 2010). The established connection between molecules upstream and downstream of
NR4A transcription factors in memory storage provides a strong impetus for further
investigation of the role of this family in memory formation.
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Future directions to examine the role of NR4A function in memory formation.

NR4A family members play differing roles in distinct cell types. Because of the intrinsic
heterogeneity of brain tissue, this issue needs to be considered in the study of NR4A
proteins in memory formation.

Manipulations of NR4A function in a particular brain

region may impact distinct biological processes in different cell types within a single
brain region. For instance, lipopolysaccharide (LPS) injection into the substantia nigra
activates microglia leading to an inflammatory response that destroys tyrosine
hydroxylase-expressing (TH+) dopaminergic neurons (Herrera et al. 2000; Saijo et al.
2009).

Treatment with LPS is accompanied by increased expression of NR4A2 in

microglia and astrocytes, and the knockdown of NR4A2 in these cells speeds neuronal
loss. Thus, it appears that NR4A2 functions in a neuroprotective role by reducing the
NFκ-B-driven astrocytic inflammatory response through a novel interaction with a
transcriptional repression complex (Saijo et al. 2009). In the same brain region, NR4A2
plays a complementary role within midbrain dopaminergic neurons to maintain the TH+
neuronal cell fate in the substantia nigra, presumably through the role of NR4A2 in
activating transcription of target genes important for defining the identity of these
neurons (Kadkhodaei et al. 2009).

The co-occurrence of these two distinct roles in

different cell types within the same brain region highlights the importance using cell-type
specific approaches to investigate the contribution of these pleiotropic genes to memory
formation.

A related concern in studying the role of NR4A proteins in memory formation is that
NR4A proteins may impact memory formation through distinct mechanisms in different
brain regions.

This concern is clearly illustrated by the role of NR4A2 in the
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development and maintenance of the dopaminergic system (Zetterstrom et al. 1997;
Kadkhodaei et al. 2009) and the role of dopamine signaling in memory formation
(O'Carroll et al. 2006; Bethus et al. 2010). Intrahippocampal infusion of D1/D5 receptor
antagonists impairs long-term memory (O'Carroll et al. 2006; Rossato et al. 2009;
Bethus et al. 2010), and intrahippocampal infusion of D1 agonists has even been found
to enhance long-term memory (Rossato et al. 2009).

For these reasons, it will be

important to examine the role of these proteins in learning and memory by specifically
manipulating NR4A function in memory-related brain structures, such as the
hippocampus, without impairing function in midbrain dopaminergic areas.

NR4A family transcription factors contribute to gene expression individually and as
heterodimers. As discussed previously, heterodimers can synergistically enhance
expression at NurRE sites (Maira et al. 1999) or have opposing action at certain NBRE
variants (Murphy et al. 1996).

Thus, reducing expression of a single NR4A family

member could have an effect on target genes controlled by multiple NR4A proteins or
theoretically produce a paradoxical enhancement in expression of certain NR4A targets.
In contrast to the unique requirement for individual family members potentially produced
by the synergistic or opposing interaction of NR4A family members, NR4A family
members appear to be somewhat interchangeable in certain cellular contexts.

For

instance, considerable overlap was observed in the genes regulated by overexpression
of the three NR4A family members in a macrophage-derived cell line (Pei et al. 2006).
In HeLa cells, both NR4A1 and NR4A2 act in a similar manner to promote cell survival
and reduce anchorage dependence (Ke et al. 2004).

Also, the elimination of self-

reactive T cells by TCR-mediated apoptosis appears to be mediated by both NR4A1 and
NR4A3, the two family members expressed in this cell type (Liu et al. 1994; Woronicz et
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al. 1994; Cheng et al. 1997; Winoto and Littman 2002). Mice expressing a dominant
negative form of NR4A1 that inhibits all NR4A family members (Cheng et al. 1997) have
deficits in TCR-mediated T-cell selection (Calnan et al. 1995; Zhou et al. 1996), but
Nr4a1 homozygous null mutant mice have normal T-cell selection, apparently due to
redundant functions of NR4A1 and NR4A3 (Cheng et al. 1997). Thus, an approach that
simultaneously impairs the function of all three NR4A family members was required to
reveal the role of this signaling pathway in TCR-mediated apoptosis. A similar approach
was required to provide compelling genetic evidence that PKA signaling plays a role
long-term memory formation for similar reasons (Abel et al. 1997; Abel and Nguyen
2008), and may be important for understanding the role of NR4A transcription factors in
learning and memory.

Conclusions

Signaling mechanisms that are critical for memory formation regulate the genes
encoding the NR4A family transcription factors, and these genes have increased
expression after learning in brains structures required for memory formation. Functional
analysis of the role of this family in memory has begun for one family member, NR4A2,
but more work is required to establish the importance of these transcription factors in the
cascade of gene expression that mediates memory storage. From a clinical perspective,
a possible contribution of these nuclear receptors to cognitive function is particularly
exciting because they represent potential targets for pharmacological agents. The
connection of this gene family with schizophrenia, a disorder associated with impaired
cognitive performance, suggests that modulation of NR4A function may be a useful
avenue for improving cognitive function in patients with neuropsychiatric disorders.
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Figure Legends

Figure 1. The cAMP-PKA-CREB pathway, a signaling cascade that is critical for
memory formation, induces expression of the genes encoding NR4A nuclear receptors.
Newly translated NR4A proteins translocate into the nucleus to drive transcription of
NR4A target genes. MAPK signaling is capable of activating NR4A-mediated
transcription or reducing this activity by nuclear export of these proteins, depending on
the cellular context. Nuclear export is opposed by PKA signaling. Several NR4A target
genes, including BDNF, c-REL, and receptor protein tyrosine phosphatases (RPTPs),
have been previously implicated in memory formation.

Figure 2. A. NR4A primary protein structure consists of an amino (NH2) -terminal A/B
transactivation domain (TAD) that includes the activator function (AF)-1 region
implicated in coactivator recruitment. The DNA-binding domain (DBD) and C-terminal
extension (CTE) both contribute to target sequence specificity and contain nuclear
localization signals (NLS) that regulate the nuclear import of NR4A proteins. The
carboxy (COOH) -terminal ligand-binding domain (LBD) contains the AF-2 domain and
three putative nuclear export sequences. Phosphorylation sites (pSer) on NR4A proteins
regulate nuclear-cytoplasmic shuttling and DNA-binding capacity. B. NR4A proteins
activate transcription of target genes as monomers at NBRE sites or as dimers as
NurRE sites. Additionally, heterodimers formed between NR4A1 or NR4A2 and RXR (in
orange) confer retinoid-sensitive (9-cis RA) activation to genes targeted by NBRE or
DR5 sites.
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Figure 3.

A. Hierarchical clustering of nuclear receptors based on the anatomical

distribution of nuclear receptor gene expression places each of the three Nr4a genes
(Nr4a1/NGFI-B, Nr4a2/NURR1, Nr4a3/NOR-1) in a cluster that is defined by high
expression in the central nervous system (wheel dendrogram from Bookout et al. 2006).
B. Nr4a family gene expression overlaps in the hippocampus (right panel) but diverges
in other brain regions (left panel). Nr4a gene expression is illustrated in sagittal brain
sections using heat map representations of in situ hybridizations (red indicates highest
expression, blue indicates low expression). Images were obtained from the Allen Brain
Atlas (http://mouse.brain-map.org/).
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Chapter 3: NR4A orphan nuclear receptors
contribute to memory consolidation and the
enhancement of memory by histone deacetylase
inhibitors

Abstract. The formation of long-lasting memories requires a transcription-dependent
consolidation process that converts short-term memory into long-term memory.
Disruption of the interaction between the transcription factor CREB and the histone
acetyltransferase CBP impairs memory consolidation. In contrast, blocking the function
of histone deacetylases enhances long-term memory consolidation. We have found that
the Nr4a family of CREB target genes is induced after learning and that expression of
one member of this family, Nr4a2, is regulated by CBP-dependent activation and HDACmediated repression. Perturbation of HDAC function by genetic ablation of the HDACrecruiting molecule SIN3A enhances memory formation and increases Nr4a2
expression. Following learning, expression of all three Nr4a genes is induced. Therefore,
we examined the role of NR4A function in memory formation and HDAC-induced
memory enhancement using a dominant negative strategy. We found that blocking
NR4A signaling impairs memory consolidation and interferes with the ability of HDAC
inhibitors to enhance memory.
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Introduction

NR4A orphan nuclear receptors were identified nearly twenty years ago as genes
induced by activity in neurons and neuronal precursors (Milbrandt 1988; Law et al. 1992;
Ohkura et al. 1994), but research into the functional role of this transcription factor family
in activity-induced neuronal processes is only beginning. A classic activity-induced
neuronal process is the conversion of a short-term memory into a stable long-term
memory through a time- and transcription-dependent process known as memory
consolidation (see (Hawk and Abel 2010) for review). The molecular underpinnings of
memory consolidation have been most thoroughly studied in a region of the brain known
as the hippocampus during spatial and contextual memory formation (Hawk and Abel
2010). Hippocampus-dependent memory requires two waves of protein synthesis
(Bourtchouladze et al. 1998), cAMP-dependent kinase (PKA) activity (Bourtchouladze et
al. 1998) and de novo transcription (Igaz et al. 2002) in the hours following learning.
Intriguingly, memory consolidation requires many of the same signaling cascades that
activate Nr4a family gene expression (Hawk and Abel 2010), including cAMP (Lee and
Nikodem 2004), PKA (Lee and Nikodem 2004), and cAMP-response element binding
protein (CREB) (Fass et al. 2003).

The Nr4a gene family encodes the three NR4A nuclear receptors, NR4A1 (also known
as NGFI-B, NUR77, and TR3), NR4A2 (also known as NURR1, HZF-3, and RNR1), and
NR4A3 (also known as NOR1, MINOR, and TEC). Because NR4A proteins are ligandindependent nuclear receptors (Wang et al. 2003), the level of gene expression is a
major factor determining NR4A activity. In the hippocampus, Nr4a family expression
comprises a significant portion of the CREB-dependent immediate-early gene response
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after neuronal activity, as Nr4a1 and Nr4a2 are 2 of only 19 genes for which induction
was blocked in CREB conditional mutant mice after seizure activity (Lemberger et al.
2008). Thus, Nr4a expression may be an important step by which CREB initiates a
cascade of gene expression to support the formation of long-term memory. Gene
expression of both Nr4a1 and Nr4a2 increases in neuronal subfields of the hippocampus
after hippocampus-dependent learning (Pena de Ortiz et al. 2000; von Hertzen and
Giese 2005). Further, Nr4a2 heterozygous null mice have impaired hippocampusdependent passive avoidance memory (Rojas et al. 2007), and Nr4a2 knockdown using
antisense oligodeoxynucleotide injection into the hippocampus impairs long-term
memory in a spatial discrimination task (Colon-Cesario et al. 2006). Memory
enhancement by pharmacologically increasing histone acetylation with histone
deacetylase (HDAC) inhibitors requires CREB-mediated gene expression, and HDAC
inhibitor treatment was observed to increase expression of only two of thirteen CREB
target genes, namely Nr4a1 and Nr4a2 (Vecsey et al. 2007). These data suggest that
Nr4a family gene expression may be an important component of the consolidation of
memory and/or the enhancement in memory by HDAC inhibitors, possibilities that we
have pursued in this work.

Here we report that Nr4a gene expression is induced in the hippocampus as part of the
first-wave transcriptional response to contextual fear conditioning. We have also found
that CBP-dependent histone acetylation regulates Nr4a2 expression after learning.
Genetic ablation of a transcriptional corepressor that recruits class I HDACs to specific
genetic loci increases Nr4a2 expression and enhances long-term memory. In further
support of a role for NR4A signaling in both memory consolidation and memory
enhancement by HDAC inhibitors, transgenic expression of a dominant negative form of
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NR4A impairs long-term contextual memory consolidation and blocks memory
enhancement by post-training intrahippocampal infusion of HDAC inhibitors.

Results

Nr4a family gene expression increases after contextual fear conditioning
To address whether Nr4a family members might be associated with memory
consolidation, we examined the expression of Nr4a genes after contextual fear
conditioning, a form of hippocampus-dependent memory (Maren and Quirk 2004). We
chose this task because contextual fear conditioning is associated with two waves of
post-training CREB phosphorylation (Stanciu et al. 2001), and long-term contextual fear
memory is sensitive to inhibitors of translation or PKA during two time windows that
coincide with these two peaks of CREB phosphorylation (Bourtchouladze et al. 1998).
The first of these windows occurs within the first hour after learning, and the second
occurs between the third and sixth hour after learning (Bourtchouladze et al. 1998;
Stanciu et al. 2001). In situ analyses have shown that Nr4a1 expression increases in
hippocampal area CA1 (von Hertzen and Giese 2005) and that Nr4a2 expression
increases in hippocampal areas CA1 and CA3 (Pena de Ortiz et al. 2000) following
training, but have not examined a detailed time course of changes in expression of this
gene family. Therefore, we examined Nr4a family expression over a time course that
spans the two critical windows after learning (Fig. 1). Expression of each of the three
Nr4a family members increases 30 minutes after contextual fear conditioning relative to
homecage expression (Fig. 1a; Nr4a1 p=0.009, Nr4a2 p=0.009, Nr4a3 p=0.028). Nr4a1
and Nr4a2 transcript levels remain elevated at 60 minutes after training (Fig. 1b; Nr4a1
p=0.009, Nr4a2 p=0.174, Nr4a3 p=0.016) and levels of all transcripts return to baseline
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at 120 minutes (Fig. 1c) and 240 minutes (Fig. 1d) after training. HDAC inhibitor
administration into the dorsal hippocampus enhances Nr4a1 and Nr4a2 expression 120
minutes after contextual fear conditioning, effects that were accompanied by increased
histone acetylation at the promoters of these genes (Vecsey et al. 2007), suggesting that
HDAC inhibitors act to prolong expression of these two genes (Vecsey et al. 2007).
These data imply that the genes encoding the NR4A family are a part of the first wave of
gene expression following learning, and the fact that these are transcription factors
suggests that they may contribute to the later second wave of gene expression to
support memory formation.

The CREB interaction domain of CBP is required for Nr4a2 gene expression after
contextual fear learning
Research over the past several years has shown that histone acetylation is an important
component of memory consolidation (Levenson et al. 2004; Guan et al. 2009; Peleg et
al. 2010). Increased histone H3 acetylation occurs in the hours after learning (Levenson
et al. 2004; Peleg et al. 2010), and mice bearing several distinct mutations in the histone
acetyltransferase CBP have defects in long-term memory formation (Oike et al. 1999;
Alarcon et al. 2004; Korzus et al. 2004; Wood et al. 2005; Wood et al. 2006). These
mutations include both point mutations in the histone acetyltransferase (HAT) (Korzus et
al. 2004) and kinase-inducible CREB interaction (KIX) domains of CBP (Wood et al.
2006). Because Nr4a genes are CREB targets (Impey et al. 2004), we examined
whether the KIX interaction domain that recruits CBP to phosphorylated CREB is
required for expression of Nr4a genes after contextual fear conditioning using mice with
homozygous knock-in mutations in the KIX domain of CBP (CBPkix/kix mice) (Kasper et al.
2002). These CBPkix/kix mutant mice have selective deficits in long-term hippocampus77

dependent memory (Wood et al. 2006). No differences were observed in Nr4a family
expression in CBPkix/kix mice without training (Fig. 2a), suggesting that basal expression
of Nr4a genes does not require the kinase-inducible interaction between CREB and
CBP. In contrast, a deficit emerges for Nr4a2 gene expression in CBPkix/kix mice relative
to wild-type littermates at 30 minutes after contextual fear conditioning (Fig. 2b,
p=0.027). The magnitude of this defect is equivalent to the magnitude of Nr4a2 induction
at this time point after training (Fig. 1a), suggesting that the CREB-CBP interaction is
required for Nr4a2 expression after learning. Expression of both Nr4a1 and Nr4a3 was
unaffected in CBPkix/kix mice at 30 minutes after training (Fig. 2b), despite the elevated
expression of both of these genes after conditioning (Fig. 1a). At 60 minutes after fear
conditioning, the deficit in Nr4a2 expression was still observed (Fig. 2c; p=0.030). Nonsignificant trends toward reduced Nr4a1 and Nr4a3 expression are suggested by the
data (Fig. 2c; Nr4a1 p=0.060, Nr4a3 p=0.093), but the magnitude of this potential deficit
for Nr4a1 (11% decrease) is meager in comparison to the level of induction after
conditioning (112% increase; Fig. 1). It is interesting to note that no deficit was observed
in Nr4a2 expression under basal “homecage” conditions (Fig. 2a), suggesting that
mutation of the interaction between CBP and CREB selectively blocks the activitydependent component of Nr4a2 expression (Fig. 2b). To our knowledge, these data are
the first to identify a memory-impairing mutation that selectively blocks de novo gene
expression after learning, and they provide support for the importance of de novo gene
expression in memory formation.
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Contextual fear conditioning induces histone acetylation at the Nr4a2 gene
promoter in a CBP-dependent fashion.
Each of the three Nr4a genes is regulated by CREB (Impey et al. 2004), and CREB
mutation attenuates hippocampal expression of both Nr4a1 and Nr4a2 1 hour after
kainic acid-induced seizure activity (Lemberger et al. 2008). Therefore, it was surprising
to find that only Nr4a2 expression was particularly sensitive to mutation of the CREB
interaction domain of CBP (Fig. 2). One potential explanation of this finding is that only
the Nr4a2 promoter requires CBP-dependent histone acetylation. For instance, the
promoters of the other Nr4a genes may be primed by histone acetylation before
activation, as has been observed for other inducible genes (Shahbazian and Grunstein
2007). To investigate this issue, we examined histone acetylation during the peak of
gene expression at 30 minutes after contextual fear conditioning using chromatin
immunoprecipitation (ChIP) with antibodies specific to acetylated histone H3 (Fig. 3), the
predominant histone modification observed to change in hippocampal area CA1 after
fear conditioning (Levenson et al. 2004). Interestingly, only the Nr4a2 promoter is
significantly increased histone H3 acetylation after fear conditioning (Fig. 3a, p=0.049).
Nr4a1 promoter H3 acetylation was unchanged (p=0.827), and Nr4a3 promoter
acetylation shows a trend toward an increase (p=0.127). The absence of an increase in
histone acetylation at the Nr4a1 promoter 30 minutes after fear conditioning was
surprising, as Nr4a1 expression and promoter histone acetylation were enhanced two
hours after post-training HDAC inhibitor treatment (Vecsey et al. 2007), but this finding
would be consistent with the Nr4a1 gene being primed by histone acetylation prior to
learning and suggests a dissociation between the mechanisms governing induction and
maintenance of gene expression at this promoter.
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Based on the working hypothesis that the heightened sensitivity of Nr4a2 to the CBP KIX
domain mutation may represent a requirement for CBP-dependent histone acetylation at
this promoter, we examined histone acetylation in CBPkix/kix mice and wild-type
littermates at 30 minutes after training. Using ChIP, we found that only the Nr4a2
promoter has a significant reduction in histone H3 acetylation in CBPkix/kix mice after
conditioning (Fig. 3b; Nr4a1 p=0.772, Nr4a2 p=0.049, Nr4a3 p=0.309). Together, these
studies demonstrate that CBP-dependent histone acetylation occurs at the Nr4a2
promoter after learning, and that the CREB-interaction domain of CBP is required for this
acetylation (Fig. 3b) and for the induction of Nr4a2 expression after learning (Fig. 2).
Because the CBP-CREB interaction is important for memory consolidation (Wood et al.
2006) and memory enhancement by HDAC inhibitors (Vecsey et al. 2007), these
experiments suggest that Nr4a family members could contribute to the memory deficit in
CBP mutant mice and/or memory enhancement by HDAC inhibitors.

HDAC2-containing complexes regulate the Nr4a2 promoter
The finding that Nr4a2 expression after learning requires CBP-dependent histone
acetylation suggests the possibility that HDAC complexes actively limit Nr4a2
expression. Repression of Nr4a2 by HDAC complexes is especially interesting because
blocking HDAC activity enhances long-term memory formation (Alarcon et al. 2004;
Korzus et al. 2004; Levenson et al. 2004; Yeh et al. 2004; Guan et al. 2009; Peleg et al.
2010). Inhibitors that block the activity of class I HDACs appear to be most efficacious at
memory enhancement (Guan et al. 2009), and HDAC2 is the predominant class I HDAC
in neurons (MacDonald and Roskams 2008). Deletion of HDAC2 increases long-term
memory, whereas overexpression of HDAC2 impairs memory, suggesting that HDAC2 is
a critical modulator of memory formation (Guan et al. 2009). Therefore, we asked
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whether Nr4a genes are regulated by HDAC2 using ChIP (Fig. 4a). The Nr4a2 promoter
shows significantly greater enrichment with antibodies against HDAC2 than either of the
other two family members (Fig. 4a; vs. Nr4a1 p=0.013, vs. Nr4a2 p=0.024). Thus, the
requirement for CBP-dependent histone acetylation to activate Nr4a2 gene expression
after learning may be a consequence of this preferential recruitment of HDAC2 to the
Nr4a2 promoter. One mechanism that could account for HDAC2 recruitment at the
Nr4a2 promoter is repression by MEF2, a sequence-specific transcription factor that
regulates Nr4a genes in other cellular contexts (Youn and Liu 2000; Flavell et al. 2008)
and can act as a repressor by indirect association with SIN3A, a co-repressor that
recruits HDAC2 (Youn and Liu 2000). Therefore, we performed a ChIP experiment to
examine whether MEF2 is preferentially associated with the Nr4a2 promoter in
hippocampal tissue (Fig. 4b). MEF2 ChIP showed a pattern similar to HDAC2 ChIP with
significantly greater enrichment for the Nr4a2 promoter relative to Nr4a1 (p=0.002) and
Nr4a3 (p=0.001). The higher sensitivity of Nr4a2 to mutation in CBP may be due to
greater recruitment of SIN3A-HDAC2 complexes mediated by the transcription factor
MEF2.

SIN3A-HDAC2 complexes regulate Nr4a2 expression and deletion of Sin3a
enhances long-term memory
If SIN3A-HDAC2 complexes repress Nr4a2 expression, then removing Sin3a from
hippocampal neurons should increase Nr4a2 gene expression. To selectively remove
Sin3a from forebrain neurons, we combined homozygous loxP-flanked Sin3a alleles
(Dannenberg et al. 2005) with a CaMKII-Cre transgene that expresses Cre recombinase
in forebrain neurons (Dragatsis and Zeitlin 2000) (Sin3a cKO mice; Fig. 5a). Deletion
was observed in all neuronal layers of the hippocampus (Fig. 5b), as well as in the
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cortex (Supplementary Fig. 2). Consistent with the HDAC ChIP data, deletion of Sin3a
from forebrain neurons increases hippocampal Nr4a2 expression after contextual fear
conditioning (Fig. 5c, p=0.050). Expression of Nr4a2 increases by a magnitude similar to
the reduction observed with CBP mutation (Fig. 2), suggesting that CBP-dependent
acetylation and SIN3A-targeted deacetylation finely balance the level of Nr4a2
expression in hippocampal neurons.

Inhibition of HDAC activity in the hippocampus enhances long-term memory and
increases hippocampal expression of Nr4a1 and Nr4a2 (Vecsey et al. 2007). Because
we observed that deletion of the HDAC-recruiting factor SIN3A from forebrain neurons
enhances hippocampal Nr4a2 expression, we tested whether this manipulation of HDAC
function similarly impacts long-term memory performance using the fear-conditioning
paradigm (Fig. 5d). As with the contextual version of this task, cued fear conditioning
uses freezing to measure the retention of associations between a conditioned stimulus
and a previously paired foot-shock. When the association between the context and the
shock is measured in the contextual version of this task both the hippocampus and the
amygdala are required. Yet, when a discrete cue, such as a white noise, is associated
with the shock, freezing in response to the cue in a distinct context requires the
amygdala without requiring the hippocampus (Maren and Quirk 2004). Sin3a deletion
enhances long-term contextual fear memory (Fig. 5d; p=0.004) without affecting
hippocampus-independent
performance,

which

cued

requires

fear

memory

learning

without

(p=0.676).
requiring

Short-term

memory

transcription-dependent

consolidation processes, was normal in Sin3a cKO mice (p=0.546), showing that Sin3a
deletion functions like HDAC inhibition to enhance memory consolidation rather than
learning (Vecsey et al. 2007).
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Generation of a NR4A dominant negative transgenic mouse line
Our data demonstrate that learning induces de novo gene expression for all three Nr4a
genes during a window in which new gene synthesis is required for long-term memory
formation (Hawk and Abel 2010). We observed a role for histone acetylation in the
induction of Nr4a2 gene expression, and HDAC inhibitors increase the expression for
both Nr4a1 and Nr4a2 at 2 hours after learning (Vecsey et al. 2007), apparently by
extending expression into a period during which these genes normally return to baseline
conditions (Fig. 1c). Also, Nr4a family members can act as heterodimers, and the
relative amount of individual Nr4a isoforms impacts target gene selection (Murphy et al.
1996; Maira et al. 1999). In other biological contexts, Nr4a family members have been
observed to have redundant functions (Cheng et al. 1997; Ke et al. 2004). In these
contexts, a truncated version of NR4A1 that acts as a dominant negative to silence all
three family members has been an invaluable tool in deciphering the physiological role
of NR4A signaling (Cheng et al. 1997; Robert et al. 2006). Further, the involvement of
NR4A signaling in distinct processes in different cell types (Kadkhodaei et al. 2009; Saijo
et al. 2009) and in different anatomical regions (Kadkhodaei et al. 2009) calls for a celltype and regionally restricted approach to examine the role of NR4A signaling in memory
formation.

For these reasons, we adapted the NR4A dominant negative approach to examine the
role of NR4A signaling in learning and memory. The dominant negative form of NR4A1
(Nr4aDN) contains the DNA-binding and dimerization domains but lacks the
transactivation domain, allowing it to form non-productive dimers with all three NR4A
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proteins (Cheng et al. 1997). As previously reported (Cheng et al. 1997; Robert et al.
2006), Nr4aDN expression efficiently blocks NR4A-mediated transcriptional activity
(Supplementary Fig. 3). We generated a transgenic mouse line expressing the Nr4aDN
construct under control of the tetracycline operator (tetO), which we combined with the
CaMKII-tTA transgene to achieve expression selectively within postnatal excitatory
forebrain neurons (Mayford et al. 1996) (Fig. 6a and Fig. 6b). Transgene expression is
further restricted within the forebrain to the striatum, sparse cortical areas, and
subregions of the hippocampal formation (CA1 and the dentate gyrus) (Fig. 6c).
Transgene expression was not observed in the amygdala or in area CA3 of the
hippocampus (Fig. 6c). Endogenous NR4A2 protein was immunoprecipitated from
hippocampal extracts with antibodies for the YFP tag of the Nr4aDN protein (Fig. 6c),
demonstrating that the dominant negative protein interacts with NR4A proteins in vivo.

NR4A dominant negative transgenic mice display reduced NR4A target gene
expression
To examine whether the Nr4aDN transgene acts as a dominant negative in vivo, we
quantified expression of a known NR4A target gene. Previous reports have
demonstrated that NR4A2 regulates the expression of select Bdnf promoters in midbrain
neurons (Volpicelli et al. 2007), leading us to examine expression from individual Bdnf
promoters in the hippocampi of Nr4aDN mutant mice (Fig. 6d). Bdnf transcripts from
promoters 1 and 2 were decreased by ~50% in Nr4aDN mice (p=0.006 and p=0.005,
respectively). Additionally, overall expression of the common exon (Bdnf8), representing
total Bdnf levels, was significantly reduced (Fig 6d; p=0.020). Reduced expression of an
endogenous Nr4a target in Nr4aDN mice (Fig. 6d) supports findings in other
physiological contexts (Cheng et al. 1997; Robert et al. 2006) that Nr4aDN forms non84

productive dimers with endogenous NR4A proteins (Fig. 6c) to impede NR4A-mediated
gene expression. Because Bdnf contributes to memory formation, including contextual
fear conditioning (Cunha et al.), these findings provide a strong rationale to examine
long-term memory formation in Nr4aDN mutant mice.
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negative

transgenic

mice

display

impaired

long-term

hippocampus-dependent memory
To investigate the role of the NR4A function in memory formation, we examined
associative memory in Nr4aDN mice using the fear-conditioning paradigm (Fig. 7a). As
discussed for Sin3a mice, the contextual version of this task requires hippocampal
function, whereas the cued version requires the same behavioral output without
requiring hippocampal function. Nr4aDN mice have reduced freezing in a 24-hr test of
long-term contextual memory (p=0.03). In contrast, long-term cued fear memory is
unaffected in Nr4aDN mice (p=0.81), suggesting that the deficit in contextual memory
performance is due to defects in hippocampal function. Long-term memory deficits could
result from either impaired learning or impaired memory consolidation, but performance
in short-term memory tests requires learning without requiring transcription-dependent
memory consolidation processes (Hawk and Abel 2010). Therefore, we examined shortterm contextual fear memory in Nr4aDN mice to test whether Nr4a transcription factors
are involved in learning or memory consolidation (Fig. 7a). Nr4aDN mice displayed
levels of freezing in a 1-hr memory test that were similar to wild-type littermates
(p=0.71), demonstrating that Nr4aDN mice are capable of learning the fear conditioning
task but have reduced ability to retain the memory. Suppressing transgene expression
by doxycycline eliminates the long-term memory deficit in Nr4aDN mice (p=0.68,
Supplementary Fig. 4), suggesting that developmental or transgene insertion effects do
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not account for the observed deficit. Thus, it appears that Nr4a family function
contributes to the consolidation of long-term contextual memory.

Memory enhancement by HDAC inhibitors is blocked in Nr4aDN mutant mice
The observation that NR4A signaling plays a role in memory consolidation suggests that
increased Nr4a gene expression after HDAC inhibitor treatment (Vecsey et al. 2007)
could contribute to memory enhancement by these drugs. Because Nr4aDN mice retain
some degree of long-term memory (Fig. 7a), we were able to ask whether HDAC
inhibitors are capable of enhancing memory in these mutant mice (Fig. 7b). We injected
the HDAC inhibitor trichostatin A (TSA) directly into the hippocampus immediately after
contextual fear conditioning. Immunolabeling with an antibody against acetylated H3
(AcH3) illustrates that this method of TSA delivery increases histone acetylation in
hippocampal area CA1 of both wild-type and Nr4aDN mice (Supplementary Fig. 5).
Consistent with our previous findings, post-training intra-hippocampal TSA injection
increases long-term contextual fear memory in wild-type littermates of Nr4aDN mice
(Fig. 7c, p=0.038). However, TSA does not enhance memory in Nr4aDN mutant mice
(p=0.99). Thus, the function of Nr4a family transcription factors is required for memory
enhancement caused by HDAC inhibitors, suggesting that NR4A nuclear receptors
contribute to the enhancement in memory by HDAC inhibition.

Discussion
Increased expression of Nr4a genes after learning (Fig. 1) is consistent with these
genes being important activity-dependent targets of CREB (Lemberger et al. 2008), a
transcription factor involved in long-term memory formation (Josselyn and Nguyen
2005). After learning, expression of one of these family members, Nr4a2, depends on
86

the interaction mediated by the CBP-KIX domain between CREB and the histone
acetyltransferase CBP (Fig. 2), an interaction that is required for efficient memory
formation (Wood et al. 2006). Interestingly, the increased expression of Nr4a2 after
learning is accompanied by increased Nr4a2 promoter acetylation (Fig. 3a) and this
acetylation requires the CREB-CBP interaction (Fig. 3b). The requirement for CBPdependent histone acetylation at the Nr4a2 promoter may be explained by the presence
of HDAC2 (Fig. 3), the putative target of HDAC inhibitors whose inhibition accounts for
the memory-enhancing effect of this class of drugs (Guan et al. 2009). Further,
genetically perturbing HDAC recruitment increases expression of Nr4a2 (Fig. 5c) and
enhances long-term memory formation (Fig. 5d), as has been previously observed with
pharmacological inhibition of HDACs (Alarcon et al. 2004; Korzus et al. 2004; Levenson
et al. 2004; Yeh et al. 2004; Guan et al. 2009). These data suggest that Nr4a2 may be a
central component of memory formation and memory enhancement by HDAC inhibitors.
Yet, the Nr4a genes are expressed in overlapping patterns within the hippocampus
(Zetterstrom et al. 1996) and NR4A transcription factors act as heterodimers and
homodimers (Maira et al. 1999). Indeed, at different target DNA-binding sites both
antagonism (Murphy et al. 1996) and synergistic cooperation (Maira et al. 1999) have
been observed among NR4A proteins. Thus, shifting the relative amounts of NR4A
proteins could dramatically alter the gene expression profile activated by this signaling
pathway. For these reasons, we undertook an analysis of NR4A function in memory
formation using a well-tested dominant negative strategy (Fig. 6) that was developed for
the analysis of NR4A function in other physiological contexts (Cheng et al. 1997; Robert
et al. 2006). Using this approach, we found that impeding NR4A function impairs longterm memory formation (Fig. 7a) and blocks the ability to enhance memory by HDAC
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inhibitors (Fig. 7c), suggesting that this family of nuclear receptors may be a useful
target for modulating memory function.

An important future direction is identification of the mechanism by which NR4A signaling
supports memory formation, which is likely through the activation of downstream target
genes. We found that mice expressing the Nr4aDN transgene have impaired expression
of the gene Bdnf (Fig. 6d), an Nr4a target gene (Volpicelli et al. 2007) that contributes to
memory formation (Cunha et al. 2010). The specific Bdnf promoters, 1 and 2, that were
impaired in Nr4aDN mice are activated in a second, late response to neuronal
stimulation (Marmigere et al. 2001). Thus, regulation of these promoters by NR4A could
represent an important mechanism governing Bdnf expression in later waves of
transcription after learning, an intriguing idea in light of the growing appreciation that
Bdnf contributes to memory at late time-points after learning (Cunha et al. 2010). The
impact of the Nr4aDN transgene on Bdnf expression provides a direct link between
NR4A signaling and an effector gene known to be involved in memory formation (Cunha
et al. 2010), but further work is needed to identify the full range of NR4A target genes
affected by this mutation and to determine which of these targets are functionally
relevant for memory formation.

We have shown that NR4A signaling is required for both contextual memory formation
and enhancement of this form of memory by HDAC inhibitors, but it is important to note
that a requirement for this signaling mechanism does not rule out a possible contribution
from other parallel processes. For instance, the transcription factor C/EBP is another
CREB target gene induced in the first wave of transcription after learning that contributes
to the cascade of gene expression that governs long-term memory formation (Alberini
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2009). Similarly, other signaling cascades are likely to be affected by HDAC inhibitors
and some of these may support memory enhancement. The importance of the present
findings lies in the fact that this transcription factor family is required for both memory
formation and memory enhancement, while also positioned at the intersection between
two competing regulatory mechanisms known to be functionally involved in memory
modulation by histone acetylation. The CREB-CBP pathway is necessary for memory
enhancement (Vecsey et al. 2007) and HDAC2 is the putative target of HDAC inhibitors
for memory enhancement (Guan et al. 2009). Because NR4A signaling is at the
intersection of these two mechanisms known to be involved in memory formation and
memory enhancement (Supplementary Fig. 1), the involvement of NR4A signaling in
both of these processes suggest that these nuclear receptors may be an important node
in the consolidation of long-term memory that could lead to the development of selective
pharmacological strategies to enhance memory.

The present findings are especially exciting because Nr4a polymorphisms have been
identified in schizophrenic patients (Buervenich et al. 2000), and Nr4a gene expression
is reduced in schizophrenic patients (Xing et al. 2006). Thus, impaired Nr4a function
may contribute to the cognitive impairments that accompany this psychiatric disorder.
Future

approaches

to

ameliorate

the

cognitive

impairment

associated

with

neuropsychiatric disorders will greatly benefit from the knowledge that Nr4a family
function is required for memory consolidation and the enhancement in memory formation
by HDAC inhibitors. The specific requirement for NR4A signaling in memory
enhancement by HDAC inhibitors promises to provide more refined targets for memory
improvement than would be possible with even the most specific HDAC inhibitors.
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Methods
Subjects. Mice were maintained under standard conditions consistent with National
Institute of Health guidelines and approved by the Institutional Care and Use Committee.
Food and water were available ad libitum. Adult mice (2-5 months of age) were used for
all experiments. Mice were kept on a 12-h light/12-h dark cycle with all behavioral and
biochemical experiments performed during the light cycle.

CBPkix/kix mutant mice were produced as described in previous work(Kasper et al., 2002;
Wood et al., 2006). Mice heterozygous for the triple point mutation in CBP (Tyr650Ala,
Ala654Gln, and Tyr658Ala) were backcrossed on a C57BL/6J background for at least 10
generations. Heterozygous mutant mice (CBPkix/+) crosses produced homozygous
mutant mice and wild-type littermates for experiments. PCR genotyping for the mutant
CBP allele was performed using PureTaq RTG beads (GE-Amersham) with the primers
KIX-F and KIX-R (Supplementary Table 1) and the following thermal cycling
parameters: 94ºC for 3 min, [94ºC for 30s, 60ºC for 30s, 72ºC for 60s] x34 cycles, 72ºC
for 10 min.

To generate mice with forebrain-specific deletion of Sin3a, we crossed mice
homozygous for a loxP-flanked exon 4 of the Sin3a gene (Sin3aL/L)(Dannenberg et al.,
2005) with mice carrying the CaMKIIα-Cre transgene (L7ag#13)(Dragatsis and Zeitlin,
2000) and heterozygous for a loxP-flanked exon 4 of Sin3a (CaMKIIα-Cre; Sin3a+/L).
This mating produced CaMKIIα-Cre; Sin3aL/L (Sin3a cKO) mice and control littermates
after more than 6 generations of backcrossing of the loxP-flanked Sin3a allele and more
than 9 generations of backcrossing of the CaMKIIα-Cre transgene into C57BL/6J. To
identify mice bearing floxed alleles of the Sin3a gene, PCR was performed with allele91

specific primers 3A-2 and 3A-3 (Supplementary Table 1). To exclude mice with germline deletion of the floxed allele, PCR was performed with the primers 3A-5 and 3A-6
using RedExtract-N-Amp (Sigma, R4775) with the following thermal cycling parameters:
94ºC for 15 min, [94ºC for 30s, 55 ºC for 30s, 72ºC for 30s] x 50 cycles, 72ºC for 10 min.
For CaMKII-Cre genotyping, PCR was performed with the primers Cre1, Cre2, Bglob1,
Bglob2 (Supplementary Table 1) and the following thermal cycling parameters: 94ºC
for 3 min, [94ºC for 45s, 61ºC for 45s, 72ºC for 60s] x30 cycles, 72ºC for 10 min.

The HA-tagged truncated Nr4a1 plasmid(Robert et al., 2006) was PCR amplified
followed by TOPO-TA subcloning in-frame with the YFP tag in the pcDNA6.2 N-YFP-GW
TOPO vector (Invitrogen, #45-1903). The Nr4aDN was fully sequenced to confirm that
no coding mutations were produced during the subcloning process. The YFP-HANr4aDN fragment was removed from pcDNA6.2 using EcoRV and PmeI, and then
ligated into the EcoRV site of MM400 to place the YFP-Nr4aDN into a hybrid intron
structure under control of the tetO(Mayford et al., 1996). MM400-YFP-HA-Nr4aDN was
purified by CsCl gradient centrifugation. The 2.7kb tetO-YFP-HA-Nr4aDN transgene was
removed from MM400 using NotI and PvuI, isolated by agarose gel electrophoresis, and
purified using Elutip columns (Schleicher and Schuell). This purified transgene was
injected into pronuclei of C57BL/6J zygotes (Transgenic and Chimeric Mouse Facility at
the University of Pennsylvania). Founders were crossed to C57BL/6J mice bearing the
CaMKII-tTA (line B) transgene(Mayford et al., 1996). Genotyping was performed by
Southern blotting using transgene-specific probes and/or PCR using primers specific to
the YFP tag and the tTA transgene. PCR genotyping of the tTA transgene was
performed with primers TCRA-F, TCRA-R, tTA-F, tTA-R (Supplementary Table 1).
PCR genotyping of the Nr4aDN transgene was performed with the primers EGFP-F,
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EGFP-R, Actb-F, Actb-R (Supplementary Table 1) using PureTaq RTG beads (GEAmersham) with the following thermal cycling parameters: 94ºC for 3 min, [94ºC for 30s,
60ºC for 45s, 72ºC for 45s] x30 cycles, 72ºC for 10 min.

Behavior. Fear conditioning was performed as previously described(Vecsey et al.,
2007) with handling for 3 days prior to conditioning. Briefly, the conditioning protocol
entailed a single 2-sec, 1.5mA footshock terminating at 2.5 minutes after placement of
the mouse in the novel chamber. Testing was performed at 1 hr or 24 hr after training
over a 5-min interval. For experiments involving TSA injection and Sin3a cKO mice,
0.75-mA shock intensity was used to avoid a ceiling effect. Cued fear conditioning was
performed as described for contextual fear conditioning, except that a 30-s cue (white
noise) co-terminated with a 0.75-mA footshock. For cued testing, mice were placed into
a new context (a distinct conditioning chamber with smooth flat flooring, altered chamber
dimensions, and a different odorant) for 2-min pre-CS period, followed by a 3-min CS
presentation. Conditioning was quantified by measuring freezing behavior, the absence
of non-respiratory movement(Maren and Quirk, 2004) using automated scoring software
(Clever Systems, Reston, VA).

Intrahippocampal TSA injection. TSA injection was performed as previously
described(Vecsey et al., 2007). Bilateral 22 gauge guide cannula were implanted one
week prior to training at the following coordinates: anteroposterior -1.7mm, mediolateral
+/- 1.5mm, 1.5mm below the guide pedestal. Injection cannula extended 0.7mm below
the guide cannula. TSA (16.5mM, AG Scientific) or vehicle (50% ethanol) was injected at
a rate of 0.5 µL/min for 1min immediately after training.
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RNA preparation. Hippocampal dissections were performed on ice after conditioning
alternating between control and experimental groups. RNA preparation was performed
as previously described(Vecsey et al., 2007). Briefly, a modified Trizol RNA extraction
was followed by RNeasy (Qiagen) purification and DNA-free (Ambion) DNase treatment.
RNA concentration was ascertained using a NanoDrop spectrophotometer
(ThermoFisher Scientific).

cDNA synthesis. Real-time PCR template cDNA was produced using the RETROscript
kit (Ambion). For each reaction, 1µg of total RNA was added to a 20µl total reaction
volume composed of 50mM Tris-HCl (pH 8.3), 75mM KCl, 3mM MgCl2, 5mM
dithiothreitol, 500µM each dNTP, 5µM random decamer, 10 units RNase inhibitor, and
100 units MMLV-RT. Control reactions were performed lacking template or reverse
transcriptase. Reactions were performed at 44˚C for 1 hr, followed by heat inactivation at
100˚C for 10 min. Reactions were diluted to 2ng/µl in water to 500µl final volume.

Real-time RT-PCR. Real-time RT-PCR reactions were prepared in 96-well optical
reaction plates with optical adhesive covers (ABI). Each reaction was composed of 9µl
template cDNA (2ng/µl), 1µl Taqman assay, and 10µl 2x Taqman reaction buffer (ABI)
and performed in triplicate. Reactions were performed on the ABI7500 Fast Real-Time
PCR system. Relative quantification of gene expression was based on the ABI users’
bulletin using a ∆∆Ct method and described previously(Vecsey et al., 2007). Fold
difference in mean value for biological replicates is presented, and all samples are
distinct biological replicates. The following Taqman assays were used: Nr4a1Mm00439358_m1, Nr4a2-Mm00443056_m1, Nr4a3-Mm00450074_m1, Bdnf1Mm01334047_m1, Bdnf2-Mm01334044_m1, Bdnf4-Mm00432069_m1, Bdnf594

Mm01334042_m1, Gapdh-Mm99999915_g1, Tuba4a-Mm00849767_s1, and HprtMm01545399_m1.

Chromatin Immunoprecipitation (ChIP). ChIP assays were performed as previously
described(Vecsey et al., 2007). Briefly, finely chopped hippocampi were cross-linked in
2% paraformaldehyde in PBS. Nuclei were prepared and cross-linked chromatin was
extracted as described(Vecsey et al., 2007). Chromatin isolated from nuclei was
sonicated to between 200 and 1000 bp using the Bioruptor (Diagenode) with high power
sonication for 30 minutes with a 1.5-min rest between 1-min pulses of sonication.
Soluble chromatin quantity and fragmentation size was assessed using agarose gel
electrophoresis and Nanodrop (Wilmington, DE) spectrophotometry. For each chromatin
immunoprecipitation (ChIP) assay, 2µg chromatin and 2µg antibody (anti-MEF2A, Santa
Cruz SC313; anti-acetyl histone H3, 1:1000, Millipore #06-599; anti-HDAC2, Abcam,
ab7029) were incubated overnight at 4˚C. Mock immunoprecipitation with pre-immune
IgG was performed in parallel. Immunoprecipitation was performed with 100µl protein G
plus agarose beads (Invitrogen) at 4˚C for 2 hr. Beads were washed in low salt buffer,
high salt buffer, LiCl buffer, and TE buffers as described previously(Vecsey et al., 2007).
Chromatin-antibody conjugates were released from beads in 1% SDS, 100mM NaHCO3
elution buffer. Cross-linking was reversed by overnight incubation at 65˚C in the
presence of 200mM NaCl, followed by proteinase K treatment for 1 hr at 55˚C. DNA was
isolated using MinElute spin columns (Qiagen). Quantitative real-time PCR was
performed with gene promoter-specific ChIP primers (Nr4a1-F, Nr4a1-R, Nr4a2-F,
Nr4a2-R, Nr4a3-F, Nr4a3-R, LINE1-F, and LINE1-R) as listed in Supplementary Table
1. Amplification detection was performed using PowerSYBR green mix (ABI) on the
ABI7500 Fast real-time PCR system using 7500 standard cycling parameters.
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Immunolabeling. For immunolabeling experiments, mice were transcardially perfused
with 4% PFA and coronal sections prepared as previously described(Vecsey et al.,
2007). Sections were permeabilized in 0.1% Triton X-100, then incubated in 1% H2O2 in
PBS for 15 min at room temperature. Sections were given three washes for 5 min each
before being blocked in PBS with 5% pre-immune serum and 0.3% Triton X-100 for 50
min at room temperature. Sections were triple-washed for 5 min each in PBS, then
incubated overnight at 4ºC in PBS with 2% preimmune serum (same species as
secondary; Jackson Immunoresearch, West Grove, PA), 0.3% Triton X-100, and primary
antibody (anti-acetyl histone H3 antibody, 1:1000, Millipore #06-599; anti-GFP, 1:1000,
Invitrogen #A11122; anti-HA, 1:1000, Roche clone 3F10; anti-SIN3A, 1:300, Pharmingen
#610886). Sections were triple-washed for 5 min each in PBS followed by incubation in
biotinylated secondary for 2 hr at room temperature in PBS. For HA
immunohistochemistry, biotinylated goat anti-rat antibody (1:1000, Jackson
Immunoresearch, West Grove, PA) was used as secondary, and biotinylated donkey
anti-rabbit antibody (1:1000, Jackson Immunoresearch, West Grove, PA) was used for
the remaining labeling. Three 5-min washes in PBS were followed with incubation for 1.5
hr at room temperature in Vectastain ABC solution (Vector Laboratories). Sections were
again triple washed in PBS, and then incubated for 10-15 min in 0.2 mg/mL 3,3'diaminobenzidine in PBS, triple washed in PBS with sodium azide (0.01%). Stained
sections were mounted on to glass microscope slides in 0.7% gelatin. Sections were
examined and digitally photographed through a light microscope. For
immunofluorescence, Alexa488-coupled Chicken anti-rabbit IgG (1:5000; Invitrogen)
was used as secondary antibody. After incubation in fluorescent antibody, sections were
washed three times in PBS for 5 min each and then mounted on to glass slides in 50%
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glycerol/PBS containing 20µg/mL propidium iodide. Images were captured using a Leica
(Wetzlar, Germany) TCS SP2 confocal microscope.

Co-Immunoprecipitation. Mice were cervically dislocated 30 min after placement in a
novel context. Hippocampi were dissected and flash-frozen on dry ice. Hippocampi were
homogenized in 1mL of hypotonic lysis buffer (10mM HEPES pH 7.9, 1.5mM MgCl2,
10mM KCl, 1mM EDTA, plus protease and phosphatase inhibitors (Sigma, St. Louis,
MO), followed by rocking at 4°C for 30 min and then centrifugation at 1000 RCF for 15
min at 4°C to pellet nuclei. Nuclear pellets were resuspended in 300µL E1A lysis buffer
(250mM NaCl, 0.1% Nonidet P-40, 50mM HEPES pH 7.0, 5mM EDTA, plus protease
and phosphatase inhibitors (Sigma)) and gently rocked at 4°C for 30 min. Nuclear
lysates were centrifuged at 1000 RCF for 15 min and 4°C to pellet nuclear debris.
Supernatants were diluted to 1mL in E1A lysis buffer containing 1µg biotinylated antiGFP (Invitrogen) and gently rocked overnight at 4°C. For immunoprecipitation, 50µL of
Pierce streptavidin magnetic beads (Thermo, Rockford, IL) were then added to the
protein solution on the following day. Beads were washed three times in E1A buffer and
antigens were eluted in 30µL of 0.1 M glycine (pH 2.5). NuPage SDS loading buffer and
2-mercaptoethanol (Invitrogen) were added to the eluate prior to a 10-min incubation at
100°C. Proteins in samples were resolved by polyacrylamide electrophoresis on a
NuPage 10% BT gel (Invitrogen) and transferred to a PVDF membrane (Invitrogen) for
Western blotting. A 1-hr blocking period in PBS with 0.1% Tween20 (PBST) containing
5% milk was followed by overnight incubation at 4°C in PBST with 5% milk and antiNR4A2 antibody (1:2000; SC991, Santa Cruz Biotechnology, Santa Cruz, CA). Three 5min washes were followed by incubation in PBST with HRP-conjugated goat anti-rabbit
secondary antibody (1:1000, Santa Cruz Biotechnologies). The blot was washed three
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times in PBST for 5 min each and treated with ECL Western Blotting Detection Reagent
(GE Healthcare, Piscataway, NJ) for chemiluminescence detection. Membranes were
then exposed to film for 1-10 minutes and developed for analysis.

Data Analysis. Data are expressed as mean +/- s.e.m. Statistical analysis was
performed in SPSS (version 17) and JMP (version 5). For behavioral experiments,
ANOVAs were performed followed by Student-Newman-Keuls post hoc tests. Gene
expression and ChIP statistical analysis was performed with non-parametric KruskallWallis ANOVAs. Experimenters were blind to genotype, and genotypes were confirmed
after experiments were completed.
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Figure 1. Nr4a family gene expression increases
after contextual fear learning.
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Figure 2. Nr4a2 gene expression after learning
requires the CREB-CBP interaction domain
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Figure 3. Nr4a2 is regulated by
CBP-dependent histone acetylation
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Figure 4. HDAC2 complexes localize to Nr4a2 promoter
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Figure 5. Deletion of Sin3a from forebrain neurons
increases Nr4a2 expression and enhances long-term memory
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Figure 7. Nr4a family function contributes to memory formation
and the enhancement of memory by HDAC inhibitors
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Figure Legends
Figure 1. Nr4a family gene expression increases after contextual fear learning. (a)
Expression for each of the Nr4a genes increases 30 minutes after contextual fear
conditioning (FC) (Nr4a1 p=0.009, Nr4a2 p=0.009, Nr4a3 p=0.028). (b) At 60 minutes
after contextual fear conditioning, Nr4a1 and Nr4a3 transcript levels remain elevated
relative to homecage littermates (Nr4a1 p=0.009, Nr4a2 p=0.175, Nr4a3 p=0.028
p=0.016). (c) At 120 minutes after contextual fear conditioning, expression of each of the
Nr4a family members returns to homecage levels (Nr4a1 p=0.675, Nr4a2 p=0.676,
Nr4a3 p=0.465). (d) Fear conditioning does not alter expression of Nr4a genes at 240
minutes after conditioning (Nr4a1 p=0.754, Nr4a2 p=0.251, Nr4a3 p=0.917). Data are
normalized to wildtype expression levels for each experiment. All error bars denote
s.e.m.

Figure 2. Nr4a2 gene expression after learning requires the CREB-CBP interaction
domain. (a) Nr4a gene expression in CBPkix/kix mice is indistinguishable from wild-type
littermates under homecage (HC) conditions (Nr4a1 p=0.970, Nr4a2 p=0.496, Nr4a3
p=0.910). (b) At 30 minutes after contextual fear conditioning (FC), Nr4a2 gene
expression is impaired in CBPkix/kix mutant mice relative to wildtype littermates (Nr4a1
p=0.999, Nr4a2 p=0.028, Nr4a3 p=0.583). (c) Nr4a2 gene expression is impaired in
CBPkix/kix mutant mice relative to wildtype littermates at 60 minutes after contextual fear
conditioning (Nr4a1 p=0.061, Nr4a2 p=0.030, Nr4a3 p=0.094). Data are normalized to
wildtype expression levels for each experiment. All error bars denote s.e.m.

Figure 3. Nr4a2 is regulated by CBP-dependent histone acetylation. (a) Increased
histone H3 acetylation at the Nr4a2 promoter accompanies increased expression 30
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minutes after contextual fear conditioning (Nr4a1 p=0.827, Nr4a2 p=0.049, Nr4a3
p=0.127). (b) CBPkix/kix mice have significantly diminished H3 acetylation at the Nr4a2
promoter 30 minutes after contextual fear conditioning (Nr4a1 p=0.772, Nr4a2 p=0.049,
Nr4a3 p=0.309). ChIP data are normalized to the retrotransposon LINE1. All error bars
denote s.e.m.

Figure 4. HDAC2 complexes localize to Nr4a2 promoter. (a) HDAC2 was significantly
enriched at the Nr4a2 promoter relative to the Nr4a1 (p=0.013) and Nr4a3 (p=0.024)
promoters. (b) MEF2 immunoprecipitation was significantly greater at the Nr4a2
promoter relative to the Nr4a1 (p=0.002) and Nr4a3 (p=0.003) promoters. ChIP data are
normalized to the retrotransposon LINE1. All error bars denote s.e.m.

Figure 5. Deletion of Sin3a from forebrain neurons increases Nr4a2 expression
and enhances long-term memory. (a) Forebrain-specific deletion of the HDACrecruiting protein SIN3A was achieved by combining loxP-flanked Sin3a alleles with a
CaMKII-Cre recombinase transgene selectively expressed in forebrain neurons,
producing Sin3a conditional knockout (Sin3a cKO) mice. (b) Immunohistochemistry with
an antibody specific to SIN3A shows a loss of the protein in hippocampal neurons of
Sin3a cKO mice, but neuronal expression is clear in wildtype (Wt) littermates. (c) Nr4a2
gene expression is enhanced in Sin3a cKO mice relative to wild-type littermates at 30
minutes after contextual fear conditioning (p=0.050). (d) Sin3a cKO mice have enhanced
long-term contextual fear memory performance (p=0.004), but normal levels of cued fear
(p=0.676) and normal short-term contextual memory (p=0.576). All error bars denote
s.e.m.
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Figure 6. Nr4aDN transgenic mouse line impairs NR4A signaling in the
hippocampus. (a) To impair Nr4a family function in forebrain neurons, a dominant
negative Nr4a transgene (Nr4aDN) under control of the tetracycline operator (tetO) was
regulated by a forebrain specific tetracycline transactivator (tTA) transgene under control
of the CaMKII promoter. (b) In the upper three panels, immunolabeling for the Nr4aDN
HA (brown) with cresyl violet counterstain (purple) shows expression in the
hippocampus, as well as expression in striatum and cortex. Fluorescent immunolabeling
for the YFP tag (middle panels) and propidium iodide counterstaining (lower panels)
illustrate transgene expression in hippocampal subregions CA1 and the dentate gyrus
(DG), but not the amygdala. (c) An antibody to the YFP tag on the transgenic protein coimmunoprecipitates endogenous NR4A2 protein from hippocampal protein extracts,
confirming the ability of the dominant negative to heterodimerize with NR4A proteins in
vivo. (d) Expression of the endogenous Nr4a target gene, Bdnf is reduced in Nr4aDN
mice. Bdnf promoters 1 and 2 have substantially reduced expression in the
hippocampus of Nr4aDN mice (p=0.006 and p=0.005, respectively), leading to a modest
~20% reduction in expression of total Bdnf (Bdnf8) (p=0.020). Expression of the
remaining promoters is unaffected in Nr4aDN mice. All error bars denote s.e.m.

Figure 7. Nr4a family function contributes to memory formation and the
enhancement of memory by HDAC inhibitors. (a) Nr4aDN mice have impaired longterm contextual fear memory (p=0.03), but neither short-term contextual (p=0.71) nor
long-term cued fear conditioning (p=0.81) are impaired. (b) Post-training injection of the
HDAC inhibitor trichostatin A (TSA) into hippocampus of wild-type littermates enhances
24hr contextual fear memory (p=0.038), but fails to enhance memory of Nr4aDN mice
(p=0.99). All error bars denote s.e.m.
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Chapter 3. Supplementary Materials

Model of NR4A regulation during memory consolidation.
We have used genetic, biochemical, and pharmacological studies to reveal that
NR4A signaling contributes to long-term memory formation and the enhancement in
memory by HDAC inhibitors. In our model (Supplementary Fig. 1), the histone
acetyltransferase CBP and SIN3A-coordinated HDAC complexes converge at the Nr4a2
promoter to regulate NR4A signaling after learning. Previous work has found that
memory enhancement by HDAC inhibitors requires the CREB-CBP interaction (Vecsey
et al., 2007) and is mediated by suppression of HDAC2 activity (Guan et al., 2009),
suggesting that the mechanism of memory enhancement is likely at the intersection of
these two opposing factors. We previously demonstrated that expression of the CREB
target genes Nr4a1 and Nr4a2 is enhanced after learning by post-training treatment with
HDAC inhibitors (Vecsey et al., 2007). In this study, we find that expression of all three
Nr4a genes increases after contextual fear conditioning (Fig. 1). Further, Nr4a2
expression after learning requires the CREB-CBP interaction (Fig. 2), is regulated by
CBP-dependent histone acetylation (Fig. 3), and is repressed by HDAC2-SIN3A
complexes (Fig. 4 and Fig. 5c). Elimination of SIN3A from forebrain neurons increases
Nr4a2 expression (Fig. 5c) and enhances long-term memory formation (Fig. 5d).
Because NR4A signaling can be mediated by heterodimers within this nuclear receptor
family, we used a dominant negative transgenic approach (Nr4aDN; Fig. 6) to examine
the functional contribution of NR4A signaling to memory formation (Fig. 7). Blocking
NR4A signaling reduces expression of the NR4A target gene Bdnf (Fig. 6d) (Volpicelli et
al., 2007), a gene that contributes to memory formation (Cunha et al., 2010). Further,
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blocking NR4A signaling impairs long-term memory formation (Fig. 7a) and impedes the
ability of HDAC inhibitors to enhance memory (Fig. 7b).

Sin3a cKO mice lack SIN3A throughout the forebrain.
The Nr4a2 promoter is marked by increased histone acetylation after learning
(Fig. 3a). Further, Nr4a2 expression (Fig. 2) and promoter histone H3 acetylation (Fig.
3b) are sensitive to mutation of the KIX domain interaction between the histone
acetyltransferase CBP and CREB. These findings led us to investigate whether HDACmediated repressive complexes were recruited to the Nr4a2 promoter. As illustrated in
Fig. 4a and 4b, the class I HDAC2 is recruited to the Nr4a2 promoter, as is the
sequence-specific transcription factor MEF2. Importantly, MEF2 has been demonstrated
to recruit class I HDACs to Nr4a gene promoters through SIN3A-containing complexes
(Paris et al., 2004; Youn and Liu, 2000). Therefore, we examined the role of SIN3A in
the regulation of Nr4a gene expression and memory formation (Fig. 5a-d). Elimination of
SIN3A from forebrain neurons was achieved using the Cre-loxP system, in which
homozygous loxP-flanked alleles of Sin3a (Sin3aflox/flox) were combined with a forebrainspecific Cre recombinase transgene (CaMKII-Cre) to generate conditional knockouts of
the Sin3a gene (Sin3a cKO, Fig. 5a). Sin3a cKO mice lack SIN3A protein broadly
throughout the forebrain (Supplementary Fig. 2). Complete deletion is apparent in the
CA1 and dentate gyrus of the hippocampus (Supplementary Fig. 2). Additionally,
deletion occurs in the amygdala (Supplementary Fig. 2d) and the striatum
(Supplementary Fig. 2f). It is interesting to note that a distinct subgroup of SIN3Aexpressing cells is evident in the central nucleus of the amygdala (Supplementary Fig.
2b, arrow). A previous study (Guan et al., 2009) found that ubiquitous deletion of HDAC2
increases both cued and contextual fear memory. Thus, it is possible that this population
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of SIN3A-expressing cells in the amygdala is responsible for the cued fear enhancement
observed in this earlier work and not seen in the Sin3a cKO mice studied here.
Alternatively, there may be distinct mechanisms of HDAC2 recruitment in the amygdala
that are independent of SIN3A. These possibilities will require further experiments
involving region-specific and cell type-specific deletion of HDAC2 and SIN3A.

A truncated form of Nr4a1 (Nr4aDN) blocks Nr4a-mediated gene expression.
In these studies, we have used a dominant negative strategy to impair NR4A
signaling in forebrain neurons (Supplementary Fig. 3). This dominant form of NR4A1
lacks the AF-1 transactivation domain, which is required for induction of target gene
expression by NR4A nuclear receptors (Wansa et al., 2002). Our construct was
generated from a truncated form of Nr4a1 that was used previously to demonstrate a
role of NR4A1 in Leydig cells in the testes (Robert et al., 2006). A very similar truncated
form of NR4A1 was used to demonstrate a role for Nr4a family members in TCRmediated apoptosis (Woronicz et al., 1994). These constructs contain intact DNAbinding domain and dimerization domains that allow the dominant negative to
heterodimerize with endogenous NR4A family members, blocking transcriptional
activation of NR4A target genes (Cheng et al., 1997; Robert et al., 2006). The dominant
negative NR4A efficiently impairs transcriptional activation by each of the three NR4A
family members (Cheng et al., 1997; Robert et al., 2006). To facilitate analysis of the
expression patterns of the dominant negative transgene in the brain, we have
incorporated yellow-fluorescent protein and hemagglutinin tags in place of the aminoterminal transactivation domain (Supplementary Fig. 3a). To confirm that the tagged
dominant negative protein retains the ability to suppress NR4A-mediated transcription,
we performed reporter assays in HEK cells using an NBRE-driven luciferase reporter
111

construct (Pirih et al., 2004). Expression of the NBRE-luc reporter was induced by
equimolar transfection with full length Nr4a2 expression vector (23.4x103 RLU vs 42x103
RLU). To examine the ability of the dominant negative to block this induction, we cotransfected increasing amounts (0, 0.36,1, 2.72, 7.79 µg) of the dominant negative with
constant amounts of reporter (1µg) and Nr4a2 (1µg) vectors. As illustrated in
Supplementary Fig. 3b, expression of approximately one-third the amount of dominant
negative as full-length Nr4a2 reduces induction by approximately 60% (30.5x103 RLU),
consistent with a robust dominant negative mode of action as previously reported
(Cheng et al., 1997; Robert et al., 2006; Woronicz et al., 1994).

Suppression of Nr4aDN transgene during adulthood restores long-term memory
performance.
Selective long-term hippocampal memory deficits in the Nr4a dominant negative
mouse line (Fig. 7a) suggest that NR4A family members play a role in the processes that
underlie memory consolidation. Alternative interpretations of these findings include the
possibility that blockade of NR4A function alters development of the hippocampus or that
the dominant negative transgene has inserted into a locus that is important for memory
formation. To test these possibilities, we took advantage of the ability to suppress
transgene expression by maintaining the mice on a doxycycline-containing diet for 4
weeks after weaning. As illustrated in Supplementary Fig. 4a, doxycycline-containing
food (40 mg/kg) for 4 weeks fully suppresses transgene expression as assayed by
immunohistochemistry for the HA tag. If either developmental defects or transgene
insertion site accounts for memory deficits in the Nr4aDN mice, memory deficits would
be expected to persist in the absence of transgene expression. Instead, we found that
Nr4aDN mice fed a doxycycline diet perform equivalently to wild-type littermates kept on
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the same diet regimen (p=0.87, Supplementary Fig. 4b), suggesting that active
expression of the dominant negative constructs impedes the consolidation of memory.
Thus, it appears likely that NR4A function is an important component of the memory
consolidation process.

HDAC inhibitor injection into the dorsal hippocampus increases histone H3
acetylation.
Previously, we found that post-training injection of the HDAC inhibitor TSA into
the dorsal hippocampus enhances long-term memory formation and increases the
expression of Nr4a1 and Nr4a2 (Vecsey et al., 2007). In the present study, we find that a
similar treatment fails to enhance long-term memory in mice expressing a dominant
negative transgene that blocks NR4A activity (Fig. 7b). In our model of how the
dominant negative blocks memory enhancement (Supplementary Fig. 1), we propose
that the increased expression of Nr4a genes observed after TSA treatment is a
consequence of HDAC inhibition and that the effect of this change in NR4A signaling on
target genes is blocked by the dominant negative. Alternatively, the dominant negative
NR4A could be blocking the ability of HDAC inhibitors to enhance memory by impeding
the increase in histone acetylation caused by treatment with HDAC inhibitors. To
address this possibility and to confirm the efficacy of our HDAC inhibition protocol, we
examined histone acetylation by immunohistochemistry at 1 hour after TSA injection.
Histone H3 acetylation substantially increases at the site of injection in both wild-type
and Nr4aDN mice (Supplementary Fig. 5). As previously observed(Vecsey et al.,
2007), the bulk of increased histone acetylation is focused around areas CA1, the upper
blade of the dentate gyrus in the hippocampus, and along the cannula injection track.
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Figure S1. HDAC inhibitors enhance memory through
regulation of NR4A signaling
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Figure S3. A truncated form of Nr4a1 (Nr4aDN) blocks
induction of reporter by Nr4a2 expression
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Figure S4. Suppression of Nr4aDN transgene during adulthood
restores long-term memory performance
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Figure S5. HDAC inhibitor injection into the dorsal
hippocampus increases levels of AcH3
TSA

Veh

Wildtype

Nr4aDN
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Table S1.Primer sequences for PCR genotyping
and gene-specific chromatin immunoprecipitation
Name
TCRA-F
TCRA-R
tTA-F
tTA-R

Purpose

EGFP-F
EGFP-R
Actb-F
Actb-R

Nr4aDN
Nr4aDN
Nr4aDN
Nr4aDN

3A-2
3A-3
3A-4
3A-6

Sin3a
Sin3a
Sin3a
Sin3a

Cre1
Cre2
Bglob1
Bglob2

Cre
Cre
Cre
Cre

KIX-F
KIX-R

CBPkix genotyping
CBPkix genotyping

5’-TAG TTC CCT TGT GCC ACC TT-3’
5’-TCC CAG TGA TAC CAG CAT ACC-3’

Nr4a1-F
Nr4a1-R
Nr4a2-F
Nr4a2-R
Nr4a3-F
Nr4a3-R
LINE1-F
LINE1-R

ChIP
ChIP
ChIP
ChIP
ChIP
ChIP
ChIP
ChIP

5’-CCC TTG TAT GGC CAA AGC TC-3’
5’-CTC CGC AGT CCT TCT AGC AC-3’
5’-CCG TTC CCA CCT TAA AAT CA-3’
5’-CTG CCA ACA TGC ACC TAA AG-3’
5’-GAG GGA GGA GGA GGG TGA CGT A-3’
5’-CAT AGA GTG CCT GGA ATG CGA GA-3’
5’-AAA CGA GGA GTT GGT TCT TTG AG-3'
5’-TTT GTC CCT GTG CCC TTT AGT GA-3’

tTA
tTA
tTA
tTA

genotyping
genotyping
genotyping
genotyping
genotyping
genotyping
genotyping
genotyping

flox
flox
null
null

genotyping
genotyping
genotyping
genotyping

genotyping
genotyping
genotyping
genotyping

primer
primer
primer
primer
primer
primer
primer
primer

Sequence
5'-CAA ATG TTG CTT GTC TGG TG-3'
5'- GTC AGT CGA GTG CAC AGT TT-3'
5'-CGC TGT GGG GCA TTT TAC TTT AG -3'
5'-CAT GTC CAG ATC GAA ATC GTC-3'
5'-CCT ACG GCG TGC AGT GCT TCA GC-3'
5'-CGG CGA GCT GCA CGC TGC GTC CTC-3',
5’-GAT GAC GAT ATC GCT GCG CTG GTC G-3’
5’-GCC TGT GGT ACG ACC AGA GGC ATA C-3’
5’-CAG ATC CTA TTC CAG GTG TCA AAG-3’
5’-CAT GTT CAT GTT TAG ATA TAC TTC G-3’
5’-AGC CAG CCC TGA GAC TAG TGA TAA AC-3’
5’-GGG GGA ATG CTG TGT TTT AGG TAT G-3’
5’-CTG CCA CGA CCA AGT GAC AGC-3’
5’-CTT CTC TAC ACC TGC GGT GCT-3'
5’-CCA ATC TCC TCA CAC AGG ATA GAG AGG GCA GG-3'
5’-CCT TGA GGC TGT CCA AGT GAT TCA GGC CAT CG-3'
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Supplementary Figure Legends
Supplementary Figure 1. HDAC inhibitors enhance memory through regulation of
NR4A signaling. Shown is a model of how HDAC inhibitors may enhance memory
through modulation NR4A signaling through regulation of Nr4a2 gene expression.
SIN3A-HDAC complexes basally repress the Nr4a2 promoter, creating a repressive
hypoacetylated state. This repression may be targeted by sequence-specific SIN3Arecruiting factors, such as MEF2. Learning activates second messenger signaling
systems that trigger activation of kinases, such as cAMP-dependent kinase (PKA),
mitogen-activated kinase (MAPK) and calcium/calmodulin-dependent kinases (CaMKs).
These kinase pathways converge to phosphorylate CREB family transcription factors, an
event that is required for interaction with the histone acetyltransferase CBP. Our data
show that CBP-dependent histone acetylation increases at the Nr4a2 promoter after
learning, suggesting that the hypoacetylated Nr4a2 promoter requires the histone
acetyltransferase activity of CBP to overcome a repressive basal chromatin state.
Removing SIN3A from neurons increases the expression of Nr4a2 and enhances longterm memory. By blocking SIN3A-HDAC2 complexes, HDAC inhibitors increase the
expression of Nr4a2, leading to increased expression of NR4A-regulated effectors, such
as BDNF.

Supplementary Figure 2. Sin3a cKO mice lack SIN3A throughout the forebrain.
SIN3A immunoreactivity is diminished throughout the hippocampus of Sin3a cKO mice
(b) relative to wildtype littermates (a). Some deletion occurs in the amygdala (d), but a
distinct cluster of SIN3A expressing cells is retained in the central nucleus of the
amygdala (arrow). Deletion is apparent in the striatum of Sin3a cKO mice (e) relative to
the striatum of wildtype littermates (f).
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Supplementary Figure 3. A truncated form of Nr4a1 (Nr4aDN) blocks induction of
reporter by Nr4a2 expression. (a) The transactivation domain of Nr4a1 was replaced
by yellow-fluorescent protein (YFP) and hemagglutinin (HA) tags. (b) Co-transfecting
increasing amounts of Nr4aDN (DN) into HEK293 cells with constant amounts of full
length Nr4a2 (FL) and the Nr4a family luciferase reporter (NBRE-Luc) impairs luciferase
production (p=0.007), confirming that this Nr4aDN construct indeed acts as a dominant
negative within the Nr4a family. Error bars denote s.e.m.

Supplementary Figure 4. Suppression of Nr4aDN transgene during adulthood
restores long-term memory performance. Mice were reared on standard rodent chow
and then placed on a doxycycline-containing diet at four weeks of age. (a) Nr4aDN
protein was undetectable after 4 weeks of doxycycline treatment. Suppression of
transgene expression is shown by comparison of immunohistochemical staining for the
HA tag in 2 month old Nr4aDN mice never on a doxycycline diet, “No Dox,” versus
Nr4aDN mice after 4 weeks of doxycycline treatment, “4 wks Dox”. (b) After 4 weeks of
doxycycline treatment, no difference in 24-hr contextual memory performance was
detected between Nr4aDN mice and wild-type littermates (p=0.87, n=12 mice/group).

Supplementary Figure 5. HDAC inhibitor injection into the dorsal hippocampus
increases levels of AcH3. Immunolabeling for acetylated H3 was performed 1 hr after
intrahippocampal TSA injection. In both wildtype and Nr4aDN mice, histone H3K9/K14
acetylation is robustly increased in area CA1 at the site of TSA injection (TSA) relative to
vehicle injection (Veh).
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Supplementary Table 1. Primer sequences for PCR genotyping and gene-specific
chromatin immunoprecipitation. Sequences are listed for each of the primers used in
this manuscript. The “name” refers to usage in the corresponding methods section
(“purpose”).
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Chapter 4: Post-training intrahippocampal
inhibition of class I histone deacetylases
enhances long-term object location memory

Abstract. Long-term memory formation involves covalent modification of the histone
proteins that package DNA. Reducing histone acetylation by mutating histone
acetyltransferases impairs long-term memory, and enhancing histone acetylation by
inhibiting histone deacetylases (HDACs) improves long-term memory. Previous studies
using HDAC inhibitors to enhance long-term memory have focused on the fearconditioning task using broad-spectrum HDAC inhibitors. We have found that posttraining intrahippocampal administration of the broad-spectrum HDAC inhibitor
trichostatin A (TSA) or the class I HDAC-selective inhibitor MS275 enhances long-term
object location memory, supporting a role for class I HDACs in the enhancement of
hippocampus-dependent memory induced by HDAC inhibition.

Chapter in press as:
Hawk JD, Florian C, Abel T. 2011. Post-training intrahippocampal inhibition of class I
histone deacetylases enhances long-term object location memory. Learn Mem, in press.
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The formation of a long-term memory requires de novo gene transcription in the hours
following learning (Hawk and Abel 2010). Covalent modifications, such as acetylation,
occur on the histone proteins that package genes to guide transcription (Jenuwein and
Allis 2001). It has become clear that histone acetylation contributes to memory formation
(Wood et al. 2006b; Barrett and Wood 2008; Sweatt 2009; Morris et al. 2010). Histone
acetylation increases after learning (Levenson et al. 2004; Chwang et al. 2006; Bredy et
al. 2007; Peleg et al. 2010), and the histone acetyltransferase CREB-binding protein
(CBP) is critical for memory storage (Oike et al. 1999; Alarcon et al. 2004; Korzus et al.
2004; Wood et al. 2005; Wood et al. 2006a). Specific point mutations in CBP that block
the recruitment of CBP to CREB (Wood et al. 2006a) or that eliminate the histone
acetyltransferase activity of CBP (Korzus et al. 2004) selectively impair long-term
memory. Also, the contextual fear memory deficit observed in mice lacking one copy of
CBP is ameliorated by pharmacologically inhibiting the histone deacetylases (HDACs)
that oppose CBP (Alarcon et al. 2004), presumably through enhancing the efficacy of
histone acetylation by the CBP that remains.

Treatment of rodents with inhibitors of histone deacetylases (HDACs) enhances longterm memory (Alarcon et al. 2004; Korzus et al. 2004; Levenson et al. 2004; Yeh et al.
2004; Lattal et al. 2007; Vecsey et al. 2007; Bredy and Barad 2008; Guan et al. 2009;
Stefanko et al. 2009; Peleg et al. 2010; Roozendaal et al. 2010). Most previous studies
examined the hippocampus-dependent contextual fear-conditioning task (Alarcon et al.
2004; Levenson et al. 2004; Vecsey et al. 2007; Guan et al. 2009; Peleg et al. 2010) or
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extinction of fear memory (Lattal et al. 2007; Bredy and Barad 2008). Recently, memory
enhancement by HDAC inhibitor treatment was observed for object recognition memory
(Stefanko et al. 2009). In contrast to contextual fear conditioning (Vecsey et al. 2007), the
effect of HDAC inhibition on object recognition memory does not require the CREBCBP interaction (Stefanko et al. 2009). This mechanistic distinction is supported by an
anatomical dissociation in the effect of HDAC inhibitors on different forms of objectbased memory (Roozendaal et al. 2010). Injection of the HDAC inhibitor sodium
butyrate into the insular cortex of rats enhances object recognition memory without
affecting object location memory, whereas sodium butyrate administration into the
hippocampus enhances object location memory without impacting object recognition
memory (Roozendaal et al. 2010). These findings are consistent with our recent
observation that the hippocampus is required for object location memory but not for
object recognition memory (Oliveira et al. 2010) and suggest that the object location
memory task may be a useful tool to examine the mechanisms of enhancement in
hippocampus-dependent

memory

by

HDAC

inhibitors.

Yet,

the

ability

of

intrahippocampal HDAC inhibitor treatment to enhance performance in this task has not
been tested in mice.

HDAC inhibitors used for the study of memory typically act on both class I and class II
HDACs. For instance, trichostatin A (TSA) and suberoylanilide hydroxamic acid
(SAHA) inhibit a variety of class I and class II HDACs with similar efficacy (Wu et al.
2004; Khan et al. 2008). Yet, recent experiments suggest that HDAC2, a class I HDAC,
may be the functionally relevant target of HDAC inhibitors involved in memory
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enhancement (Guan et al. 2009). Also, the common target of HDAC inhibitors that
improve memory in an Alzheimer’s mouse model appears to be class I HDACs (Kilgore
et al. 2010). These results suggest that a class I-selective HDAC inhibitor may be as
efficacious for memory enhancement as drugs that target both class I and II HDACs.
MS275 is a potent and selective class I HDAC inhibitor (Suzuki et al. 1999; Simonini et
al. 2006; Beckers et al. 2007; Khan et al. 2008) that has been found to alter depressivelike behavior mediated by HDAC2 (Covington et al. 2009), but it is not known whether
this compound is effective at enhancing long-term memory.

In the present study, we examine the ability of HDAC inhibitors to enhance object
location memory in mice. We find that post-training intrahippocampal injection of the
HDAC inhibitor TSA enhances long-term object location memory, suggesting that the
enhancement in memory mediated by HDAC inhibitors may apply broadly to
hippocampus-dependent memory. Further, post-training intrahippocampal administration
of the class I-selective inhibitor MS275 produces a similar enhancement in long-term
memory, supporting a specific role of class I HDACs in the enhancement of
hippocampus-dependent memory.

Results

We first sought to establish whether HDAC inhibition enhances long-term object location
memory in mice using the HDAC inhibitor TSA. HDAC inhibitor or vehicle was
delivered to the dorsal hippocampus through guide cannulae (Fig. 1A). Administration of
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TSA by this method increases histone acetylation in the hippocampus within 30 minutes
of administration with acetylation returning to basal levels within 24 hours of injection
(Vecsey et al. 2007). When administered immediately after fear conditioning, TSA
selectively enhances long-term contextual fear memory (Vecsey et al. 2007). Using the
same method of post-training intrahippocampal delivery for the GABA receptor type A
agonist muscimol, reversible inactivation of the hippocampus prevents memory
formation in the object location memory task (Oliveira et al. 2010).

The hippocampus-dependent object location memory task exploits the observation that
mice explore objects more when the position of the object is changed relative to previous
experiences (Save et al. 1992). Mice were habituated to the training context by allowing
them to explore the empty training arena for 6 minutes in the absence of objects. After
habituation, training consisted of re-introducing the mice to the arena containing novel
objects (Fig. 1B). This training was repeated with the same objects in the same positions
for a total of three 6-minute training sessions with an inter-training session interval of 3
minutes. Over the course of the three training sessions, object exploration time gradually
decreased (F(2,23)=50.4, p<0.001). Object exploration times in training sessions 1, 2, and
3 were 32.4 +/- 2.9 sec, 18.6 +/- 1.5 sec, 10.0 +/- 0.8 sec, respectively, suggesting that
mice acquired information about the objects.

Immediately after the last training session, TSA or vehicle was delivered bilaterally to the
hippocampi (Fig 1B). No difference was observed in exploration time during training
between mice that would ultimately be treated with TSA or vehicle (F(1,24)=2.105,
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p=0.160). Twenty-four hours after training, the mice were re-introduced to the training
arena with the displaced object (DO) moved to a new location, whereas a symmetrically
positioned non-displaced object (NDO) was not moved (Fig. 1B). No difference in
exploration time was observed during training between the objects that would ultimately
be the DO and the NDO (Fig. 1C, F(1,24)=1.50, p=0.233). Preference for the DO was
calculated as the percentage of object exploration time dedicated to this object. During
training, preferences for the future DO were at approximately chance levels (Fig. lD).
During the 24-hour test of long-term object location memory, TSA-treated mice showed
a significant increase in preference for the DO relative to the final training session (paired
samples t-test, p=0.017). In contrast, mice treated with vehicle did not show increased
preference for the DO (paired samples t-test, p=0.886). Because HDAC inhibitors were
injected after training, these data are in agreement with previous observations that HDAC
inhibitors enhance the consolidation of hippocampus-dependent memory (Vecsey et al.
2007). Further, these data are consistent with a role of the hippocampus in object location
memory (Oliveira et al. 2010) and the ability of HDAC inhibitors to enhance
performance in this task (Roozendaal et al. 2010).

We next tested the ability of the class I-selective inhibitor MS275 to improve long-term
memory in the object location memory test. Training and injection protocols were
identical to those described for TSA, except that MS275 and the appropriate vehicle were
infused after training. Object exploration time gradually decreased with training sessions
(F(2,27)=37.175, p<0.001). For training sessions 1, 2, and 3, total object exploration
times for the training sessions were 24.4 +/- 1.7 sec, 18.7 +/- 1.6 sec, 11.2 +/- 1.2 sec,
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respectively. No difference was observed during training between mice that would
ultimately be treated with MS275 or vehicle (F(1,28)=0.60, p=0.445), nor was a
difference observed during training between the objects that would ultimately be the DO
and the NDO (Fig. 2A; F(1,28)=0.214, p=0.647). Consistent with this observation, the
percent preference for the DO was approximately 50% during training (Fig. 2B). Testing
with the object displaced at 24 hours after training showed that the preference for the DO
increases in MS275-treated mice relative to the last training session (paired samples ttest, p=0.019). Vehicle injected mice did not show any change in preference for the DO
(paired samples t-test, p=0.539). Thus, our data suggest that MS275, like TSA, is able to
enhance long-term memory for the location of objects. The injection of HDAC inhibitors
after acquisition and the lack of a direct biochemical effect on histone acetylation at 24
hours after injection (Vecsey et al. 2007) together suggest that the observed increase in
memory is likely to be mediated by improved consolidation. To our knowledge, these
data are the first to show that treatment with a class I-selective HDAC inhibitor enhances
hippocampus-dependent memory.

Discussion

HDAC inhibitors can cause a variety of undesirable side-effects (Prince et al. 2009), so
identifying the most selective inhibitor capable of improving cognitive function is an
important goal. Here, we show that inhibition of class I HDACs using MS275 facilitates
long-term memory performance in a hippocampus-dependent spatial object location
memory task. Class I HDACs include HDAC1, HDAC2, HDAC3, and HDAC8, but
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MS275 shows a preference for HDAC1 and HDAC2 relative to HDAC3 and does not
appreciably inhibit HDAC8 (Hu et al. 2003; Vannini et al. 2004; Inoue et al. 2006),
suggesting that either HDAC1 or HDAC2 is the critical target of MS275 for memory
enhancement. Expression of HDAC1 is highest in neuronal precursors and glia, but
HDAC2 is expressed heavily in mature neurons (MacDonald and Roskams 2008).
Transgenic expression of mutant forms of the histone acetyltransferase CBP selectively
in neurons causes long-term memory deficits (Korzus et al. 2004; Wood et al. 2005).
Similarly, overexpression of HDAC2 in neurons causes memory impairments, whereas
neuronal overexpression of HDAC1 does not impact memory formation (Guan et al.
2009). Thus, our findings are consistent with genetic studies suggesting that neuronal
HDAC2 may be a key target of HDAC inhibitor activity to enhance long-term memory,
but it is important to note that a role of HDAC1 or HDAC3 cannot be excluded by the
present study.

Neuropsychiatric disorders such as depression and schizophrenia are accompanied by
impaired cognitive function. Histone deacetylase inhibitors are a promising class of drugs
for the amelioration of cognitive deficits in these disorders. Previous studies in rats found
that long-term object location memory is enhanced by intrahippocampal injection of
sodium butyrate (Roozendaal et al. 2010), but this is the first study to demonstrate that
HDAC inhibitors enhance this form of memory in mice. Because peripheral MS275
administration has been reported to increase hippocampal histone acetylation (Simonini
et al. 2006), it will be an intriguing future direction to determine whether peripheral
administration of MS275 improves hippocampus-dependent memory, as we observed
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with intrahippocampal administration. The use of mice in these studies is important
because pharmacological and genetic approaches can be combined in mice to define the
precise molecular mechanisms that underlie the enhancement in hippocampus-dependent
memory by HDAC inhibitors. Using such a combined approach is likely to yield insight
into the processes targeted by HDACs to enhance memory, a goal that will be a critical
step toward a truly selective pharmacological strategy to enhance cognitive performance.

Contributing Authors
Joshua D. Hawk, Cedrick Florian, and Ted Abel

Author Contributions
Experiments were conceived by J.D.H., C.F., and T.A. Cannulations and injections wre
performed by J.D.H. Behavioral training and testing was performed by C.F. The
manuscript was prepared by J.D.H. with input from C.F. and T.A.

Acknowledgements
We thank Shane Poplawski, Mathieu Wimmer, and Robbert Havekes for comments on
the manuscript and experimental design. This work was funded by NIH R01 MH060244
to T.A. Further funding from NIH Predoctoral Training Program in Genetics (T32-GM008216-20) provided support to J.D.H.

131

Materials and Methods

Subjects
Male C57BL/6J mice between 2 and 3 months of age were used in all experiments. Food
and water were provided ad libitum. All experiments were performed in the light phase of
a 12-hr light/dark cycle. At the time of cannulation, mice were singly housed for a 1week recovery period prior to experimentation. All experiments were approved by the
Institutional Animal Care and Use Committee of the University of Pennsylvania and
conducted according to National Institutes of Health guidelines.

Cannulation
Bilateral 22-gauge guide cannula (Plastics One, Roanoke, VA) were implanted by
stereotactic surgery to guide injection into the dorsal hippocampus targeting coordinates
anteroposterior -1.7 mm, mediolateral +/- 1.5mm, and dorsoventral -1.5 mm relative to
bregma. Guide cannulae were held in place by glass-ionomer dental cement (Ketac-Fil
Plus, 3M ESPE).

Injections
Injections were performed immediately after training. A 5µL Hamilton syringe (Reno,
NV) was operated by a Harvard Apparatus (Natick, MA) Pump II Dual Syringe
micropump to infuse 0.5µL of vehicle or HDAC inhibitor into each hippocampus over
the course of 1 minute. Injection cannulae were left in place for 1 minute after injection
to allow diffusion. Injections were complete within 5 minutes after the last training
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session. TSA (AG Scientific, San Diego, CA) was dissolved in 50% ethanol at a
concentration of 16.5mM. MS275 (Sigma-Aldrich, St. Louis, MO) was dissolved in 1%
DMSO at a concentration of 1mM.

Object location memory task
Object location memory experiments were performed in open rectangular training arenas
(40cm x 32cm) with wall height of approximately 30cm and a visual cue affixed to one
wall. The experimental design has been described previously (Oliveira et al. 2010). Mice
were handled in the experimental room for 1 minute per day for 3 days prior to training.
On the day of training, mice were placed into the training arena for a total of four 6minute sessions with an inter-session interval of 3 minutes in the home cage. The first
session consisted of a context habituation period without objects in the arena. In the next
three sessions, mice were placed in the training arena with three distinct objects: a glass
bottle, a plastic cylinder, and a metal tower. Twenty-four hours after training, mice were
placed into the original training arena with one of the two objects in symmetrical
positions displaced to a new location (displaced object, DO), whereas the other object in
an equivalent position was not moved (non-displaced object, NDO). The middle object
was used as a reference object only, as exploration of the object in the center of the arena
was reduced in comparison to the symmetrically placed outer objects (data not shown).
Mice were allowed to explore the arena and objects for 6 minutes. Exploration was
recorded during training and testing on a digital camera for subsequent scoring of time
spent exploring objects. Exploration was considered as time when the mouse was
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oriented toward the objects with nose in very close proximity to the object, and was
scored by an experimenter blind to drug treatment.

Data analysis
Repeated measures ANOVAs were used to examine training and testing data for object
exploration time in SPSS (version 16). Percent preference was calculated as time spent
exploring the displaced object (DO) relative to the total time spent exploring both the
non-displaced object (NDO) and displaced object, i.e. DO/(NDO+DO), and paired
samples t-tests were used for planned comparisons of final session training preference to
testing preference.
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Figure 1. Post-training intrahippocampal TSA administration
enhances long-term object location memory
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Figure 2. Post-training intrahippocampal MS-275 administration
enhances long-term object location memory
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Figure Legends
Figure 1. Post-training intrahippocampal injection of the class I and II HDAC inhibitor
TSA enhances long-term object location memory. (A) Illustration of cannula placement in
the dorsal hippocampus. Coronal brain slices were stained with cresyl violet. (B)
Schematic diagram illustrating the object location memory task during training (left
panel) and testing (right panel). A visual cue was attached to one wall (‘cue’). After the
third training session, mice were injected with TSA or vehicle. Testing was performed 24
hours after training. (C) During the three training sessions, exploration time gradually
decreased (p<0.001) for both the object to be displaced (DO) and the non-displaced
object (NDO). No difference was observed between exploration time for the DO and
NDO (p=0.223). (D) Mice injected with TSA showed increase preference for the DO
during the testing session relative to the last training session (p=0.017), whereas vehicleinjected mice did not (p=0.886). Equivalent exploration of both objects is indicated with
a dashed line at 50% (“chance”). Error bars represent s.e.m.

Figure 2. Post-training intrahippocampal injection of the class I-selective HDAC
inhibitor MS275 enhances long-term object location memory. (A) During the three
training sessions, exploration of the displaced object (DO) and the non-displaced object
(NDO) decreased (p<0.001). No difference was observed in exploration time between the
DO and the NDO (p=0.647). (B) Preference for the DO increased in mice injected with
MS275 during the testing session relative to the last training session (p=0.019), whereas
no increase in preference was observed in vehicle-injected mice (p=0.539). Equivalent
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exploration of both objects is indicated with a dashed line at 50% (“chance”). Error bars
represent s.e.m.
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Chapter 5: Genome-wide analysis reveals
gene expression defects in CBPkix/kix mutant mice

Abstract. Long-term memory formation requires de novo transcription after learning.
CBP is a transcriptional activator that modifies the chromatin environment of target
genes to facilitate transcription by acetylating the histone proteins that package DNA.
Histone acetylation is an important functional role of CBP recruitment during memory
formation, but the proper targeting of CBP is also required for memory formation. A
selective mutation in a single domain of CBP that interacts with phosphorylated CREB
(KIX) impairs the formation of long-term hippocampus-dependent memory. Therefore,
we have examined the effect of CBP KIX domain mutation on hippocampal gene
expression using microarray analysis with and without training in a hippocampusdependent long-term memory task, contextual fear conditioning. We find that gene
expression is impaired under the home-cage condition, but that many additional genes
are impaired after fear conditioning. The importance of the CBP-KIX domain for memory
formation suggests that these genes may contribute to memory storage.
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The formation of a long-lasting memory requires new gene synthesis. As a result,
transcription factors have been extensively studied as contributors to the formation of
long-term memory (Alberini 2009; Hawk and Abel 2010) In the last several years, study
of the transcriptional regulation of memory formation has been extended to
transcriptional co-activators recruited by transcription factors and to the modification of
DNA packaging that these coactivators can produce. The transcriptional co-activator
CREB-binding protein (CBP) is the most well established example of a co-activator that
is critical for memory storage (Oike et al. 1999; Bourtchouladze et al. 2003; Alarcon et al.
2004; Korzus et al. 2004; Wood et al. 2005; Wood et al. 2006; Stefanko et al. 2009).
CBP facilitates gene expression through direct interactions with basal transcriptional
machinery and through intrinsic histone acetyltransferase activity that modifies the
chromatin environment of genes (Bannister and Kouzarides 1996). Of these two
functions, it is known that the histone acetyltransferase function of CBP is critical for
memory storage, as mice containing truncation (Wood et al. 2005) and point mutations
(Korzus et al. 2004) in the histone acetyltransferase domain of CBP have deficits in
hippocampus-dependent long-term memory formation.

Because CBP is a co-activator that does not interact directly with DNA, transcription
factor are required to recruit CBP to target genes (Agalioti et al. 2000). Multiple
sequence-specific transcription factors coordinately recruit CBP to DNA in transcriptional
activator complexes known as enhanceosomes (Merika and Thanos 2001). CBP
interacts with hundreds of proteins including numerous transcription factors (Goodman
and Smolik 2000), allowing it to activate distinct genes in response to interaction with
different transcription factors. One particular interaction surface in the kinase-inducible
interaction (KIX) domain of CBP is required for memory storage (Wood et al. 2006). Mice
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bearing a mutant form of CBP with only three amino acid substitutions in the KIX domain
(CBPkix/kix mice) have impaired long-term hippocampus-dependent contextual fear
memory without deficits in short-term and hippocampus-independent fear memory. This
KIX domain triple point mutation blocks the phosphorylation-dependent interaction of
CBP with the transcription factor CREB (Parker et al. 1996) and the constitutive
interaction with the transcription factor MYB (Parker et al. 1999).

To examine the effect of the KIX domain mutation on long-term memory, we used an
unbiased microarray approach to identify genes with reduced expression in CBPkix/kix
mice under home-cage conditions and after fear conditioning. Fear conditioning training
entailed placing mice into the training context for 2 min, 28 sec prior to a single 1.5-mA,
2-sec footshock. Mice were returned to the home cage after an additional 30-sec delay.
This training protocol was used previously to show that CBPkix/kix mice have long-term
memory deficits (Wood et al. 2006). The neural circuitry underlying performance in this
task has been well characterized, including ample evidence for the essential involvement
of the hippocampus (Maren and Quirk 2004). Long-term contextual fear memory
requires new protein synthesis and activation of cAMP-dependent protein kinase (PKA)
in the hour that follows learning (Bourtchouladze et al. 1998). These requirements
coincide with windows of CREB phosphorylation (Stanciu et al. 2001) and immediateearly gene expression (Keeley et al. 2006) after contextual fear conditioning. Together
these studies suggest that gene expression in the first 30 minutes after learning is critical
for long-term memory in this task, leading us to examine gene expression at this time
point after training in CBPkix/kix mice and wild-type littermates.
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Microarray analysis was performed with Affymetrix MOE 430v2 arrays probed with
labeled RNA from the two hippocampi of each animal as a single biological replicate.
RNA was obtained using a TRIzol-chloroform extraction followed by RNeasy (Qiagen)
isolation, and RNA quality was assessed with the Agilent Bioanalyzer. RNA amplification
and labeling was performed with the NuGen Ovation system. After hybridization and
array reading at the Penn Microarray Facility, intensity scores were calculated by the
Robust Multiarray Average (RMA) method (Gentleman et al. 2004), and quality control
was performed using arrayQualityMetrics (Kauffmann et al. 2009) to ensure that overall
differences in signal intensity do not bias analysis. Volcano plots (Supplementary Fig.
1A) show the relationship between p-value and the signal ratio (log2) between CBPkix/kix
and wildtype expression to illustrate global trends in the microarray data. Following
RMA, Patterns from Gene Expression (PaGE v5.1) analysis was implemented in Perl to
assess confidence in changes in probe set expression levels between CBPkix/kix mice and
wild-type littermates. This algorithm uses permutations of the input data to empirically
determine the False Discovery Rate (FDR) for a given T-statistic level, allowing
assignment of FDR values to individual probe sets based on a modified T-statistic. FDR
values were computed with 200 permutations, and multiple instances of FDR calculation
were run to assess confidence values (Supplementary Fig. 2 and 3). The probe sets
numbers identified at confidence levels (1-FDR) from 80% to 95% are illustrated in
Supplementary Fig. 1B.

For home-cage (HC) microarray analysis, mice were handled for three days prior to
dissection (Wild-type: n=9 arrays, 9 mice; CBPkix/kix: n=8 arrays, 8 mice). At a confidence
of 80%, 81 probe sets are identified as having reduced HC expression in CBPkix/kix
mutant mice, whereas only 3 are identified as having increased expression
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(Supplementary Table 1). The genes represented by these probe sets (63
downregulated and 3 upregulated) are listed in Table 1. The preponderance of changes
in gene expression in CBPkix/kix mice are reductions, which is consistent with the known
biological function of CBP as a positive regulator of gene expression and suggests that
generalized, non-specific compensatory increases in gene expression are not apparent
in the hippocampi of CBPkix/kix mutant mice.

For the Crebbp (CBP) probe set that hybridizes with the transcript region containing the
mutated base pairs in CBPkix/kix mice, the signal is substantially reduced in the CBPkix/kix
sample. The other three probe sets for CBP are not altered (Supplementary Fig. 4A).
This selective reduction in the KIX domain probe set suggests that the reduced signal
intensity in CBPkix/kix mice is a consequence of reduced RNA hybridization due to the
three base substitutions that constitute the KIX domain mutation. Thus, the signal from
this probe set serves as a useful indicator of appropriate genotype segregation and the
ability to detect reduced hybridization signal.

Overall, the magnitude of reductions in gene expression is modest. The level of
impairment was approximately 50% for only one gene (Papss2), whereas most genes
showed a 20-30% reduction in expression (average 23% reduction). The magnitude of
these differences may be somewhat blunted relative to the true defect, as is often
reported for RMA-based analysis (Grant et al. 2007), but it is clear that the effect of the
KIX domain mutation on gene expression is composed of relatively small changes in
expression. The KIX mutation is a very selective mutation in a single interaction interface
of CBP (Parker et al. 1999), and previous ChIP studies have found that the KIX domain
mutation only partially blocks cAMP-dependent recruitment of CBP to many CREB target
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genes (Xu et al. 2007). Thus, the multiple transcription factor-mediated enhanceosome
mode of CBP recruitment (Merika and Thanos 2001) may stabilize CBP binding at genes
even in the absence of KIX domain interactions (Bedford et al. 2010), leading to the
observed modest magnitude of reduction in gene expression.

To determine whether changes in hippocampal gene expression in CBPkix/kix mice are
augmented after learning, we performed microarray analysis on wild-type and CBP
mutant hippocampi at 30 minutes after contextual fear conditioning (Wild-type: n=7
arrays, 7 mice; CBPkix/kix: n=8 arrays, 8 mice). This time point is based on the timing of
immediate early gene activation (Keeley et al. 2006), as well as the window of sensitivity
of long-term memory to the effect of translation and PKA inhibitors (Bourtchouladze et al.
1998). Using the same analysis methods as described for the HC gene expression data,
140 probe sets show evidence of reduced expresson and 1 probe set shows evidence of
increased expression at the 80% confidence level (Supplementary Table 2). The
downregulated probe sets represent 103 known genes, and the highest confidence
genes are listed in Table 2. Interestingly, a greater number of downregulated probe sets
are identified after fear conditioning than in the home cage analysis (81 HC vs 140 FC
probe sets), suggesting that certain effects of the KIX domain mutation on gene
expression may be revealed selectively after learning.

The effect of the KIX domain mutation in the HC basal condition might be expected to be
present after fear conditioning, as fear conditioning predominantly increases gene
expression (Keeley et al. 2006). Consistent with this expectation, many of the genes
identified in the HC analysis were also identified as having reduced expression after
conditioning. At 80% confidence, 17 out of the 63 genes (21 probe sets) identified as
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having reduced expression in the HC analysis were also identified in the FC analysis
(Fig. 1A and Supplementary Table 3). To illustrate the relationship between changes in
expression of the HC-derived gene list under FC conditions, HC and FC confidence
values were plotted for probe sets as a function of confidence rank in the HC experiment
(Fig. 1B). This representation suggests that the confidence of HC experiment-derived
probe sets is high in the FC experiment, as nearly 75% (60 of 81) of probe sets from the
HC analysis have greater than 50% confidence in the FC microarray. The average
confidence that HC experiment probe sets were also downregulated in the FC
experiment was approximately 65%, a reduction from ~92% in the HC experiment that
generated this probe set list (Fig. 1E). In agreement with confidence-based measures,
HC-derived genes also showed reduced expression in CBPkix/kix mice after conditioning
as measured by the average signal ratio (kix/wt) (Fig. 1F, FC: ~82% and HC ~77%).
Thus, the data suggest that many of the defects in gene expression found in the homecage condition are also present after fear conditioning.

In contrast to the HC-derived gene list, there is little evidence to suggest that most FCderived genes are changed under HC conditions. For FC-derived probe sets, high
confidence that a probe set was downregulated in the FC experiment was often
accompanied by little confidence of reduced expression in the HC experiment (Fig. 1C).
More than 50% (74 of 140) of the probe sets identified after fear conditioning at 80%
confidence show lower than 20% confidence in the HC experiment. The average
confidence for the FC-derived probe sets in the HC experiment is only 34% (Fig. 1E)
and the average magnitude of signal reduction in CBPkix/kix mice under home-cage
conditions is only ~10% (Fig. 1F). A similar conclusion is reached by plotting the pvalues from t-tests as a function of the magnitude of reduction in expression for the FC145

derived gene list in the two experiments (Fig. 1D). Both p-values and signal ratio values
for the FC-derived probe set list are well-separated from the axis when examining
performance in the FC experiment, but many of these probe sets have small changes in
signal intensity and large p-values in the HC experiment (Fig. 1D). These data suggest
that many FC-derived genes do not show evidence of changed expression in the HC
experiment.

To test whether the change in performance from the source experiment to the nonsource experiment was different between the FC-derived and the HC-derived gene lists,
we performed one-way ANOVA on the changes in metrics from source to non-source
microarray experiments. There is a significantly greater decline in the magnitude of the
signal ratio (kix/wt) detected from the source to non-source microarray in FC-derived
genes in comparison to HC-derived genes (9.4% vs 5.1%, F(1,219)=17.57, p<0.0001).
Also, there is a significantly larger diminishment in confidence in the non-source
microarray in FC-derived genes relative to the HC-derived genes (-52% vs -25%,
F(1,219)=42.18, p<0.0001), suggesting that FC-derived changes in gene expression are
more selective than HC-derived changes.

Selecting the probe sets that have more than 80% confidence in the FC experiment and
less than 20% confidence in the HC experiment generates a list of probe sets that show
little evidence of being reduced in CBPkix/kix mice in the HC experiment, but show strong
evidence in the FC experiment (Fig. 1D, FC ‘only’). This FC ‘only’ list is composed of
more than half of all probes identified in the FC analysis (74 of 140). For these probe
sets, the average confidence that expression is reduced under HC conditions is only 6%
(Fig. 1E) and the average magnitude detected reduction in gene expression for CBPkix/kix
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mice under HC conditions is only ~3% (Fig. 1F). In contrast, both confidence and the
mutant/wt expression ratio are similar between this collection of probe sets and the full
list identified as reduced in the FC experiment (Fig. 1E and 1F). The FC ‘only’ probe set
list is presented in Supplementary Table 4.

Manually curated descriptions of the molecular function of genes identified in the HC and
FC experiment are shown in Table 1 and Table 2, respectively. For genes affected
under HC conditions, several categories of molecular function are represented
consistently, including selenoamino acid metabolism, neuropeptide signaling and Gprotein signaling. Analysis using the publicly available gene ontology tool DAVID (Dennis
et al. 2003; Huang da et al. 2009) identifies neuropeptide signaling as a significantly
enriched functional category (Benjamini-corrected p= 0.0042). Several categories,
including selenoamino acid metabolism and G-protein signaling, are also well
represented on the FC list, and DAVID analysis reveals a significant enrichment for lipidbinding proteins (Benjamini-corrected p= 0.030), an effect that is discernable also in the
FC ‘only’ gene list (Benjamini-corrected p= 0.065).

We find that several genes induced by learning are impaired in CBPkix/kix mice, including
Btg2, Dusp1, Emp2, Fos, and Nr4a2. Surprisingly, only one of these genes, Emp2, was
identified as changed in the CBPkix/kix mice after fear conditioning. Examining individual
signal ratios for these genes in the FC experiment suggests each of these genes may be
reduced after fear conditioning (Supplementary Fig. 4). Yet, this observation at least
suggests that KIX-dependent activation of fear conditioning-induced genes can occur
under home cage conditions, perhaps representing unintended configural or contextual
encoding. The fear conditioning-induced genes Btg2, Fos, and Nr4a2 were also
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identified as having attenuated induction in CREB mutant mice. Two other genes
identified as having attenuated induction in CREB mutants, Csrnp2 and Egr2, have
reduced expression in hippocampi of CBPkix/kix mice. Thus, the KIX domain-dependent
genes identified in the present study include known activity-dependent CREB targets,
some of which have been previously determined to be fear conditioning-induced genes.

CBP is a transcription co-activator that is involved in numerous biological processes,
including the formation of long-term memories. Mice bearing a very selective mutation of
a single interaction surface in the KIX domain of CBP have specific deficits in long-term,
hippocampus-dependent memory formation (Wood et al. 2006). We have identified a
variety of genes that are impacted by this mutation both in the home cage and shortly
after learning. The vast majority of these changes in gene expression are reductions, an
observation that is consistent with the role of CBP as a transcriptional co-activator. The
majority of the effects on gene expression are small in magnitude, as could be predicted
by thte fact that the KIX domain mutation only partially blocks recruitment of CBP at
many genes (Bedford et al. 2010). The genes identified in this analysis are involved in
various pathways, but several genes induced by learning and with impaired induction in
CREB mutant mice also require the KIX domain, making them promising targets for
future study.

Acknowledgements
We thank Gregory Grant for help with PaGE confidence analysis. This work was funded
by NIH R01 MH060244 to T.A. Further funding from NIH Predoctoral Training Program
in Genetics (T32-GM-008216-20) provided support to J.D.H.

148

Contributing Authors
Joshua D. Hawk, Lucia Peixoto, and Ted Abel

Author contributions
Experiments were conceived by J.D.H. and T.A. Behavioral training, dissections and
RNA preparation were performed by J.D.H. RNA labeling, microarray hybridization, and
microarray data acquisition were performed by the Penn Microarray Core Facility. Data
analysis was performed by J.D.H and L.P. The manuscript was prepared by J.D.H.

149

Table 1. Highest confidence changes in home-cage gene expression in CBPkix/kix mice
Gene Symbol

Confidence

Downregulated genes
Slc25a34
0.995
Papss2 ##
0.995
Efcab6
0.993
Crebbp
0.993
Nts
0.991
Lipm #
0.991
Cenpa
0.991
Pmch
0.988
Fos
0.988
Crhbp
0.988
#
Ccl6
0.988
Cth
0.987
Nqo1
0.98
Tbx1
0.975
Spata13
0.975
Rec8
0.975
Bglap
0.972
Cyp11a1 #
0.965
Pdlim2
0.962
Zdbf2
0.955
Pcsk1
0.955
Gpnmb
0.955
Dusp10
0.955
#
Dbp
0.955
Plcd1
0.952
Mmel1
0.952
Cort
0.952
Pxmp2
0.948
Gna14
0.948
Tekt5
0.94
#
Selenbp1
0.937
Clspn
0.937
Acy1
0.932
Gm11627
0.931
Chi3l1
0.925
Necab3
0.924
Cd164l2
0.918
Trpa1
0.917
Serpinb8
0.913
Arr3
0.91
Sphk2
0.89
Cyp4f14
0.89
Cldn23
0.88
Pax6os1
0.877
Emp2
0.874
Trib1
0.873
Gas2l3
0.873
Myh8
0.868
Egr2 #
0.868
Aldh3a1
0.868
Dusp1
0.854
Pvrl2
0.846
Cbs
0.846
Cbln2
0.837
Btg2
0.837
Fbp1
0.832
Rtkn2
0.83
Kcnh8
0.83
Nr4a2
0.82
Ccl28
0.82
Fzd9
0.818
Adhfe1
0.818
Sytl2
0.805

Probe set

Molecular role

Wt(Log2)

% change

1455506_at
1421987_at
1453766_a_at
1459804_at
1422860_at
1430550_at
1450842_a_at
1429361_at
1423100_at
1436127_at
1420249_s_at
1426243_at
1423627_at
1425779_a_at
1454656_at
1419147_at
1449880_s_at
1448804_at
1423946_at
1456783_at
1421396_at
1448303_at
1417163_at
1418174_at
1448432_at
1449432_a_at
1449820_at
1417841_at
1447791_s_at
1429355_at
1417580_s_at
1456280_at
1419173_at
1442917_at
1451537_at
1431946_a_at
1443664_s_at
1457164_at
1458882_at
1425232_x_at
1426230_at
1419559_at
1424409_at
1440445_at
1433670_at
1424880_at
1453416_at
1426650_at
1427682_a_at
1418752_at
1448830_at
1424456_at
1425623_a_at
1434779_at
1448272_at
1448470_at
1418108_at
1440980_at
1450750_a_at
1455577_at
1427529_at
1424392_at
1421594_a_at

Mitochondrial solute carrier protein
Sulfate and Selenium assimulation, cysteine synthesis
Calcium-binding transcriptional co-repressor
Transcriptional co-activator CBP, KIX domain
Neuropeptide
Triglyceride hydrolysis
Double-strand break repair, centromere organization
Neuropeptide
DNA-binding transcription factor
Regulator of hormone signaling
Cytokine, inflammatory response
Sulfate and Selenium assimulation, cysteine synthesis
Positive regulator of translation; quinone detoxification
DNA-binding transcription factor
Guanine nucleotide exchange factor
Meiotic chromatid cohesion
Osteogenic marker
Steriod hormone metabolism, cholesterol metabolism
Negative regulator of NFkappa-B and STAT signaling
Unknown
Pro-neuropeptide cleavage
Transmembrane glycoprotein
Phosphatase
DNA-binding transcription factor
Calcium-dependent phospholipase, phosphotidyl inositol-signaling
Membrane metalloprotease
Neuropeptide
Peroxisomal pore protein
G-alpha q family member, adrenergic-coupled
Unknown
Selenium-binding, intraGolgi transport
DNA damage and repair regulator
Metallopeptidase, hydrolysis of N-acetylated amino acids
Unknown
Inflammatory response, extracellular matrix remodeling
Amyloid precursor metabolism
Transmembrane adhesion molecule
Cation channel
Serine protease inhibitor
Beta-adrenergic signaling
Sphingosine kinase
Eicosanoid metabolism
Cell adhesion molecule; tight junction component
Non-coding RNA
Transmembrane glycoprotein associated with beta-integrin
Regulator of MAPK signaling
Unknown
Myosin
DNA-binding transcription factor
Aldehyde dehydrogenase
Phosphatase
Transmembrane adhesion molecule
Sulfate and Selenium assimulation, cysteine synthesis
Secreted glycoprotein, putative transneuronal cytokine
Regulator of transcription and mRNA turnover
Glycolysis
Rho-GTPase interacting protein
Voltage-gate potassium channel
DNA-binding transcription factor
Cytokine, inflammatory response
Wnt signaling
Alcohol dehydrogenase, gamma hydroxybuyrate metabolism
Vesicular trafficking

7.99
6.89
8.02
8.41
10.73
5.38
6.75
7.33
9.55
11.03
6.79
7.89
9.27
5.65
9.44
6.68
7.13
7.43
9.46
10.51
7.91
7.84
8.96
10.63
8.69
5.17
9.01
9.26
6.53
7.23
10.06
6.60
8.33
8.18
9.65
9.28
7.23
4.39
5.66
4.36
10.67
7.73
6.46
5.31
9.78
7.78
7.70
6.97
7.10
6.58
10.74
7.71
9.14
9.92
8.62
6.19
6.84
5.53
10.86
8.01
7.83
9.71
10.26

-43%
-42%
-25%
-37%
-31%
-40%
-29%
-24%
-33%
-20%
-25%
-24%
-20%
-25%
-19%
-26%
-38%
-28%
-21%
-16%
-24%
-18%
-17%
-24%
-18%
-28%
-30%
-20%
-24%
-31%
-21%
-26%
-13%
-15%
-15%
-24%
-14%
-34%
-19%
-25%
-21%
-21%
-23%
-23%
-18%
-17%
-15%
-19%
-27%
-24%
-17%
-16%
-14%
-17%
-20%
-17%
-18%
-22%
-18%
-32%
-15%
-18%
-17%

1427747_a_at
1426278_at
1449846_at

interferon, alpha-inducible protein 27 like 2A
lipocalin 2
eosinophil-associated, ribonuclease A family, member 2

2.19
10.03
5.10

358%
23%
64%

Upregulated genes
Ifi27l2a
Lcn2
Ear2
#

0.995
0.816
0.816

: indicates that a second probe set for this gene was also present in the 80% confidence probe set list
: Indicates that two additional probe sets for this gene were present in the 80% confidence probe set list

##
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Table 2. Highest confidence changes in gene expression after fear conditioning in CBPkix/kix mice
Gene Symbol

Confidence

Downregulated genes
Slc25a34
0.995
Papss2 ##
0.995
Nqo1
0.995
Emp2 #
0.995
Crebbp
0.995
Cth
0.992
#
Selenbp1
0.989
Ccl6
0.989
Popdc3
0.983
Ccnd1
0.975
Tnfrsf17
0.973
Cyp4f14
0.973
Tekt5
0.956
Slc13a5
0.956
Gchfr
0.953
Prss35
0.95
Hsd17b14
0.95
Tmprss2
0.94
#
Cyp11a1
0.936
Tnni1
0.934
B3gnt5
0.933
Mctp2
0.929
Pxmp2
0.928
Synpo2
0.926
Btbd17 #
0.924
Igf1 ##
0.921
Adhfe1 #
0.921
Nsl1
0.916
#
Ugt1a1
0.903
Pdlim3
0.903
Gstk1
0.903
Efcab6
0.903
Ltc4s
0.901
Ypel1
0.898
Upp2 #
0.898
Rspo2
0.898
Hmga2-ps1
0.898
Dock2
0.898
Dmrt3
0.898
Taf6l
0.897
Lysmd4
0.897
Dock3
0.894
Qrfpr
0.878
Ncaph2
0.878
Fzd2
0.878
Stk30
0.874
Shisa9 #
0.874
Golt1a
0.874
Ttc32
0.87
Ccl19
0.849
Fktn
0.848
C85492
0.848
Csrnp1
0.845
Cby3
0.841
Chi3l1
0.835
Cdc42ep5
0.835
Acbd7
0.835
Ogfrl1
0.831
Igsf3
0.831
Cd177
0.831
Aldh1l1
0.831
Acbd6
0.831
Rspo1
0.829

Probe set

Molecular role

Wt(Log2)

% change

1455506_at
1434510_at
1423627_at
1433670_at
1459804_at
1426243_at
1450699_at
1417266_at
1423856_at
1417420_at
1420782_at
1419559_at
1429355_at
1435936_at
1435750_at
1434195_at
1447678_at
1449369_at
1439947_at
1450813_a_at
1420994_at
1457707_at
1417841_at
1435399_at
1428303_at
1434413_at
1424393_s_at
1447705_at
1426260_a_at
1449178_at
1452823_at
1453766_a_at
1419692_a_at
1431781_at
1451548_at
1430104_at
1440559_at
1438334_at
1440707_at
1452600_at
1444291_at
1452930_at
1457048_at
1423698_at
1418533_s_at
1449476_at
1453428_at
1425159_at
1432810_at
1449277_at
1451853_at
1435677_at
1434350_at
1432569_at
1451537_at
1418712_at
1430107_at
1424412_at
1455048_at
1424509_at
1424401_at
1452601_a_at
1449319_at

Mitochondrial solute carrier protein
Sulfate and Selenium assimulation, cysteine synthesis
Positive regulator of translation; quinone detoxification
Transmembrane glycoprotein associated with beta-integrin
Transcriptional co-activator CBP, KIX domain
Sulfate and Selenium assimulation, cysteine synthesis
Selenium-binding, intraGolgi transport
Cytokine, inflammatory response
Transmembrane adhesion molecule
Cyclin D1
TNF receptor superfamily, inflammatory response
Eicosanoid omega-hydroxylation
Unknown
Sodium/citrate symporter
GTP metabolism, THB synthesis
Serine protease
Steriod hormone metabolism
Serine protease
Steriod hormone biosynthesis, cholesterol metabolism
Troponin
N-acetylglucosaminylation; UDP N-acetylglucosaminyltransferase
Transmembrane calcium-binding protein
Peroxisomal pore protein
Actin-binding, synaptic plasticity
Unknown
Neuropeptide
Alcohol dehydrogenase, gamma hydroxybuyrate metabolism
Kinetochore component
Steriod hormone metabolism; UDP glucuronosyltransferase
Cytoskeletal protein
Oxidative stress response, detoxification
Calcium-binding transcriptional co-repressor
Eicosanoid metabolism
Unknown
Nucleotide biosynthesis; UDP synthesis
Wnt signaling
Unknown
Guanine nucleotide exchange factor, microglial innate immunity
DNA-binding transcription factor
Transcription factor, associated with P/CAF complexes
Unknown
Guanine nucleotide exchange factor, regulates axon outgrowth
Neuropeptide receptor
Mitotic chromosome assembly
Wnt signaling
Serine/threonine kinase, MAPK superfamily
AMPA-receptor modulation
Vesicle transport
Unknown
Cytokine, inflammatory response
Putative glycosyltransferase
Putative glycosyltransferase
DNA-binding transcription factor
Similar to inhibitor of Wnt signaling
Inflammatory response, extracellular matrix remodeling
Rho-GTPase interacting protein, cytoskeletal remodeling
Acyl-CoA-binding protein with unknown function
Putative neuropeptide receptor
Transmembrane glycoprotein in immunogobulin superfamily
GPI-anchored glycoprotein, inflammatory response
Aldehyde dehydrogenase, cytoskeletal remodeling
Acyl-CoA-binding protein with unknown function
Wnt signaling

7.55
9.15
9.08
9.43
8.20
7.95
9.73
8.44
9.88
8.46
6.39
7.04
6.66
9.51
5.75
8.84
3.80
5.38
8.64
7.20
5.93
6.55
8.86
6.57
7.65
8.49
10.00
4.76
8.15
5.01
10.30
6.98
6.30
7.21
6.38
5.59
7.02
3.83
7.29
6.45
9.67
3.83
6.69
10.01
5.87
7.77
8.22
5.10
5.08
6.99
6.47
9.10
8.44
5.13
8.93
6.65
6.41
12.22
9.73
3.66
5.36
10.21
5.40

-35%
-52%
-30%
-32%
-43%
-26%
-29%
-21%
-21%
-17%
-27%
-23%
-26%
-17%
-20%
-16%
-21%
-17%
-21%
-20%
-22%
-23%
-18%
-24%
-13%
-24%
-21%
-20%
-25%
-12%
-13%
-26%
-12%
-14%
-30%
-14%
-16%
-15%
-27%
-13%
-17%
-13%
-33%
-11%
-25%
-9%
-19%
-16%
-14%
-30%
-14%
-11%
-11%
-16%
-21%
-13%
-19%
-9%
-12%
-15%
-22%
-7%
-28%

1415964_at

Fatty acid biosynthesis

12.68

7%

***
Upregulated gene
Scd1

0.935

: indicates that a second probe set for this gene was also present in the 80% confidence probe set list
: Indicates that two additional probe sets for this gene were present in the 80% confidence probe set list
***: All downregulated probe sets identified with >80% confidence are listed in Supplementary Table 2
#

##
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Figure 1. Analysis of relationship between HC and FC microarray data
A.

B.

HC: 80% confidence gene list
FC: 80% confidence gene list
FC&HC: 80% confidence gene list
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Figure Legend

Figure 1. (A) Of the 63 known genes reduced in CBPkix/kix mice in the home cage (HC),
17 were also identified in the 103 genes reduced in CBPkix/kix mice after fear conditioning
(FC). (B) Confidence values for the probe sets identified in the HC analysis were plotted
according to HC confidence rank. 75% of HC-derived probe sets have higher than 50%
confidence of downregulation in the FC experiment. (C) Confidence values for the probe
sets identified in the FC analysis were plotted according to FC confidence rank. More
than 50% (74 of 140) of FC-derived probe sets show less than 20% confidence of
reduced HC expression in CBPkix/kix mice. (D) FC-derived probesets with less than 20%
confidence in the HC experiment (FC ‘only’) have high p-values and low signal ratios
(kix/wt) in the HC experiment, but perform similarly to other probe sets in the FC
experiment. Signal ratio is shown on log2 scale. (E) Quantification of confidence values
in home cage (HC, blue) and fear conditioning (FC, red) microarray experiments for
probe sets derived from the HC experiment (HC gene list), the FC experiment (FC gene
list) or the FC ‘only’ gene list. (F) Quantification of the relative expression of probes sets
in CBPkix/kix mice for the HC and FC experiments. Probe sets are clustered by the three
gene lists and represented on a linear scale with 1 as the wild-type expression level.
Error bars represent the s.e.m.
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Figure S1. Volcano plots and PaGE confidence lists
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Figure S2. PaGE analysis of HC microarrays
A. PaGE analysis was performed on the RMA normalized set of HC Affymetrix arrays
consisting of wild-type (n=9) and mutant (n=8) hippocampal samples
- Five different instances (version) of the algorithm were computed using identical settings
- Affy IDs confidence values were ranked according to one version for each graph
- The confidence values were for plotted the highest 2000 ranked Affy IDs
- Version 4 shows median overall performance

B.

Correlation coefficients (r) for confidence values of different instances of PaGE
- Version 4 with the maximal average r value was selected for analysis
V1
V1
V2
V3
V4
V5
Average:

0.94819795
0.9089431
0.93738953
0.85878558
0.913329

V2
0.94819795
0.95218724
0.97898201
0.94392347
0.9583642
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V3
0.9089431
0.95218724
0.99232474
0.95986945
0.9681271

V4
0.93738953
0.97898201
0.99232474
0.96842989
0.9799122

V5
0.85878558
0.94392347
0.95986945
0.96842989
0.9574076

Figure S3. PaGE analysis of HC microarrays
A. PaGE analysis was performed on the RMA normalized set of FC Affymetrix arrays
consisting of wild-type (n=7) and mutant (n=8) hippocampal samples
- Five different instances (version) of the algorithm were computed using identical settings
- Affy IDs confidence values were ranked by one version per graph
- The confidence values of all versions was for plotted the highest 2000 ranked Affy IDs
- Version 4 shows median overall performance

B.

Correlation coefficients (r) for confidence values of different instances of PaGE
- Version 1 with the maximal average r value was selected for analysis
V1
V1
V2
V3
V4
V5
Average:

0.99728589
0.99854687
0.99978566
0.99864322
0.9985654

V2
0.99728589
0.99508961
0.99684029
0.99450336
0.9954778
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V3
0.99854687
0.99508961
0.9993505
0.99947073
0.9979703

V4
0.99978566
0.99684029
0.9993505
0.99932388
0.9985049

V5
0.99864322
0.99450336
0.99947073
0.99932388
0.997766

Figure S4. Select probe sets of interest
A.

Gene
Crebbp
Crebbp
Crebbp
Crebbp

Probe set
1459804_at
1436983_at
1435224_at
1434633_at

B.

Gene
Emp2
Fos
Nr4a2
Btg2
Dusp1
Egr2
Egr2
Csrnp1

Probe set
1433670_at
1423100_at
1450750_a_at
1448272_at
1448830_at
1427683_at
1427682_a_at
1434350_at

HC confidence
99.5%
0.0%
0.0%
0.0%

HC confidence
87.4%
98.8%
82.0%
83.7%
85.4%
84.6%
86.8%
62.1%
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HC kix/wt ratio
0.63
1.06
1.01
1.02

HC kix/wt ratio
0.82
0.67
0.82
0.80
0.83
0.73
0.73
0.87

FC confidence
99.3%
0.0%
0.0%
0.0%

FC confidence
99.5%
73.7%
53.3%
75.7%
52.1%
37.9%
38.1%
84.5%

FC kix/wt ratio
0.57
1.00
1.07
0.99

FC kix/wt ratio
0.68
0.75
0.86
0.79
0.91
0.83
0.82
0.89

Supplementary Figure 1. (A) Volcano plots showing the relationship between t-testderived p-values (y-axis) and the signal ratio between wild-type and CBPkix/kix mice for all
probe sets. The left panel shows the results from the home cage (HC) microarray, and
the right panel shows the results from microarray analysis at 30 minutes after fear
conditioning (FC). (B) The total number of genes identified as changed with confidences
greater than 80% are listed.

Supplementary Figure 2. (A)

PaGE analysis uses permutations of the data to

empirically assess the confidence values at different levels of the T-statistic. Because
there are many replicates for each condition, tens of thousands of permutations are
possible. Therefore, PaGE analysis was run 5 times with 200 permutations of the HC
data each time, and the results were compared among these runs (versions). Three of
the runs (versions 2, 3, and 4) show very similar performance with version 4 having
median overall confidence estimation. (B) The correlation coefficient was calculated
between each pair of runs to establish which version has the highest overall correlation
with the other versions. The median version, V4, has the highest average correlation
with the other versions (r= 0.9799) and was chosen as the source of confidence values
for subsequent analysis.

Supplementary Figure 3. (A) PaGE analysis was run 5 times (version 1-5) each with
200 permutations of the FC data. The resulting confidence values for versions 1, 3, 4,
and 5 showed similar behavior (B) Correlation coefficients were calculated between
pairs of runs. Version 1, V1, has the highest correlation with the other versions (r=
0.9986) and was chosen as the list of confidence values for subsequent analysis.
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Supplementary Figure 4. (A) The four probe sets for CBP, official gene symbol Crebbp,
are shown. Only the probe set that hybridizes to the KIX domain (1459804_at) shows
evidence of reduced signal intensity in CBPkix/kix mice. The approximately 40% reduction
in signal only for this probe set is likely due to the three base pair mutations introduced
by the KIX domain mutation. (B) The confidence and signal ratio (kix/wt) are shown for
genes previously identified as being induced after fear conditioning or having attenuated
expression in CREB mutant mice.
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Table S1. Full probe set list for downregulated genes: HC 80% confidence
Confidence
0.995
0.995
0.995
0.995
0.993
0.993
0.991
0.991
0.991
0.988
0.988
0.988
0.988
0.987
0.987
0.98
0.975
0.975
0.975
0.975
0.972
0.968
0.965
0.962
0.96
0.955
0.955
0.955
0.955
0.955
0.955
0.955
0.952
0.952
0.952
0.948
0.948
0.94
0.937
0.937
0.935
0.932
0.932
0.931
0.925
0.924
0.918
0.917
0.913
0.91
0.891
0.89
0.89
0.883
0.88
0.877
0.874
0.873
0.873
0.868
0.868
0.868
0.868
0.854
0.846
0.846
0.846
0.837
0.837
0.837
0.832
0.83
0.83
0.83
0.824
0.82
0.82
0.818
0.818
0.818
0.805

Probe set
1434510_at
1421989_s_at
1455506_at
1421987_at
1459804_at
1453766_a_at
1430550_at
1422860_at
1450842_a_at
1423100_at
1420249_s_at
1429361_at
1436127_at
1426243_at
1417266_at
1423627_at
1419147_at
1425779_a_at
1455203_at
1454656_at
1449880_s_at
1425469_a_at
1448804_at
1423946_at
1436099_at
1430551_s_at
1418174_at
1421396_at
1457389_at
1448303_at
1417163_at
1456783_at
1449820_at
1449432_a_at
1448432_at
1447791_s_at
1417841_at
1429355_at
1456280_at
1417580_s_at
1443122_at
1450699_at
1419173_at
1442917_at
1451537_at
1431946_a_at
1443664_s_at
1457164_at
1458882_at
1425232_x_at
1439947_at
1419559_at
1426230_at
1435976_at
1424409_at
1440445_at
1433670_at
1424880_at
1453416_at
1427682_a_at
1418752_at
1438211_s_at
1426650_at
1448830_at
1427683_at
1424456_at
1425623_a_at
1448272_at
1434779_at
1454233_at
1448470_at
1440980_at
1459626_at
1418108_at
1457558_at
1455577_at
1450750_a_at
1424392_at
1427529_at
1452827_at
1421594_a_at

Gene Symbol
Papss2
Papss2
Slc25a34
Papss2
Crebbp
Efcab6
Lipm
Nts
Cenpa
Fos
Ccl6
Pmch
Crhbp
Cth
Ccl6
Nqo1
Rec8
Tbx1
A930003A15Rik
Spata13
Bglap
--Cyp11a1
Pdlim2
AI836003
Lipm
Dbp
Pcsk1
9830166K06Rik
Gpnmb
Dusp10
Zdbf2
Cort
Mmel1
Plcd1
Gna14
Pxmp2
Tekt5
Clspn
Selenbp1
--Selenbp1
Acy1
Gm11627
Chi3l1
Necab3
Cd164l2
Trpa1
Serpinb8
Arr3
Cyp11a1
Cyp4f14
Sphk2
--Cldn23
Pax6os1
Emp2
Trib1
Gas2l3
Egr2
Aldh3a1
Dbp
Myh8
Dusp1
Egr2
Pvrl2
Cbs
Btg2
Cbln2
2310006M14Rik
Fbp1
Kcnh8
--Rtkn2
A330050F15Rik
Ccl28
Nr4a2
Adhfe1
Fzd9
1500009C09Rik
Sytl2

Molecular role
Sulfate and Selenium assimulation, cysteine synthesis
Sulfate and Selenium assimulation, cysteine synthesis
Mitochondrial solute carrier protein
Sulfate and Selenium assimulation, cysteine synthesis
Transcriptional co-activator #NOTE#
Calcium-binding transcriptional co-repressor
Triglyceride hydrolysis
Neuropeptide
Double-strand break repair, centromere organization
DNA-binding transcription factor
Cytokine, inflammatory response
Neuropeptide
Regulator of hormone signaling
Sulfate and Selenium assimulation, cysteine synthesis
Cytokine, inflammatory response
Positive regulator of translation; quinone detoxification
Meiotic chromatid cohesion
DNA-binding transcription factor
Unknown
Guanine nucleotide exchange factor
Osteogenic marker
Unknown
Steriod hormone metabolism, cholesterol metabolism
Negative regulator of NFkappa-B and STAT signaling
Unknown
Triglyceride hydrolysis
DNA-binding transcription factor
Pro-neuropeptide cleavage
Unknown
Transmembrane glycoprotein
Phosphatase
Unknown
Neuropeptide
Membrane metalloprotease
Calcium-dependent phospholipase, phosphotidyl inositol-signaling
G-alpha q family member, adrenergic-coupled G-alpha subunit
Peroxisomal pore protein
Unknown
DNA damage and repair regulator
Selenium-binding, intraGolgi transport
Unknown
Selenium-binding, intraGolgi transport
Metallopeptidase, hydrolysis of N-acetylated amino acids
Unknown
Inflammatory response, extracellular matrix remodeling
Amyloid precursor metabolism
Transmembrane adhesion molecule
Cation channel
Serine protease inhibitor
Beta-adrenergic signaling
Steriod hormone biosynthesis, cholesterol metabolism
Eicosanoid metabolism
Sphingosine kinase
Unknown
Cell adhesion molecule; tight junction component
Non-coding RNA
Transmembrane glycoprotein associated with beta-integrin
Regulator of MAPK signaling
Unknown
DNA-binding transcription factor
Aldehyde dehydrogenase
DNA-binding transcription factor
Myosin
Phosphatase
DNA-binding transcription factor
Transmembrane adhesion molecule
Sulfate and Selenium assimulation, cysteine synthesis
Regulator of transcription and mRNA turnover
Secreted glycoprotein, putative transneuronal cytokine
Unknown
Glycolysis
Voltage-gate potassium channel
Unknown
Rho-GTPase interacting protein
Unknown
Cytokine, inflammatory response
DNA-binding transcription factor
Alcohol dehydrogenase, gamma hydroxybuyrate metabolism
Wnt signaling
Unknown
Vesicular trafficking
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Wt(Log2)
9.57
8.67
7.99
6.89
8.41
8.02
5.38
10.73
6.75
9.55
6.79
7.33
11.03
7.89
8.76
9.27
6.68
5.65
6.83
9.44
7.13
3.91
7.43
9.46
8.30
4.96
10.63
7.91
8.37
7.84
8.96
10.51
9.01
5.17
8.69
6.53
9.26
7.23
6.60
10.06
7.32
9.86
8.33
8.18
9.65
9.28
7.23
4.39
5.66
4.36
8.29
7.73
10.67
9.06
6.46
5.31
9.78
7.78
7.70
7.10
6.58
11.92
6.97
10.74
6.95
7.71
9.14
8.62
9.92
5.61
6.19
5.53
8.77
6.84
10.34
8.01
10.86
9.71
7.83
10.82
10.26

% change
-50%
-43%
-43%
-42%
-37%
-25%
-40%
-31%
-29%
-33%
-25%
-24%
-20%
-24%
-24%
-20%
-26%
-25%
-20%
-19%
-38%
-18%
-28%
-21%
-20%
-37%
-24%
-24%
-20%
-18%
-17%
-16%
-30%
-28%
-18%
-24%
-20%
-31%
-26%
-21%
-20%
-22%
-13%
-15%
-15%
-24%
-14%
-34%
-19%
-25%
-17%
-21%
-21%
-19%
-23%
-23%
-18%
-17%
-15%
-27%
-24%
-21%
-19%
-17%
-27%
-16%
-14%
-20%
-17%
-14%
-17%
-22%
-21%
-18%
-13%
-32%
-18%
-18%
-15%
-11%
-17%

Table S2a. Probe set list for downregulated genes: FC 80% confidence
Confidence
0.995
0.995
0.995
0.995
0.995
0.995
0.992
0.991
0.989
0.989
0.983
0.975
0.975
0.973
0.973
0.973
0.956
0.956
0.953
0.95
0.95
0.95
0.94
0.939
0.936
0.934
0.933
0.929
0.928
0.926
0.924
0.921
0.921
0.921
0.916
0.903
0.903
0.903
0.903
0.903
0.903
0.901
0.898
0.898
0.898
0.898
0.898
0.898
0.898
0.898
0.897
0.897
0.894
0.878
0.878
0.878
0.878
0.874
0.874
0.874
0.87
0.849
0.849
0.848
0.848
0.848
0.845
0.845
0.841
0.836
0.835
0.835
0.835
0.831
0.831
0.831
0.831
0.831
0.831
0.829
0.829

Probe set
1434510_at
1441794_at
1459804_at
1455506_at
1433670_at
1423627_at
1426243_at
1421989_s_at
1450699_at
1417266_at
1423856_at
1417580_s_at
1417420_at
1455203_at
1420782_at
1419559_at
1429355_at
1435936_at
1435750_at
1421987_at
1447678_at
1434195_at
1449369_at
1439880_at
1439947_at
1450813_a_at
1420994_at
1457707_at
1417841_at
1435399_at
1428303_at
1434413_at
1457873_at
1424393_s_at
1447705_at
1425226_x_at
1453766_a_at
1426260_a_at
1432336_at
1452823_at
1449178_at
1419692_a_at
1451548_at
1440707_at
1452904_at
1440559_at
1438334_at
1431781_at
1431001_at
1430104_at
1444291_at
1452600_at
1452930_at
1457048_at
1418533_s_at
1433143_at
1423698_at
1453428_at
1425159_at
1449476_at
1432810_at
1449277_at
1437890_at
1424392_at
1451853_at
1435677_at
1457346_at
1434350_at
1432569_at
1448804_at
1451537_at
1430107_at
1418712_at
1424401_at
1435424_x_at
1424509_at
1455048_at
1424412_at
1452601_a_at
1449319_at
1457225_at

Gene Symbol
Papss2
--Crebbp
Slc25a34
Emp2
Nqo1
Cth
Papss2
Selenbp1
Ccl6
Popdc3
Selenbp1
Ccnd1
A930003A15Rik
Tnfrsf17
Cyp4f14
Tekt5
Slc13a5
Gchfr
Papss2
Hsd17b14
Prss35
Tmprss2
D630023F18Rik
Cyp11a1
Tnni1
B3gnt5
Mctp2
Pxmp2
Synpo2
Btbd17
Igf1
--Adhfe1
Nsl1
LOC665506
Efcab6
Ugt1a1
5033404E19Rik
Gstk1
Pdlim3
Ltc4s
Upp2
Dmrt3
1700026L06Rik
Hmga2-ps1
Dock2
Ypel1
9030624J02Rik
Rspo2
Lysmd4
Taf6l
Dock3
Qrfpr
Fzd2
9230118N17Rik
Ncaph2
Shisa9
Golt1a
Stk30
Ttc32
Ccl19
Btbd17
Adhfe1
Fktn
C85492
--Csrnp1
Cby3
Cyp11a1
Chi3l1
Acbd7
Cdc42ep5
Aldh1l1
Shisa9
Cd177
Igsf3
Ogfrl1
Acbd6
Rspo1
Olfr288

Molecular role
Wt(Log2)
Sulfate and Selenium assimulation, cysteine synthesis
9.15
Unknown
6.16
Transcriptional co-activator
8.20
Mitochondrial solute carrier protein
7.55
Transmembrane glycoprotein associated with beta-integrin
9.43
Positive regulator of translation; quinone detoxification
9.08
Sulfate and Selenium assimulation, cysteine synthesis
7.95
Sulfate and Selenium assimulation, cysteine synthesis
8.59
Selenium-binding, intraGolgi transport
9.73
Cytokine, inflammatory response
8.44
Transmembrane adhesion molecule
9.88
Selenium-binding, intraGolgi transport
9.66
Cyclin D1
8.46
Unknown
6.35
TNF receptor superfamily, inflammatory response
6.39
Eicosanoid omega-hydroxylation
7.04
Unknown
6.66
Sodium/citrate symporter
9.51
GTP metabolism, THB synthesis
5.75
Sulfate and Selenium assimulation, cysteine synthesis
6.63
Steriod hormone metabolism
3.80
Serine protease
8.84
Serine protease
5.38
Unknown
6.64
Steriod hormone biosynthesis, cholesterol metabolism
8.64
Troponin
7.20
N-acetylglucosaminylation; UDP N-acetylglucosaminyltransferase
5.93
Transmembrane calcium-binding protein
6.55
Peroxisomal pore protein
8.86
Actin-binding, synaptic plasticity
6.57
Unknown
7.65
Neuropeptide
8.49
Unknown
5.29
Alcohol dehydrogenase, gamma hydroxybuyrate metabolism
10.00
Kinetochore component
4.76
Simlar to T-cell beta-2 chain
6.32
Calcium-binding transcriptional co-repressor
6.98
Steriod hormone metabolism; UDP glucuronosyltransferase
8.15
Unknown
6.27
Oxidative stress response, detoxification
10.30
Cytoskeletal protein
5.01
Eicosanoid metabolism
6.30
Nucleotide biosynthesis; UDP synthesis
6.38
DNA-binding transcription factor
7.29
Unknown
6.79
UNKNOWN?
7.02
Guanine nucleotide exchange factor, microglia-mediated innate immunity
3.83
Unknown
7.21
Unknown
5.25
Wnt signaling
5.59
Unknown
9.67
Transcription factor, associated with P/CAF complexes
6.45
Guanine nucleotide exchange factor, regulates axon outgrowth
3.83
Neuropeptide receptor
6.69
Wnt signaling
5.87
Unknown
3.77
Mitotic chromosome assembly
10.01
AMPA-receptor modulation
8.22
Vesicle transport
5.10
Serine/threonine kinase, MAPK superfamily
7.77
Unknown
5.08
Cytokine, inflammatory response
6.99
Unknown
6.59
Alcohol dehydrogenase, gamma hydroxybuyrate metabolism
9.35
Putative glycosyltransferase
6.47
Putative glycosyltransferase
9.10
Unknown
4.76
DNA-binding transcription factor
8.44
Similar to inhibitor of Wnt signaling
5.13
Steriod hormone biosynthesis, cholesterol metabolism
7.06
Inflammatory response, extracellular matrix remodeling
8.93
Acyl-CoA-binding protein with unknown function
6.41
Rho-GTPase interacting protein, cytoskeletal remodeling
6.65
Aldehyde dehydrogenase, cytoskeletal remodeling
5.36
AMPA-receptor modulation
11.00
GPI-anchored glycoprotein, inflammatory response
3.66
Transmembrane glycoprotein in immunogobulin superfamily
9.73
Putative neuropeptide receptor
12.22
Acyl-CoA-binding protein with unknown function
10.21
Wnt signaling
5.40
G-protein coupled receptor
4.44
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% change
-52%
-46%
-43%
-35%
-32%
-30%
-26%
-39%
-29%
-21%
-21%
-29%
-17%
-27%
-27%
-23%
-26%
-17%
-20%
-37%
-21%
-16%
-17%
-22%
-21%
-20%
-22%
-23%
-18%
-24%
-13%
-24%
-22%
-21%
-20%
-34%
-26%
-25%
-20%
-13%
-12%
-12%
-30%
-27%
-24%
-16%
-15%
-14%
-14%
-14%
-17%
-13%
-13%
-33%
-25%
-13%
-11%
-19%
-16%
-9%
-14%
-30%
-17%
-20%
-14%
-11%
-15%
-11%
-16%
-28%
-21%
-19%
-13%
-22%
-17%
-15%
-12%
-9%
-7%
-28%
-24%

Table S2b. Probe set list for downregulated genes: FC 80% confidence
List continued from Table S2a
Confidence Probe set
Gene Symbol
Molecular role
Wt(Log2)
0.829
1450329_a_at Arr3
Beta-adrenergic signaling
4.85
0.829
1431588_at
--Unknown
6.58
0.829
1425272_at
Emp2
Transmembrane glycoprotein associated with beta-integrin
6.08
0.829
1448330_at
Gstm1
Oxidative stress response, detoxification
12.67
0.828
1419519_at
Igf1
Neuropeptide
6.43
0.828
1426031_a_at Nfatc2
DNA-binding transcription factor, axonal growth
7.72
0.828
1422269_at
Insm2
UNKNOWN?
4.15
0.826
1424783_a_at Ugt1a1
Steriod hormone metabolism; UDP glucuronosyltransferase
7.11
0.826
1425779_a_at Tbx1
DNA-binding transcription factor
6.26
0.826
1448104_at
Aldh6a1
Aldehyde dehydrogenase, acetyl-CoA synthesis
10.99
0.826
1434988_x_at Aldh2
Aldehyde dehydrogenase, acetyl-CoA synthesis
10.26
0.825
1419619_at
Krt80
Cytoskeletal protein
5.53
0.825
1426607_at
Gm7120
Unknown
10.36
0.825
1455200_at
Pak6
p21-activated kinase, cystoskeletal remodeling
9.15
0.825
1446590_at
--Unknown
4.52
0.825
1449430_a_at Treh
Carbohydrate metabolism
4.02
0.825
1439385_x_at Slc13a3
Sodium/dicarboxylate symporter
3.61
0.825
1436464_at
--Unknown
9.03
0.825
1439669_at
6430571L13Rik
Unknown
7.86
0.819
1434695_at
Dtl
E3 ubiquitin ligase regulating PCNA, Set8 and p21
8.52
0.816
1425854_x_at LOC665506
Simlar to T-cell beta-2 chain
6.19
0.816
1443634_at
--Unknown
5.51
0.816
1437401_at
Igf1
Neuropeptide
7.88
0.816
1431352_s_at Pvt1
Non-coding oncogene
8.11
0.816
1423693_at
Cela1
Serine protease, extracellular matrix remodeling
6.87
0.816
1435819_at
--Unknown
8.43
0.816
1419518_at
Tuba8
Cytoskeletal protein
8.98
0.816
1435854_at
Opalin
Transmembrane glycoprotein
11.56
0.816
1442088_at
9230111E07Rik
Unknown
6.35
0.816
1458098_at
--Unknown
5.26
0.816
1435582_at
Wdfy4
Unknown
6.76
0.816
1432939_at
5730405N03Rik Unknown
3.25
0.816
1434129_s_at Lhfpl2
Tetraspan transmembrane protein
10.75
0.813
1445748_at
--Unknown
4.42
0.813
1429248_at
2810002N01Rik Unknown
10.18
0.813
1427287_s_at Itpr2
Inositol triphosphate receptor
8.58
0.809
1418486_at
Vnn1
GPI-anchored pantetheinase
4.34
0.809
1417756_a_at Lsp1
Cytoskeletal remodeling
6.05
0.809
1419084_a_at Pcp2
Guanine nucleotide exchange factor
5.81
0.807
1439849_at
Gm12824
Unknown
6.90
0.807
1417561_at
Apoc1
Cholesterol metabolism; Amyloid regulation
7.18
0.807
1439575_at
Tmem232
Unknown
6.07
0.807
1433678_at
Pld4
Transmembrane glycoprotein, microglial expression
8.44
0.807
1419456_at
Dcxr
Diacetyl reductase
8.47
0.807
1433155_at
B230204H03Rik Unknown
4.31
0.807
1454595_at
4930451E06Rik Unknown
4.31
0.807
1437178_at
Gm149
Unknown
3.27
0.807
1428145_at
Acaa2
Acetyl-CoA acyltransferase; fatty acid biosynthesis
9.52
0.807
1438974_x_at Pitpnm1
Cytoskeletal remodeling, phosphoinositide signaling
7.68
0.803
1424969_s_at Upp2
Nucleotide biosynthesis; UDP synthesis
7.46
0.803
1429239_a_at Stard4
Cholesterol metabolism
6.20
0.803
1433667_at
Lgi3
Amyloid regulation; neurite outgrowth
10.60
0.803
1431917_at
Pigq
GPI-anchor biosynthesis; UDP-GlcNAc transfer to PI
5.73
0.803
1442851_at
C79818
Unknown
3.81
0.803
1445789_at
--Unknown
5.05
0.803
1431839_a_at Ccdc81
Unknown
6.19
0.803
1455568_at
Ccdc74a
Unknown
9.08
0.803
1417990_at
Ppp1r14d
Protein phosphatase 1 inhibitor, PKC-activated and PKA-inactivated
4.13
0.803
1423596_at
Nek6
Serine/threonine kinase
10.10
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% change
-21%
-20%
-15%
-12%
-24%
-17%
-15%
-24%
-21%
-15%
-13%
-22%
-21%
-19%
-15%
-15%
-14%
-13%
-12%
-21%
-30%
-27%
-24%
-21%
-19%
-19%
-18%
-16%
-16%
-14%
-13%
-13%
-10%
-14%
-11%
-10%
-18%
-16%
-16%
-22%
-20%
-20%
-19%
-16%
-16%
-15%
-12%
-10%
-8%
-28%
-18%
-18%
-16%
-15%
-15%
-14%
-13%
-13%
-12%

Table S3. Genes common to FC and HC 80% confidence lists
Gene Symbol
Adhfe1
Arr3
Ccl6
Chi3l1
Crebbp
Cth
Cyp11a1
Cyp4f14
Efcab6
Emp2
Nqo1
Papss2
Pxmp2
Selenbp1
Slc25a34
Tbx1
Tekt5

Probe set
1424392_at
1424392_at
1425232_x_at
1450329_a_at
1417266_at
1417266_at
1451537_at
1451537_at
1459804_at
1459804_at
1426243_at
1426243_at
1439947_at
1439947_at
1419559_at
1419559_at
1453766_a_at
1453766_a_at
1433670_at
1433670_at
1423627_at
1423627_at
1421987_at
1421987_at
1417841_at
1417841_at
1417580_s_at
1417580_s_at
1455506_at
1455506_at
1425779_a_at
1425779_a_at
1429355_at
1429355_at

Molecular role
Alcohol dehydrogenase, GHB metabolism

Source
HC
FC30m
Beta-adrenergic signaling
HC
FC30m
Cytokine, inflammatory response
HC
FC30m
Inflammatory response, extracellular matrix remodeling
HC
FC30m
Transcriptional co-activator #NOTE#
HC
FC30m
Sulfate and Selenium assimulation, cysteine synthesis
HC
FC30m
Steriod hormone biosynthesis, cholesterol metabolism
HC
FC30m
Eicosanoid metabolism
HC
FC30m
Calcium-binding transcriptional co-repressor
HC
FC30m
Transmembrane glycoprotein associated with beta-integrinHC
FC30m
Positive regulator of translation; quinone detoxification
HC
FC30m
Sulfate and Selenium assimulation, cys and met synthesis HC
FC30m
Peroxisomal pore protein
HC
FC30m
Selenium-binding, intraGolgi transport
HC
FC30m
Mitochondrial solute carrier protein
HC
FC30m
DNA-binding transcription factor
HC
FC30m
Unknown
HC
FC30m
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Confidence
0.818
0.848
0.91
0.829
0.987
0.989
0.925
0.835
0.993
0.995
0.987
0.992
0.891
0.936
0.89
0.973
0.993
0.903
0.874
0.995
0.98
0.995
0.995
0.95
0.948
0.928
0.937
0.975
0.995
0.995
0.975
0.826
0.94
0.956

Wt(Log2)
9.71
9.35
4.36
4.85
8.76
8.44
9.65
8.93
8.41
8.20
7.89
7.95
8.29
8.64
7.73
7.04
8.02
6.98
9.78
9.43
9.27
9.08
6.89
6.63
9.26
8.86
10.06
9.66
7.99
7.55
5.65
6.26
7.23
6.66

% change
-18%
-20%
-25%
-21%
-24%
-21%
-15%
-21%
-37%
-43%
-24%
-26%
-17%
-21%
-21%
-23%
-25%
-26%
-18%
-32%
-20%
-30%
-42%
-37%
-20%
-18%
-21%
-29%
-43%
-35%
-25%
-21%
-31%
-26%

Table S4. Probe sets with >80% FC confidence and <20% HC confidence
Probe set
1449369_at
1447705_at
1430104_at
1438334_at
1452930_at
1433143_at
1449476_at
1432810_at
1449277_at
1457346_at
1452601_a_at
1424509_at
1439385_x_at
1446590_at
1458098_at
1445748_at
1427287_s_at
1454595_at
1437178_at
1417990_at
1445789_at
1431839_a_at
1420782_at
1419692_a_at
1431781_at
1452904_at
1452600_at
1423698_at
1425159_at
1451853_at
1435677_at
1432569_at
1418712_at
1424412_at
1431588_at
1419519_at
1419619_at
1435582_at
1432939_at
1434129_s_at
1429248_at
1417756_a_at
1419084_a_at
1428145_at
1439849_at
1433678_at
1442851_at
1431917_at
1429239_a_at
1432336_at
1436464_at
1447678_at
1418486_at
1423596_at
1439575_at
1455568_at
1417420_at
1439669_at
1438974_x_at
1431001_at
1424401_at
1422269_at
1426031_a_at
1424783_a_at
1457873_at
1449430_a_at
1423693_at
1452823_at
1430107_at
1434988_x_at
1425226_x_at
1444291_at
1426260_a_at
1417561_at

Gene Symbol
Tmprss2
Nsl1
Rspo2
Dock2
Dock3
9230118N17Rik
Stk30
Ttc32
Ccl19
--Acbd6
Cd177
Slc13a3
------Itpr2
4930451E06Rik
Gm149
Ppp1r14d
--Ccdc81
Tnfrsf17
Ltc4s
Ypel1
1700026L06Rik
Taf6l
Ncaph2
Golt1a
Fktn
C85492
Cby3
Cdc42ep5
Ogfrl1
--Igf1
Krt80
Wdfy4
5730405N03Rik
Lhfpl2
2810002N01Rik
Lsp1
Pcp2
Acaa2
Gm12824
Pld4
C79818
Pigq
Stard4
5033404E19Rik
--Hsd17b14
Vnn1
Nek6
Tmem232
Ccdc74a
Ccnd1
6430571L13Rik
Pitpnm1
9030624J02Rik
Aldh1l1
Insm2
Nfatc2
Ugt1a1
--Treh
Cela1
Gstk1
Acbd7
Aldh2
LOC665506
Lysmd4
Ugt1a1
Apoc1

Molecular role
FC Confidence
Serine protease
94.0%
Kinetochore component
91.6%
Wnt signaling
89.8%
Guanine nucleotide exchange factor, microglial innate immunity 89.8%
Guanine nucleotide exchange factor, regulates axon outgrowth
89.4%
Unknown
87.8%
Serine/threonine kinase, MAPK superfamily
87.4%
Unknown
87.0%
Cytokine, inflammatory response
84.9%
Unknown
84.5%
Acyl-CoA-binding protein with unknown function
83.1%
GPI-anchored glycoprotein, inflammatory response
83.1%
Sodium/dicarboxylate symporter
82.5%
Unknown
82.5%
Unknown
81.6%
Unknown
81.3%
Inositol triphosphate receptor
81.3%
Unknown
80.7%
Unknown
80.7%
Protein phosphatase 1 inhibitor, PKC-activated and PKA-inactivated80.3%
Unknown
80.3%
Unknown
80.3%
TNF receptor superfamily, inflammatory response
97.3%
Eicosanoid metabolism
90.1%
Unknown
89.8%
Unknown
89.8%
Transcription factor, associated with P/CAF complexes
89.7%
Mitotic chromosome assembly
87.8%
Vesicle transport
87.4%
Putative glycosyltransferase
84.8%
Putative glycosyltransferase
84.8%
Similar to inhibitor of Wnt signaling
84.1%
Rho-GTPase interacting protein, cytoskeletal remodeling
83.5%
Putative neuropeptide receptor
83.1%
Unknown
82.9%
Neuropeptide
82.8%
Cytoskeletal protein
82.5%
Unknown
81.6%
Unknown
81.6%
Tetraspan transmembrane protein
81.6%
Unknown
81.3%
Cytoskeletal remodeling
80.9%
Guanine nucleotide exchange factor
80.9%
Acetyl-CoA acyltransferase; fatty acid biosynthesis
80.7%
Unknown
80.7%
Transmembrane glycoprotein, microglial expression
80.7%
Unknown
80.3%
GPI-anchor biosynthesis; UDP-GlcNAc transfer to PI
80.3%
Cholesterol metabolism
80.3%
Unknown
90.3%
Unknown
82.5%
Steriod hormone metabolism
95.0%
GPI-anchored pantetheinase
80.9%
Serine/threonine kinase
80.3%
Unknown
80.7%
Unknown
80.3%
Cyclin D1
97.5%
Unknown
82.5%
Cytoskeletal remodeling, phosphoinositide signaling
80.7%
Unknown
89.8%
Aldehyde dehydrogenase, cytoskeletal remodeling
83.1%
UNKNOWN?
82.8%
DNA-binding transcription factor, axonal growth
82.8%
Steriod hormone metabolism; UDP glucuronosyltransferase
82.6%
Unknown
92.1%
Carbohydrate metabolism
82.5%
Serine protease, extracellular matrix remodeling
81.6%
Oxidative stress response, detoxification
90.3%
Acyl-CoA-binding protein with unknown function
83.5%
Aldehyde dehydrogenase, acetyl-CoA synthesis
82.6%
Simlar to T-cell beta-2 chain
90.3%
Unknown
89.7%
Steriod hormone metabolism; UDP glucuronosyltransferase
90.3%
Cholesterol metabolism; Amyloid regulation
80.7%

164

FC change
-17.35%
-19.73%
-13.74%
-15.10%
-13.29%
-12.55%
-9.17%
-14.31%
-30.16%
-15.21%
-6.98%
-15.50%
-13.81%
-14.77%
-13.62%
-14.04%
-10.34%
-15.50%
-11.57%
-13.14%
-14.71%
-13.70%
-26.84%
-12.34%
-14.07%
-24.24%
-13.11%
-11.35%
-16.37%
-14.37%
-11.45%
-16.27%
-12.73%
-8.75%
-20.38%
-23.65%
-22.12%
-12.99%
-12.60%
-10.36%
-10.93%
-16.00%
-15.77%
-10.18%
-21.90%
-19.05%
-15.43%
-15.85%
-17.76%
-20.22%
-12.84%
-21.26%
-17.87%
-11.80%
-20.12%
-13.29%
-16.63%
-12.13%
-8.48%
-13.84%
-21.81%
-14.82%
-16.60%
-24.08%
-21.58%
-14.58%
-19.44%
-13.42%
-19.35%
-12.60%
-34.18%
-16.79%
-25.49%
-20.46%

HC confidence
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.6%
5.8%
6.2%
6.4%
7.1%
8.1%
8.7%
8.8%
9.0%
9.3%
9.3%
10.2%
10.2%
10.2%
11.2%
11.2%
13.3%
14.2%
14.2%
15.5%
16.4%
16.4%
17.6%
17.6%
18.2%
19.8%

HC change
2.01%
7.03%
2.68%
0.75%
3.81%
1.38%
1.18%
1.43%
5.61%
3.84%
0.74%
0.14%
7.69%
2.54%
2.49%
9.54%
0.20%
2.66%
0.06%
1.43%
2.80%
2.42%
-4.49%
-0.96%
-1.29%
-1.03%
-0.89%
-0.97%
-0.46%
-1.13%
-1.52%
-2.24%
-2.11%
-1.94%
-2.83%
-5.38%
-7.06%
-2.34%
-2.14%
-1.10%
-0.81%
-5.64%
-1.71%
-1.59%
-4.86%
-2.40%
-3.44%
-0.89%
-0.82%
-5.83%
-5.75%
-5.85%
-6.78%
-5.36%
-9.81%
-6.67%
-5.19%
-5.37%
-4.80%
-6.67%
-9.93%
-5.78%
-7.04%
-10.14%
-9.81%
-7.98%
-8.47%
-8.88%
-10.09%
-5.73%
-12.70%
-6.75%
-10.91%
-9.18%

Chapter 6. Conclusions

NR4A function contributes to hippocampus-dependent memory consolidation.
Transgenic expression of a dominant negative NR4A protein in forebrain neurons
selectively impairs long-term contextual fear memory without affecting short-term or
cued fear memory (Chapter 3, Fig. 7). These data suggest that NR4A signaling
contributes to the formation of long-term memories. Consistent with this interpretation,
reduced Nr4a2 expression by antisense injection into the hippocampus (Colon-Cesario
et al. 2006) or by heterozygous deletion of Nr4a2 (Rojas et al. 2007) is accompanied by
defects in hippocampus-dependent memory. As the defects are seen in hippocampusdependent tasks, it will be important to extend our studies of the Nr4a dominant negative
(Nr4aDN) mice to other hippocampus-dependent tasks, such as spatial object
recognition. A concern with the dominant negative strategy that was employed in our
studies is the possibility of off-target effects. This specificity concern is allayed to some
extent by results of loss-of-function approaches discussed above (Colon-Cesario et al.
2006; Rojas et al. 2007) but needs to be further addressed. Two approaches will
alleviate these concerns. First, a cell-type and brain-region specific loss of function
approach would greatly aid the study of NR4A function in memory formation. Second,
rescue of the deficit in memory in Nr4aDN mice by overexpression of Nr4a genes would
demonstrate that the defect in memory formation in these mice is a consequence of
reduced NR4A signaling rather than off-target effects.
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NR4A signaling is required for memory enhancement by HDAC inhibitors.
Impeding NR4A signaling in the hippocampus using a dominant negative approach
blocks memory enhancement by intrahippocampal administration of HDAC inhibitors
(Chapter 3, Fig. 7). This finding strongly supports involvement of increased Nr4a
expression after HDAC inhibitor treatment (Vecsey et al. 2007) in the enhancement of
memory by HDAC inhibitors. It is possible that increasing NR4A signaling alone may be
sufficient to enhance long-term memory, but the present studies do not rule out the
possibility that other signaling cascades need to be activated in parallel by HDAC
inhibition to improve long-term memory. Viral overexpression experiments represent a
promising avenue to distinguish these possibilities with the added benefit of allowing the
redundancy of individual NR4A family members in memory formation to be examined.
An important caveat in these future studies is that immediate-early gene activation
occurs only in select neurons after learning (Chapter 1, Figures 6 and 7), so the
increase in Nr4a expression by HDAC inhibitors may also be regulated in a neuronspecific fashion. Thus, it may be critical to increase NR4A signaling only in the
appropriate activity-stimulated subset of neurons to enhance memory. Alternatively,
increasing NR4A signaling may bias neural network to incorporate these neurons into
representations, an effect observed with viral overexpression of CREB (Han et al. 2007)
that would obviate activity-selective targeting.

In addition to addressing the sufficiency of NR4A signaling for memory enhancement, it
is important to understand the generality of this mechanism, especially in non-aversive
memory tasks. As described in Chapter 4, long-term memory in the incidentally encoded
object location task is enhanced by post-training intrahippocampal HDAC administration
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(Figure 1). Future studies should examine whether NR4A signaling is required for
memory enhancement in this task.

Nr4a2 is regulated by opposing activity of CBP-dependent activation and Sin3amediated repression. Within the Nr4a gene family, Nr4a2 expression is tightly
regulated by the opposing activity of CBP KIX domain-mediated activating complexes
and SIN3A-coordinated class I HDAC complexes (Chapter 3, Figures 2 to 5). Because
NR4A signaling is a result of interactions among all three NR4A proteins (Chapter 2,
Figure 2), the role of each Nr4a gene in memory formation and enhancement by HDAC
inhibitors should be examined. Yet, the requirement for CBP KIX domain interactions
(Vecsey et al. 2007) and the proposed role of class I HDACs in memory enhancement
by HDAC inhibitors (Chapter 4, Figure 2) suggest that Nr4a2 is the most promising
candidate within this family.

Involvement of class I HDACs in memory enhancement by HDAC inhibitors.
Deletion of Sin3a from forebrain neurons enhances long-term contextual fear memory
and increases expression of Nr4a2 (Chapter 3, Figure 5). SIN3A is a co-repressor that
links the targeting function of transcription repressors with the repressive capacity of the
class I HDACs HDAC1 and HDAC2. The consequences of Sin3a loss on memory
formation are consistent with the observation that post-training intrahippocampal
inhibition of class I HDACs with MS-275 enhances long-term object location memory
(Chapter 4, Figure 2). Yet, it will be important to bridge the divide between these
observations.

Future

directions

will

include

determining

whether

post-training

intrahippocampal MS-275 administration improves contextual fear memory and
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enhances Nr4a2 expression. In parallel, it will be useful to test whether Sin3a deletion
enhances object location memory.

The efficacy of class I-selective HDAC inhibitors and Sin3a deletion for memory
enhancement together suggest that either HDAC1 or HDAC2 is a critical target of HDAC
inhibition for memory enhancement. Several lines of evidence support HDAC2 rather
than HDAC1 as the key player in this phenotype. Of these two proteins, HDAC2 is the
predominant form in adult neurons (MacDonald and Roskams 2008). Pan-neuronal
overexpression of HDAC2 impairs long-term memory, whereas neuronal overexpression
of HDAC1 does not (Guan et al. 2009). Also, constitutive knockout of HDAC2 improves
performance in measures of long-term memory, but HDAC1 knockout does not (Guan et
al. 2009). In future studies, combining pharmacological approaches with genetic ablation
of HDAC2 selectively within postnatal forebrain neurons will help to cement the
conclusion that HDAC2 function is a central memory suppressor gene (Abel et al. 1998).

CBPkix/kix memory deficit is accompanied by reduced expression of learninginduced CREB target genes that contribute to memory formation. The histone
acetyltransferase activity of CBP is targeted to genes by interactions with transcription
factors, such as the interaction with phosphorylated CREB via the kinase-inducible
interaction (KIX) domain (Bedford et al. 2010). This particular interaction domain is
important for the formation of long-term memories (Wood et al. 2006) and the
enhancement of these memories by HDAC inhibitors (Vecsey et al. 2007). Unbiased
genome-wide analysis of gene expression in CBPkix/kix mice (Chapter 5) identified a
variety of genes with impaired expression as a result of KIX domain mutation, including
at least five genes that are induced by learning (Pena de Ortiz et al. 2000; Keeley et al.
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2006): Btg2, Emp2, Dusp1, Fos, and Nr4a2. In addition to being learning-induced genes,
Fos, Btg2, and Nr4a2 have each been identified as genes with impaired induction in
CREB mutant mice (Lemberger et al. 2008).

Of these five genes, mice bearing mutations in Fos (Fleischmann et al. 2003; Gass et al.
2004), Btg2 (Farioli-Vecchioli et al. 2009), and Nr4a2 (Rojas et al. 2007) have defects in
long-term memory, and the other two genes have hallmarks of memory-regulating
genes. Dusp1 encodes a phosphatase that negatively regulates MAPK signaling by
inactivating nuclear ERK (Reffas and Schlegel 2000), and Dusp1-mediated inactivation
of JNK is required for BDNF-induced axonal branching (Jeanneteau et al. 2010). Emp2
encodes a transmembrane protein that regulates cell-surface expression of GPIanchored proteins and integrins (Wadehra et al. 2005). A cadre of lipid-binding proteins
was identified by functional analysis of the genome-wide analysis described in Chapter
5, including GPI-anchored membrane-associated proteins. It is possible that these lipidbinding proteins contribute to spine remodeling in conjunction with EMP2. Interestingly,
EMP2 regulates the activity of focal adhesion kinase (FAK) (Morales et al. 2009), a
kinase that contributes to the stability of mature dendritic spines (Shi et al. 2009). Nr4a2
is a strong candidate for mediating the memory-enhancing effects of HDAC inhibitors
(Chapter 3). Yet, as discussed above, other parallel pathways may also contribute to
this enhancement, and the other four learning-induced, KIX domain-dependent genes
should be considered in this role.

Conclusion. The identification of NR4A signaling as an integral part of memory
formation and the enhancement in memory by HDAC inhibitors represents a substantial
advance in understanding the mechanisms of memory formation. This work has moved
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the field beyond the phenomenological observation that HDAC inhibitors enhance
memory to the mechanistic realization that NR4A signaling lies at the crux between the
two known opposing functional contributions of histone acetylation to memory formation,
CBP-dependent

transcriptional

activation

and

HDAC-mediated

transcriptional

repression. Two very specific mechanisms regulating histone acetylation, KIX domainmediated CBP recruitment and SIN3A-mediated HDAC recruitment, converge to control
Nr4a2 expression after learning. Regulation of NR4A signaling by these two processes
may modulate memory through NR4A target genes, such as Bdnf. Future studies will
address the role of individual Nr4a genes in memory formation, the sufficiency of
increased NR4A signaling for memory enhancement, and the contribution of NR4A
targets to memory enhancement by HDAC inhibitors. The potential involvement of NR4A
signaling in schizophrenia (Buervenich et al. 2000; Xing et al. 2006; Rojas et al. 2007)
suggests that modulating this pathway may provide an avenue to ameliorate the
intractable cognitive symptoms associated with this disorder.
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